Document:

EX-4.4

 Exhibit 4.4 

Execution 
 FIFTH
AMENDED AND RESTATED SHAREHOLDERS AGREEMENT 
 THIS FIFTH AMENDED AND RESTATED SHAREHOLDERS AGREEMENT (this
“Agreement”) is entered into on September 25, 2020 (the “Effective Date”), by and among: 
  

	1.	 Exacloud Limited, an exempted company incorporated under the Laws of the Cayman Islands (the
“Company”); 

  

	2.	 Mr. Xiaohuang Huang (黄晓煌), a
citizen of the PRC with the identification card number *** (“Mr. Huang”); 

  

	3.	 Mr. Hang Chen (陈航), a citizen of
the PRC with the identification card number *** (“Mr. Chen”); 

  

	4.	 Mr. Hao Zhu (朱皓), a citizen of the
PRC with the identification card number *** (“Mr. Zhu”, together with Mr. Huang and Mr. Chen, each a “Founder” and collectively, the “Founders”); 

 

	5.	 Exacloud (Hong Kong) Limited, a company organized and existing under the Laws of Hong Kong and wholly owned by
the Company (the “HK Company”); 

  

	6.	 Hangzhou Yunjiazhuang Network Technology Co., Ltd.
(杭州云家装网络科技有限公司), a limited liability company organized and existing under the Laws of the PRC and
wholly owned by the HK Company (the “WFOE”); 

  

	7.	 Shanghai Kujiale Network Technology Co., Ltd.
(上海酷家乐网络科技有限公司), a limited liability company organized and exiting under the Laws of the PRC and
wholly owned by the WFOE (the “WFOE’s Subsidiary”); 

  

	8.	 Hangzhou QunHe Information Technology Co., Ltd.
(杭州群核信息技术有限公司), a limited liability company organized and existing under the Laws of the PRC (the
“Domestic Company”); 

  

	9.	 Shanghai Modai Internet Technology Co., Ltd.
(上海模袋网络科技有限公司), a limited liability company organized and existing under the Laws of the PRC
(“Shanghai Modai”); 

  

	10.	 Shanghai Mengdai Network Technology Co., Ltd.
(上海蒙袋网络科技有限公司), a limited liability company organized and existing under the Laws of the PRC
(“Shanghai Mengdai”); and 

  

	11.	 Mountain Glacier Investments Ltd.
(冰川山脉投资有限公司), a company incorporated under the Laws of the British Virgin Islands (the “Key Ordinary
Shareholder”); 

  

	12.	 Aquanauts 3820 III L.P., an exempted limited partnership organized and existing under the laws of the Cayman
Islands (“Aquanauts”); 

	13.	 IDG Technology Venture Investment IV, L.P., a limited partnership organized under the Laws of the State of
Delaware (“IDG Venture IV”); 

  

	14.	 IDG Technology Venture Investment V, L.P., a limited partnership organized and existing under the laws of the
State of Delaware (“IDG Venture V”, together with IDG Venture IV, collectively, “IDG”); 

  

	15.	 New Gultar Limited, a corporation established and existing under the laws of British Virgin Islands
(“New Gultar”); 

  

	16.	 GGV Capital V L.P., a limited partnership organized under the Laws of the State of Delaware;

  

	17.	 GGV Capital V Entrepreneurs Fund L.P., a limited partnership organized under the Laws of the State of Delaware;

  

	18.	 Shanghai Yuanyan Enterprise Management Consulting Partnership (Limited Partnership) (上海源彦企业管理咨询合伙企业(有限合伙)), a limited partnership established
in the PRC (“Shanghai Yuanyan”, together with GGV Capital V L.P. and GGV Capital V Entrepreneurs Fund L.P., collectively, “GGV”); 

 

	19.	 Matrix Partners China III Hong Kong Limited, a company duly incorporated under the Laws of Hong Kong
(“Matrix”); 

  

	20.	 Linear Venture, Ltd., a company organized in the Cayman Islands (“Linear”);

  

	21.	 Yun Qi Partners I, L.P., an exempted limited partnership organized in the Cayman Islands (“Yun
Qi”); 

  

	22.	 HES Ventures I, Inc., a Delaware corporation (“HES”); 

 

	23.	 Hearst Ventures Inc., a Delaware corporation (“Hearst”); 

 

	24.	 Qingting Investments Pte. Ltd., a private company limited by shares organized in Singapore
(“Qingting”); 

  

	25.	 Shunwei Growth III Limited, a company incorporated under the Laws of the British Virgin Islands
(“Shunwei”); 

  

	26.	 HH SUM-I Holdings Limited, an exempted company organized in the Cayman
Islands together with its successors and assigns and transferees, (“Hillhouse”); 

  

	27.	 Coatue PE Asia 36 LLC, a company duly incorporated under the Laws of the State of Delaware (together with its
successors, assigns and permitted transferees, “Coatue”, and together with IDG, GGV, Shunwei, Linear, Matrix, Yun Qi, HES, Hearst, Qingting, Shanghai Yuanyan, New Gultar and Hillhouse, collectively, the “Investors”
and each, an “Investor”). 

 Each of the parties listed above referred to herein individually as a
“Party” and collectively as the “Parties”. 

  
 2 

 This Agreement shall be effective as to all Parties as of the Effective Date. 

Capitalized terms used herein without definition shall have the meanings set forth in the Series E Purchase Agreement (as defined below). 

RECITALS 
  

	A	 The Company, the Founders, the HK Company, the WFOE, the WFOE’s Subsidiary, the Domestic Company, the Key
Ordinary Shareholder, Coatue, Hillhouse, Shunwei, New Gultar, Shanghai Yuanyan and certain other parties have entered into a Series E Preferred Share Purchase Agreement (the “Series E Purchase Agreement”) on September 25, 2020,
pursuant to which Coatue, Hillhouse, Shunwei, New Gultar and Shanghai Yuanyan agreed to, severally and not jointly, purchase from the Company, and the Company has agreed to sell to such parties, certain Series E Preferred Shares of the Company on
the term and conditions set forth therein. 

  

	B	 The Series E Purchase Agreement provides that it shall be a condition precedent to the consummation of the
transactions contemplated under the Series E Purchase Agreement that the Parties have entered into this Agreement. 

  

	C	 It is in the interests of the Company and its shareholders to secure the consummation of the transactions
contemplated under the Series E Purchase Agreement, and it is in the interests of the Parties hereto to regulate the rights and obligations among the Parties as contemplated hereunder. 

 

	D	 The Company, the HK Company, the WFOE, the WFOE’s Subsidiary, the Domestic Company, the Founders, the Key
Ordinary Shareholder, IDG, GGV, Matrix, Yun Qi, HES, Hearst, Shunwei, Hillhouse, Shanghai Yuanyan and certain other Parties entered into a Fourth Amended and Restated Shareholders Agreement dated August 12, 2019 (the “Prior
Agreement”). 

  

	E	 The Parties now wish to amend and restate the Prior Agreement in its entirety as contemplated herein.

  

	F	 The undersigned represent the Company, all Founders, and the requisite holders of the Series A Preferred
Shares, the Series A-1 Preferred Shares, the Series B Preferred Shares, the Series C Preferred Shares, the Series D Preferred Shares, the Series D+ Preferred Shares and the Ordinary Shares, and, by entry
hereinto, the requisite parties to the Prior Agreement have consented to the amendment and restatement of the Prior Agreement, satisfying the requirements set forth in Section 13.11 thereof for amendment of the Prior
Agreement. 

 WITNESSETH 

NOW, THEREFORE, in consideration of the foregoing recitals, the mutual promises hereinafter set forth, and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties intending to be legally bound hereto hereby agree as follows: 
  

	1.	 Definitions. 

1.1    The following terms shall have the meanings ascribed to them below: 

“Accounting Standards” means PRC GAAP, US GAAP, IFRS or such other accounting standards acceptable to the Supermajority
Preferred Holders, as applicable, applied on a consistent basis. 

  
 3 

 “Affiliate” means, (i) in the case of a Person other than a natural
person, any other Person that, directly or indirectly, Controls, is Controlled by or is under common Control with such Person; and (ii) in the case of a natural person, any other Person that directly or indirectly is Controlled by such Person
or is a Relative of such Person. In the case of an Investor, the term “Affiliate” also includes (v) any shareholder of the Investor, (w) any of such shareholder’s or Investor’s general partners or limited partners,
(x) the fund manager managing such shareholder or Investor (and general partners, limited partners and officers thereof) and other funds managed by such fund manager, and (y) trusts controlled by or for the benefit of any such Person
referred to in (v), (w) or (x). With respect to Hillhouse, “Affiliate” shall also include (i) any Controlling shareholder of Hillhouse, (ii) any entity or individual which has a direct or indirect Controlling interest in such
Controlling shareholder referred to in (i) above (including, any general partner or limited partner, or any fund manager thereof, if any) or any fund manager thereof; (iii) any Person that directly or indirectly Controls, is Controlled by,
under common Control with, or is managed by Hillhouse, any Controlling shareholder or any fund manager referred to in (i) and (ii) above, (iv) a child, brother, sister, parent, or spouse of any individual referred to in (ii) above,
and (v) any trust controlled by or held for the benefit of such persons referred to in (i) to (iv) above. With respect to Coatue, “Affiliate” shall also include (i) any Controlling shareholder of Coatue, (ii) any entity
or individual which has a direct or indirect Controlling interest in such Controlling shareholder referred to in (i) above (including, any general partner or limited partner, or any fund manager thereof, if any) or any fund manager thereof;
(iii) any Person that directly or indirectly Controls, is Controlled by, under common Control with, or is managed by Coatue, any Controlling shareholder or any fund manager referred to in (i) and (ii) above, (iv) a child, brother,
sister, parent, or spouse of any individual referred to in (ii) above, and (v) any trust controlled by or held for the benefit of such persons referred to in (i) to (iv) above. 

“Applicable Securities Laws” means (i) with respect to any offering of securities in the United States, or any other act
or omission within that jurisdiction, the securities laws of the United States, including the Exchange Act and the Securities Act, and any applicable Law of any state of the United States, and (ii) with respect to any offering of securities in
any jurisdiction other than the United States, or any related act or omission in that jurisdiction, the applicable Laws of that jurisdiction. 

“Associate” means, with respect to any Person, (1) a corporation or organization (other than the Group Companies) of
which such Person is an officer or partner or is, directly or indirectly, the beneficial owner of ten percent (10%) or more of any class of Equity Securities of such corporation or organization, (2) any trust or other estate in which such
Person has a substantial beneficial interest or as to which such Person serves as trustee or in a similar capacity, or (3) any relative or spouse of such Person, or any relative of such spouse. 

“Big 4” means any of Pricewaterhouse Coopers, KPMG International, Deloitte Touche Tohmatsu, or Ernst & Young, or any
successor company thereto. 
 “Board” or “Board of Directors” means the board of directors of the Company.

  
 4 

 “Business Day” means any day that is not a Saturday, Sunday, legal
holiday or other day on which commercial banks are required or authorized by law to be closed in (v) the Cayman Islands, with respect to any action to be undertaken or notice to be given in the Cayman Islands, or (w) the PRC, the U.S.,
Ireland, or Hong Kong, with respect to any action to be undertaken or notice to be given in such jurisdiction. 
 “CFC”
means a controlled foreign corporation as defined in the Code. 
 “Charter Documents” means, with respect to a particular
legal entity, the articles of incorporation, certificate of incorporation, formation or registration (including, if applicable, certificates of change of name), memorandum of association, articles of association, bylaws, articles of organization,
certificate of formation, limited liability company agreement, trust deed, trust instrument, operating agreement, joint venture agreement, business license, or similar or other constitutive, governing, or charter documents, or equivalent documents,
of such entity. 
 “Closing” shall have the meaning set forth in the Series E Purchase Agreement. 

“Code” means the United States Internal Revenue Code of 1986, as amended. 

“Commission” means (i) with respect to any offering of securities in the United States, the Securities and Exchange
Commission of the United States or any other federal agency at the time administering the Securities Act, and (ii) with respect to any offering of securities in a jurisdiction other than the United States, the regulatory body of the
jurisdiction with authority to supervise and regulate the offering or sale of securities in that jurisdiction. 
 “Consent”
means any consent, approval, authorization, release, waiver, permit, grant, franchise, concession, agreement, license, exemption or order of, registration, certificate, declaration or filing with, or report or notice to, any Person, including any
Governmental Authority. 
 “Control” of a given Person means the power or authority, whether exercised or not, to direct
the business, management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by Contract or otherwise (including via a VIE structure); provided, that such power or authority shall conclusively be
presumed to exist upon possession of beneficial ownership or power to direct the vote of more than fifty percent (50%) of the votes entitled to be cast at a meeting of the members or shareholders of such Person or power to control the composition of
a majority of the board of directors of such Person. The terms “Controlled” and “Controlling” have meanings correlative to the foregoing. 

“Control Documents” has the meaning ascribed thereto in the Series E Purchase Agreement. 

“Conversion Shares” means Ordinary Shares issuable upon conversion of any Preferred Shares. 

“Director” means a director serving on the Board. 

“Dragging Parties” means, collectively, (a) the Supermajority Preferred Holders (which shall include the Majority Series
E Holders), and (g) the Majority Ordinary Holders. 
 “Equity Securities” means, with respect to any Person that is a
legal entity, any and all shares of capital stock, membership interests, units, profits interests, ownership interests, equity interests, registered capital, and other equity securities of such Person, and any right, warrant, option, call,
commitment, conversion privilege, preemptive right or other right to acquire any of the foregoing, or security convertible into, exchangeable or exercisable for any of the foregoing, or any Contract providing for the acquisition of any of the
foregoing. 

  
 5 

 “Exchange Act” means the United States Securities Exchange Act of 1934, as
amended. 
 “Form F-3” means Form F-3
promulgated by the Commission under the Securities Act or any successor form or substantially similar form then in effect. 
 “Form S-3” means Form S-3 promulgated by the Commission under the Securities Act or any successor form or substantially similar form then in effect. 

“GGV Convertible Loan Agreement” means the Convertible Loan Agreement
(可转债协议) by and among the Domestic Company, the Founders and GGV RMB Investor dated
September 25, 2020. 
 “GGV RMB Investor” means Xiamen Jiyuan Ronghui Investment Managing Partnership (Limited
Partnership) (厦门纪源融汇投资管理合伙企业(有限合伙)). 
 “GGV Warrant” means a warrant issued by the Company to
Shanghai Yuanyan at the Closing, under which Shanghai Yuanyan shall have the right to purchase up to 1,911,967 newly issued Series E Preferred Shares (as adjusted pursuant to share dividend, split, combination, recapitalization and other similar
transactions) from the Company. 
 “Governmental Authority” means any government of any nation or any federation, province
or state or any other political subdivision thereof, any entity, authority or body exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government, including any government authority, agency,
department, board, commission or instrumentality of any country, or any political subdivision thereof, any court, tribunal or arbitrator, and any self-regulatory organization. 

“Governmental Order” means any applicable order, ruling, decision, verdict, decree, writ, subpoena, mandate, precept,
command, directive, consent, approval, award, judgment, injunction or other similar determination or finding by, before or under the supervision of any Governmental Authority. 

“Group Company” shall have the meaning ascribed thereto in the Series E Purchase Agreement, and “Group”
refers to all of the Group Companies collectively. 
 “Holders” means the holders of Registrable Securities who are parties
to this Agreement from time to time, and their permitted transferees that become parties to this Agreement from time to time. 

“Hong Kong” means the Hong Kong Special Administrative Region, the People’s Republic of China. 

“IFRS” means the International Financial Reporting Standards, as amended. 

“IDG Convertible Loan Agreement” means the Convertible Loan Agreement
(可转债协议) by and among the Domestic Company, the Founders and IDG RMB Investors dated
September 25, 2020 

  
 6 

 “IDG RMB Investors” means Henan Province He Xie Jin Yu Industrial
Investment Fund (Limited Partnership)(河南省和谐锦豫产业投资基金(有限合伙)), Suzhou Jin Yu Equity Investment Fund Partnership (Limited
Partnership)(苏州锦虞股权投资基金合伙企业(有限合伙)), Suzhou Ai Qi Jin Su Equity Investment Fund Partnership (Limited
Partnership)(苏州爱奇锦苏股权投资基金合伙企业(有限合伙)
), Suzhou Jin Wu Equity Invsetment Fun Partnership (Limited
Partnership)(苏州锦吴股权投资基金合伙企业(有限合伙)), collectively. 
 “IDG Warrant” means a warrant issued by the
Company to New Gultar at the Closing, under which New Gultar shall have the right to purchase up to 9,559,832 newly issued Series E Preferred Shares (as adjusted pursuant to share dividend, split, combination, recapitalization and other similar
transactions) from the Company. 
 “Indebtedness” of any Person means, without duplication, each of the following of such
Person: (i) all indebtedness for borrowed money, (ii) all obligations issued, undertaken or assumed as the deferred purchase price of property or services (other than trade payables entered into in the ordinary course of business), (iii)
all reimbursement or payment obligations with respect to letters of credit, surety bonds and other similar instruments, (iv) all obligations evidenced by notes, bonds, debentures or similar instruments, including obligations so evidenced that
are incurred in connection with the acquisition of properties, assets or businesses, (v) all indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as financing, in either case with respect to
any property or assets acquired with the proceeds of such indebtedness (even though the rights and remedies of the seller or bank under such agreement in the event of default are limited to repossession or sale of such property), (vi) all
obligations that are capitalized in accordance with the Accounting Standards, (vii) all obligations under banker’s acceptance, letter of credit or similar facilities, (viii) all obligations to purchase, redeem, retire, defease or
otherwise acquire for value any Equity Securities of such Person, (ix) all obligations in respect of any interest rate swap, hedge or cap agreement, and (x) all guarantees issued in respect of the Indebtedness referred to in clauses
(i) through (ix) above of any other Person, but only to the extent of the Indebtedness guaranteed. 
 “Initiating
Holders” means, with respect to a request duly made under Section 2.1 or Section 2.2 to Register any Registrable Securities, the Holders initiating such request. 

“Intellectual Property” means any and all (i) patents, patent rights and applications therefor and reissues,
reexaminations, continuations, continuations-in-part, divisions, and patent term extensions thereof, (ii) inventions (whether patentable or not), discoveries,
improvements, concepts, innovations and industrial models, (iii) registered and unregistered copyrights, copyright registrations and applications, mask works and registrations and applications therefor, author’s rights and works of
authorship (including artwork, software, computer programs, source code, object code and executable code, firmware, development tools, files, records and data, and related documentation), (iv) URLs, web sites, web pages and any part thereof,
(v) technical information, know-how, trade secrets, drawings, designs, design protocols, specifications, proprietary data, customer lists, databases, proprietary processes, technology, formulae, and
algorithms, (vi) trade names, trade dress, trademarks, domain names, service marks, logos, business names, and registrations and applications therefor, and (vii) the goodwill symbolized or represented by the foregoing. 

  
 7 

 “IPO” means the first firm underwritten registered public offering by the
Company of its Ordinary Shares pursuant to a Registration Statement that is filed with and declared effective by either the Commission under the Securities Act or another Governmental Authority for a public offering in a jurisdiction other than the
United States. 
 “Key Employee” shall have the meaning as defined in the Series E Purchase Agreement. 

“Law” or “Laws” means any and all provisions of any applicable constitution, treaty, statute, law,
regulation, ordinance, code, rule, or rule of common law, any governmental approval, concession, grant, franchise, license, agreement, directive, requirement, or other governmental restriction or any similar form of decision of, or determination by,
or any interpretation or administration of any of the foregoing by, any Governmental Authority, in each case as amended, and any and all applicable Governmental Orders. 

“Lien” means any claim, charge, easement, encumbrance, lease, covenant, security interest, lien, option, pledge, rights of
others, or restriction (whether on voting, sale, transfer, disposition or otherwise), whether imposed by Contract, understanding, law, equity or otherwise. 

“Majority Ordinary Holders” means the holders of more than fifty percent (50%) of the voting power of the then outstanding
Ordinary Shares held by the Founders. 
 “Majority Series D+ Holders” means the holders of more than sixty-one (61%) of the voting power of the then outstanding Series D+ Preferred Shares (voting together as a single class and to the exclusion of other classes and series of Shares). 

“Majority Series E Holders” means the holders of at least two thirds (2/3) of the voting power of the then outstanding Series
E Preferred Shares. 
 “Memorandum and Articles” means the Seventh Amended and Restated Memorandum of Association of the
Company and the Seventh Amended and Restated Articles of Association of the Company, as each may be amended and/or restated from time to time. 

“Ordinary Holders” means, collectively, the Founders, the Key Ordinary Shareholder, Aquanauts and any Person who directly or
indirectly holds any Ordinary Shares, Class A Ordinary Shares or Class B Ordinary Shares (each as defined in the Memorandum and Articles) (if applicable) of the Company, and each an “Ordinary Holder”; for the avoidance of
doubt “Ordinary Holders” shall not include any Investor or any holder of any Conversion Shares. 
 “Ordinary Share
Equivalents” means any Equity Security which is by its terms convertible into or exchangeable or exercisable for Ordinary Shares or other share capital of the Company, including without limitation, the Preferred Shares. 

“Ordinary Shares” means the Company’s ordinary shares, par value US$0.000025 per share. 

  
 8 

 “Person” means any individual, corporation, partnership, limited
partnership, proprietorship, association, limited liability company, firm, trust, estate or other enterprise or entity. 

“PFIC” means passive foreign investment company as defined in the Code. 

“PRC” means the People’s Republic of China, but solely for the purposes of this Agreement, excluding Hong Kong, the
Macau Special Administrative Region and the islands of Taiwan. 
 “PRC GAAP” means generally accepted accounting principles
in PRC, as in effect from time to time. 
 “Preferred Shares” means, collectively, the Series A Preferred Shares, the
Series A-1 Preferred Shares, the Series B Preferred Shares, the Series C Preferred Shares, the Series D Preferred Shares,the Series D+ Preferred Shares and the Series E Preferred Shares. 

“Public Official” means any executive, official, or employee of a Governmental Authority, political party or member of a
political party, political candidate; executive, employee or officer of a public international organization; or director, officer or employee or agent of a wholly owned or partially state-owned or controlled enterprise, including a PRC state-owned
or controlled enterprise. 
 “Qualified IPO” has the meaning given to such term in the Memorandum and Articles. 

“Registrable Securities” means (i) the Ordinary Shares issued or issuable upon conversion of the Preferred Shares,
(ii) any Ordinary Shares of the Company issued or issuable as a dividend or other distribution with respect to, in exchange for, or in replacement of, the shares referenced in (i) herein, and (iii) any Ordinary Shares owned or
hereafter acquired by any Investor; excluding in all cases, however, any of the foregoing sold by a Person in a transaction other than an assignment pursuant to Section 13.3. For purposes of this Agreement, Registrable
Securities shall cease to be Registrable Securities when such Registrable Securities have been disposed of pursuant to an effective Registration Statement. 

“Registration” means a registration effected by preparing and filing a Registration Statement and the declaration or ordering
of the effectiveness of that Registration Statement; and the terms “Register” and “Registered” have meanings concomitant with the foregoing. 

“Registration Statement” means a registration statement prepared on Form F-1, F-3, S-1, or S-3 under the Securities Act (including, without limitation, Rule 415 under the Securities Act), or on any comparable form
in connection with registration in a jurisdiction other than the United States. 
 “Relative” of an individual means a
husband, wife, father, mother, son, daughter, brother, sister, grandparent, grandchild of such individual, or spouse of any of these, or any other person living in the same household with such individual. 

“Related Party” means any Affiliate, officer, director, supervisory board member, employee, or holder of any Equity Security
of any Group Company, and any Affiliate or Associate of any of the foregoing. 
 “Right of First Refusal & Co-Sale Agreement” has the meaning ascribed thereto in the Series E Purchase Agreement, as amended from time to time. 

  
 9 

 “Restricted Shares Agreement” has the meaning ascribed thereto in the
Series E Purchase Agreement, as amended from time to time. 
 “SAFE” means the State Administration of Foreign Exchange of
the PRC. 
 “SAMR” shall mean, the State Administration for Market Regulation of the PRC or, with respect to the issuance
of any business license or filing or registration to be effected by or with the State Administration for Market Regulation, any Governmental Authority which is similarly competent to issue such business license or accept such filing or registration
under the laws of the PRC. 
 “Securities Act” means the United States Securities Act of 1933, as amended. 

“Series A Preferred Shares” means the Series A Preferred Shares of the Company, par value US$0.000025 per share, with the
rights and privileges as set forth in the Memorandum and Articles. 
 “Series A-1 Preferred
Shares” means the Series A-1 Preferred Shares of the Company, par value US$0.000025 per share, with the rights and privileges as set forth in the Memorandum and Articles. 

“Series A Purchase Agreement” means that certain Share Purchase Agreement, dated December 13, 2013, by and among the
Company, the HK Company, the Domestic Company, the WFOE, and certain other parties named therein, for the sale and issuance of certain Series A Preferred Shares. 

“Series B-1 Preferred Shares” means the Series
B-1 Preferred Shares of the Company, par value US$0.000025 per share, with the rights and privileges as set forth in the Memorandum and Articles. 

“Series B-2 Preferred Shares” means the Series
B-2 Preferred Shares of the Company, par value US$0.000025 per share, with the rights and privileges as set forth in the Memorandum and Articles. 

“Series B Preferred Shares” means, collectively, the Series B-1 Preferred Shares and
the Series B-2 Preferred Shares. 
 “Series B Purchase Agreement” means that
certain Share Purchase Agreement, dated August 29, 2014, by and among the Company, the HK Company, the Domestic Company, the WFOE, and certain other parties named therein, for the sale and issuance of certain Series B Preferred Shares. 

“Series C Preferred Shares” means the Series C Preferred Shares of the Company, par value US$0.000025 per share, with the
rights and privileges as set forth in the Memorandum and Articles. 
 “Series C Purchase Agreement” means that certain
Share Purchase Agreement, dated December 29, 2016, by and among the Company, the HK Company, the Domestic Company, the WFOE, and certain other parties named therein, for the sale and issuance of certain Series C Preferred Shares. 

  
 10 

 “Series D Preferred Shares” means, the Series D-1 Preferred Shares and/or the Series D-2 Preferred Shares (as the case may be). 

“Series D-1 Preferred Shares” means, collectively, the Series D-1 Preferred Shares of the Company, par value US$0.000025 per share, with the rights and privileges as set forth in the Memorandum and Articles. 

“Series D-2 Preferred Shares” means the Series
D-2 Preferred Shares of the Company, par value US$0.000025 per share, with the rights and privileges as set forth in the Memorandum and Articles. 

“Series D Purchase Agreement” means that certain Series D Share Purchase Agreement, dated January 26, 2018, by and among
the Company, the HK Company, the Domestic Company, the WFOE, and certain other parties named therein, for the sale and issuance of certain Series D Preferred Shares. 

“Series D+ Preferred Shares” means, collectively, the Series D+1 Preferred Shares and the Series D+2 Preferred Shares. 

“Series D+1 Preferred Shares” means the Series D+1 Preferred Shares of the Company, par value US$0.000025 per share, with the
rights and privileges as set forth in the Memorandum and Articles. 
 “Series D+2 Preferred Shares” means the Series D+2
Preferred Shares of the Company, par value US$0.000025 per share, with the rights and privileges as set forth in the Memorandum and Articles. 

“Series D+ Purchase Agreement” means that certain Series D+ Purchase Agreement, dated August 12, 2019, by and among the
Company, the HK Company, the Domestic Company, the WFOE, and certain other parties named therein, for the sale and issuance of certain Series D+ Preferred Shares. 

“Series E Preferred Shares” means the Series E Preferred Shares of the Company, par value US$0.000025 per share, with the
rights and privileges as set forth in the Memorandum and Articles. 
 “Shanghai Yuanyan” means Shanghai Yuanyan Enterprise
Management Consulting Partnership (Limited Partnership)
(上海源彦企业管理咨询合伙企业(有限合伙)). 
 “Shares” means the Ordinary Shares and the Preferred
Shares. 
 “Subsidiary” means, with respect to any given Person, any other Person that is Controlled directly or indirectly
by such given Person. 
 “Supermajority Preferred Holders” means the holder(s) of at least 2/3 of the voting power of the
then outstanding Preferred Shares (voting together as a single class and to the exclusion of other classes and series of Shares). 

  
 11 

 “Trade Sale” means any the following events: 

(1)    any consolidation, merger, amalgamation, scheme of arrangement, or reorganization of any Group Company with or into
any other Person or other corporate reorganization, in which the shareholders of such Group Company immediately prior to such consolidation, merger, amalgamation, scheme of arrangement or reorganization, own less than a majority of such Group
Company’s voting power in the aggregate immediately after such consolidation, merger, amalgamation, scheme of arrangement or reorganization, or any transaction or series of related transactions in which no less than fifty percent (50%) of such
Group Company’s voting power is transferred; 
 (2)    a sale, transfer, lease or other disposition of all or
substantially all of the assets of any Group Company (or any series of related transactions resulting in such sale, transfer, lease or other disposition of all or substantially all of the assets of such Group Company); or 

(3)    the exclusive licensing of all or substantially all of any Group Company’s intellectual property to a third
party. 
 “Transaction Documents” has the meaning set forth in the Series E Purchase Agreement. 

“U.S.” means the United States of America. 

“United States Person” means United States person as defined in Section 7701(a)(30) of the Code. 

“Warrant” means either the GGV Warrant or the IDG Warrant. 

“US GAAP” means U.S. generally accepted accounting principles. 

1.2    Other Defined Terms. The following terms shall have the meanings defined for such terms in the
Sections set forth below: 
  

			
	Additional Number	  	Section 7.4 (ii)
	Agreement	  	Preamble
	Approved Sale	  	Section 11.1
	Arbitration Notice	  	Section 13.5 (i)
	Auditors	  	Section 8.1(i)
	Circular 37	  	Section 12.17
	Company	  	Preamble
	Coatue Director	  	Section 9.1 (iii)
	Corporate Opportunity	  	Section 12.28(iii)
	Competitors	  	Section 8.1
	Confidential Information	  	Section 12.13 (i)
	Direct US Investor	  	Section 12.11 (iii)
	Disclosing Party	  	Section 12.13 (iii)
	Dispute	  	Section 13.5 (i)
	Dissenting Member	  	Section 11.5
	Domestic Company	  	Preamble
	Domestic Equity Transfer	  	Section 12.3
	Effective Date	  	Preamble
	ESIP	  	Section 12.1
	Exempt Registrations	  	Section 3.4

  
 12 

			
	First Participation Notice	  	Section 7.4 (i)
	Founder/Founders	  	Preamble
	GGV	  	Preamble
	GGV Director	  	Section 9.1(i)
	HES	  	Preamble
	Hearst	  	Preamble
	Hillhouse	  	Preamble
	Hillhouse Director	  	Section 9.1 (ii)
	HK Company	  	Preamble
	HKIAC	  	Section 13.5 (ii)
	HKIAC Rules	  	Section 13.5 (ii)
	IDG	  	Preamble
	IDG Director	  	Section 9.1(i)
	IDG Venture IV	  	Preamble
	IDG Venture V	  	Preamble
	Indirect US Investor	  	Section 12.11 (iii)
	Investors/Investor	  	Preamble
	Investor Director(s)	  	Section 9.1(i)
	Key Ordinary Shareholder	  	Preamble
	Majority Ordinary Director	  	Section 9.1(i)
	Matrix	  	Preamble
	Meeting Notice	  	Section 9.3
	Mr. Chen	  	Preamble
	Mr. Huang	  	Preamble
	Mr. Zhu	  	Preamble
	New Entity	  	Section 8.3(i)
	New Securities	  	Section 7.3
	Observer	  	Section 9.1(iii)
	Oversubscription Participant	  	Section 7.4 (ii)
	Party/Parties	  	Preamble
	PFIC Annual Information Statement	  	Section 12.11(iii)
	PFIC Shareholder	  	Section 12.11 (iii)
	Prior Agreement	  	Recitals
	Preemptive Right	  	Section 7.1
	Preemptive Rights Holder	  	Section 7.1
	Pro Rata Share	  	Section 7.2
	Qingting	  	Preamble
	Remaining Members	  	Section 11.2
	Restricted Business	  	Section 12.9
	Restricted Investment	  	Section 8.1
	SAFE Rules and Regulations	  	Section 12.17
	Second Participation Notice	  	Section 7.4 (ii)
	Second Participation Period	  	Section 7.4 (ii)
	Security Holder	  	Section 12.17
	Selling Investor	  	Section 12.12(ii)
	Series A/A-1 Investment Amount	  	Section 12.12(ii)
	Series C Investment Amount	  	Section 12.12(ii)
	Series D Investment Amount	  	Section 12.12(ii)
	Series D+ Investment Amount	  	Section 12.12(ii)
	Series E Investment Amount	  	Section 12.12(ii)
	Series E Purchase Agreement	  	Recitals
	Subsidiary Board	  	Section 9.1 (ii)
	Shunwei	  	Preamble
	Shunwei Director	  	Section 9.1(i)
	Transfer	  	Section 12.14
	Violation	  	Section 5.1(i)
	WFOE	  	Preamble
	WFOE’s Subsidiary	  	Preamble
	Yun Qi	  	Preamble

  
 13 

 1.3    Interpretation. For all purposes of this Agreement,
except as otherwise expressly herein provided, (i) the terms defined in this Section 1 shall have the meanings assigned to them in this Section 1 and include the plural as well as the
singular, (ii) all accounting terms not otherwise defined herein have the meanings assigned under the Accounting Standards, (iii) all references in this Agreement to designated “Sections” and other subdivisions are to the
designated Sections and other subdivisions of the body of this Agreement, (iv) pronouns of either gender or neuter shall include, as appropriate, the other pronoun forms, (v) the words “herein”, “hereof” and
“hereunder” and other words of similar import refer to this Agreement as a whole and not to any particular Section or other subdivision, (vi) all references in this Agreement to designated Schedules, Exhibits and Appendices are to the
Schedules, Exhibits and Appendices attached to this Agreement, (vii) references to this Agreement, any other Transaction Documents and any other document shall be construed as references to such document as the same may be amended, supplemented
or novated from time to time, (viii) the term “or” is not exclusive, (ix) the term “including” will be deemed to be followed by “, but not limited to,” (x) the terms “shall”, “will”, and
“agrees” are mandatory, and the term “may” is permissive, (xi) the phrase “directly or indirectly” means directly, or indirectly through one or more intermediate Persons or through contractual or other
arrangements, and “direct or indirect” has the correlative meaning, (xii) the expression “Investors”, “Ordinary Holder”, “Holder” and “Founder” shall, unless the context prohibits, include its
respective successors, permitted transferees and assigns and any Persons deriving title under it, (xiii) the term “voting power” refers to the number of votes attributable to the Shares (on an
as-converted basis) in accordance with the terms of the Memorandum and Articles, (xiv) the headings used in this Agreement are used for convenience only and are not to be considered in construing or
interpreting this Agreement, (xv) references to laws include any such law modifying, re-enacting, extending or made pursuant to the same or which is modified,
re-enacted, or extended by the same or pursuant to which the same is made, (xvi) all references to dollars or to “US$” are to the currency of the United States of America and all references to
RMB are to currency of the PRC (and each shall be deemed to include reference to the equivalent amount in other currencies) and (xvii) the term “Ordinary Shares” (a) under the phrase “holders of Ordinary Shares that were
converted from Preferred Shares”, “Ordinary Shares issued or issuable upon conversion of the Preferred Shares”, “conversion of such Preferred Shares into Ordinary Shares”, if any, or (b) issuable under any other
scenarios as a result of the conversion of Preferred Shares shall mean Ordinary Shares or Class A Ordinary Shares upon the closing of a Qualified IPO (if applicable). 

  
 14 

	2.	 Demand Registration. 

2.1    Registration Other Than on Form F-3 or Form S-3. Subject to the terms of this Agreement, at any time or from time to time after the earlier of (i) the date that is three (3) years after August 29, 2014 or (ii) the date that is one
hundred and eighty (180) days after the closing of the IPO, Holders holding ten percent (10%)or more of the voting power of the then outstanding Registrable Securities held by all Holders are entitled to request in writing that the Company
effect a Registration of each Initiating Holder’s Registrable Securities or any lesser percentage of each Initiating Holder’s Registrable Securities if the anticipated gross receipts from the offering (of the Registrable Securities that
the Initiating Holders and other Holders elect to include in such Registration) exceed US$5,000,000 on any internationally recognized exchange that is reasonably acceptable to such requesting Holders. Upon receipt of such a request, the Company
shall (x) promptly give written notice of the proposed Registration to all other Holders and (y) as soon as practicable, use its reasonable best efforts to cause the Registrable Securities specified in the request, together with any
Registrable Securities of any Holder who requests in writing to join such Registration within fifteen (15) days after the Company’s delivery of written notice, to be Registered and/or qualified for sale and distribution in such
jurisdiction as the Initiating Holders may request. The Company shall not be obligated to effect more than three (3) Registrations pursuant to this Section 2.1 that have been declared and ordered effective; provided
that if the sale of all of the Registrable Securities sought to be included pursuant to this Section 2.1 is not consummated for any reason other than solely due to the action or inaction of the Holders including Registrable
Securities in such Registration, such Registration shall not be deemed to constitute one of the Registration rights granted pursuant to this Section 2.1. 

2.2    Registration on Form F-3 or Form
S-3. The Company shall use its best efforts to qualify for registration on Form F-3 or Form S-3. Subject to the terms
of this Agreement, if the Company qualifies for registration on Form F-3 or Form S-3 (or any comparable form for Registration in a jurisdiction other than the United
States), any Holder is entitled to request the Company to file, in any jurisdiction in which the Company has had a registered underwritten public offering, unlimited number of Registration Statements on Form
F-3 or Form S-3 (or any comparable form for Registration in a jurisdiction other than the United States), including without limitation any registration statements filed
under the Securities Act providing for the registration of, and the sale on a continuous or a delayed basis by the Holders of, all of the Registrable Securities pursuant to Rule 415 under the Securities Act and/or any similar rule that may be
adopted by the Commission, provided that the anticipated gross receipts of such Holder from the sale of Registrable Securities sought to be included in such Registration Statement shall exceed US$500,000. Upon receipt of such a request, the Company
shall (i) promptly give written notice of the proposed Registration to all other Holders and (ii) as soon as practicable, cause the Registrable Securities specified in the request, together with any Registrable Securities of any Holder who
requests in writing to join such Registration within fifteen (15) days after the Company’s delivery of written notice, to be Registered and qualified for sale and distribution in such jurisdiction. The Company shall be obligated to effect
no more than two (2) Registrations that have been declared and ordered effective within any twelve (12)-month period pursuant to this Section 2.2; provided that if the sale of all of the Registrable Securities sought
to be included pursuant to this Section 2.2 is not consummated for any reason other than solely due to the action or inaction of the Holders including Registrable Securities in such Registration, such Registration shall not
be deemed to constitute one of the Registration rights granted pursuant to this Section 2.2. 

  
 15 

 2.3    Right of Deferral. 

(i)    The Company shall not be obligated to Register or qualify Registrable Securities pursuant to this
Section 2: 
 (1)    during the period starting with the date of filing by the
Company of, and ending six (6) months following the effective date of any Registration Statement pertaining to Ordinary Shares of the Company other than an Exempt Registration, provided, that the Holders are entitled to join such Registration
in accordance with Section 3; 
 (2)    in any jurisdiction in which the
Company would be required to execute a general consent to service of process in effecting such Registration or qualification, unless the Company is already subject to service of process in such jurisdiction; or 

(3)    with respect to the registration on Form F-3 or Form S-3 (or any comparable form for Registration in a jurisdiction other than the United States), if Form F-3 or Form S-3 (or any comparable form for Registration in a
jurisdiction other than the United States) (as the case may be) is not available for such offering by the Holders. 

(ii)    If, after receiving a request from Holders pursuant to Section 2.1 or
Section 2.2 hereof, the Company furnishes to the Holders a certificate signed by the chief executive officer of the Company stating that, in the good faith judgment of the Board, it would be materially detrimental to the
Company or its members for a Registration Statement to be filed in the near future, then the Company shall have the right to defer such filing for a period during which such filing would be materially detrimental, provided, that the Company
may not utilize this right (x) for a Registration under Section 2.1 for more than ninety (90) days and (y) for a Registration under Section 2.2 for more than sixty (60) days, on
any one occasion or more than once during any twelve (12) month period; provided, further, that the Company may not Register any other its Securities during such period (except for Exempt Registrations). 

2.4    Underwritten Offerings. If, in connection with a request to Register Registrable Securities under
Section 2.1 or Section 2.2, the Initiating Holders seek to distribute such Registrable Securities in an underwritten offering, they shall so advise the Company as a part of the request, and the
Company shall include such information in the written notice to the other Holders described in Section 2.1 and Section 2.2. In such event, the right of any Holder to include its Registrable
Securities in such Registration shall be conditioned upon such Holder’s participation in such underwritten offering and the inclusion of such Holder’s Registrable Securities in the underwritten offering (unless otherwise mutually agreed by
the Initiating Holders and such Holder) to the extent provided herein. All Holders proposing to distribute their securities through such underwritten offering shall enter into an underwriting agreement in customary form with the underwriter or
underwriters of internationally recognized standing selected for such underwritten offering by the Company and reasonably acceptable to the holders of two-thirds (2/3) of the voting power of all Registrable
Securities proposed to be included in such Registration. Notwithstanding any other provision of this Agreement, if the managing underwriter advises the Company that marketing factors (including without limitation the aggregate number of securities
requested to be Registered, the general condition of the market, and the status of the Persons proposing to sell securities pursuant to the Registration) require a limitation of the number of Registrable Securities to be underwritten in a
Registration pursuant to Section 2.1 or Section 2.2, the underwriters may exclude up to seventy-five percent (75%) of the Registrable Securities requested to be Registered but only after first
excluding all other Equity Securities from the Registration and underwritten offering, including, without limitation, all shares that are not Registrable Securities and are held by any other Person, including, without limitation, any Person who is
an employee, officer or director of the Company or any subsidiary of the Company, provided, that the number of shares to be included in the Registration on behalf of the non-excluded Holders is
allocated among all Holders in proportion, as nearly as practicable, to the respective amounts of Registrable Securities requested by such Holders to be included. If any Holder disapproves the terms of any underwriting, the Holder may elect to
withdraw therefrom by written notice to the Company and the underwriters delivered at least ten (10) days prior to the effective date of the Registration Statement. Any Registrable Securities excluded or withdrawn from such underwritten
offering shall be withdrawn from the Registration. To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriters may round the number of shares allocated to a Holder to the nearest one hundred
(100) shares. 

  
 16 

 2.5    IPO Purchase Right. Subject to applicable law and
regulations, each Investor shall have the right to purchase or direct its Affiliate to purchase, at its option, at the final price per share set forth in the Company’s final prospectus with respect to an IPO, up to the number of the Ordinary
Shares of the Company offered in the IPO that enable such Investor to maintain, in the aggregate, its percentage ownership interest in the Company immediately prior to the consummation of the IPO, provided that such IPO Purhcase Right as provided in
this Section 2.5 shall not adversely affect the consummation of such IPO. 
 2.6    IPO Participation
Right. Notwithstanding Section 3.3(i) below, if any Equity Securities of the Company are offered in an underwritten public offering (whether or not a Qualified IPO) for the account of any shareholder of the Company,
each Investor shall have the right to include a pro rata number of shares in the offering on terms and conditions no less favourable to such Investor than to any other selling shareholder(s), provided that such IPO Participation Right as provided in
this Section 2.6 shall not adversely affect the consummation of such underwritten public offering. 
  

	3.	 Piggyback Registrations. 

3.1    Registration of the Company’s Securities. Subject to the terms of this Agreement,
if the Company proposes to Register for its own account any of its Equity Securities, or for the account of any holder (other than a Holder) of Equity Securities any of such holder’s Equity Securities, in connection with the public offering of
such securities (except for Exempt Registrations), the Company shall promptly give each Holder written notice of such Registration and, upon the written request of any Holder given within fifteen (15) days after delivery of such notice, the
Company shall include in such Registration any Registrable Securities thereby requested to be Registered by such Holder. If a Holder decides not to include all or any of its Registrable Securities in such Registration by the Company, such Holder
shall never 
 theless continue to have the right to include any Registrable Securities in any subsequent Registration Statement or
Registration Statements as may be filed by the Company, all upon the terms and conditions set forth herein. 

3.2    Right to Terminate Registration. The Company shall have the right to terminate or withdraw any
Registration initiated by it under Section 3.1 prior to the effectiveness of such Registration, whether or not any Holder has elected to participate therein. The expenses of such withdrawn Registration shall be borne by the
Company in accordance with Section 4.3. 

  
 17 

 3.3    Underwriting Requirements. 

(i)    In connection with any offering involving an underwriting of the Company’s Equity Securities, the Company
shall not be required to Register the Registrable Securities of a Holder under this Section 3 unless such Holder’s Registrable Securities are included in the underwritten offering and such Holder enters into an
underwriting agreement in customary form with the underwriter or underwriters of internationally recognized standing selected by the Company and setting forth such terms for the underwritten offering as have been agreed upon between the Company and
the underwriters. In the event the underwriters advise Holders seeking Registration of Registrable Securities pursuant to this Section 3 in writing that market factors (including the aggregate number of Registrable
Securities requested to be Registered, the general condition of the market, and the status of the Persons proposing to sell securities pursuant to the Registration) require a limitation of the number of Registrable Securities to be underwritten, the
underwriters may exclude up to seventy-five percent (75%) of the Registrable Securities requested to be Registered but only after first excluding all other Equity Securities (except for securities sold for the account of the Company) from the
Registration and underwriting, including, without limitation, all shares that are not Registrable Securities and are held by any other Person, including, without limitation, any Person who is an employee, officer or director of the Company or any
subsidiary of the Company, provided, that the number of shares to be included in the Registration on behalf of the non-excluded Holders is allocated among all Holders in proportion, as nearly as
practicable, to the respective amounts of Registrable Securities requested by such Holders to be included. To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriters may round the number of shares
allocated to a Holder to the nearest one hundred (100) shares. 
 (ii)    If any Holder disapproves the terms of
any underwriting, the Holder may elect to withdraw therefrom by written notice to the Company and the underwriters delivered at least ten (10) days prior to the effective date of the Registration Statement. Any Registrable Securities excluded
or withdrawn from the underwritten offering shall be withdrawn from the Registration. 
 3.4    Exempt
Registrations. The Company shall have no obligation to Register any Registrable Securities under this Section 3 in connection with a Registration by the Company (i) relating solely to the sale of securities to
participants in a Company share incentive plan that has been approved with the requisite prior written consents in accordance with Section 10, or (ii) relating to a corporate reorganization or other transaction under Rule 145 of the
Securities Act (or comparable provision under the Laws of another jurisdiction, as applicable) (collectively, “Exempt Registrations”). 
  

	4.	 Registration Procedures. 

4.1    Registration Procedures and Obligations. Whenever required under this Agreement to effect the
Registration of any Registrable Securities held by the Holders, the Company shall, as expeditiously as reasonably possible: 

(i)    Prepare and file with the Commission a Registration Statement with respect to those Registrable Securities and use
its reasonable best efforts to cause that Registration Statement to become effective, and, upon the request of the Holders holding two-thirds (2/3) in voting power of the Registrable Securities Registered
thereunder, keep the Registration Statement effective until the distribution thereunder has been completed; 

(ii)    Prepare and file with the Commission amendments and supplements to that Registration Statement and the prospectus
used in connection with the Registration Statement as may be necessary to comply with the provisions of Applicable Securities Laws with respect to the disposition of all securities covered by the Registration Statement; 

  
 18 

 (iii)    Furnish to the Holders the number of copies of a prospectus,
including a preliminary prospectus, required by Applicable Securities Laws, and any other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; 

(iv)    Use its reasonable best efforts to Register and qualify the securities covered by the Registration Statement
under the securities Laws of any jurisdiction, as reasonably requested by the Holders, provided, that the Company shall not be required to qualify to do business or file a general consent to service of process in any such jurisdictions; 

(v)    In the event of any underwritten public offering, enter into and perform its obligations under an underwriting
agreement, in customary form, with the managing underwriter(s) of the offering; 
 (vi)    Promptly notify each Holder
of Registrable Securities covered by the Registration Statement at any time when a prospectus relating thereto is required to be delivered under Applicable Securities Laws of (a) the issuance of any stop order by the Commission, or (b) the
happening of any event or the existence of any condition as a result of which any prospectus included in the Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be
stated therein or necessary to make the statements therein not misleading in the light of the circumstances under which they were made, or if in the opinion of counsel for the Company it is necessary to supplement or amend such prospectus to comply
with law, and at the request of any such Holder promptly prepare and furnish to such Holder a reasonable number of copies of a supplement to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of
such securities, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances under
which they were made or such prospectus, as supplemented or amended, shall comply with law; 
 (vii)    Furnish, at the
request of any Holder requesting Registration of Registrable Securities pursuant to this Agreement, on the date that such Registrable Securities are delivered for sale in connection with a Registration pursuant to this Agreement, (A) an
opinion, dated the date of the sale, of the counsel representing the Company for the purposes of the Registration, in form and substance as is customarily given to underwriters in an underwritten public offering; and (B) comfort letters dated
as of (x) the effective date of the registration statement covering such Registrable Securities, and (y) the closing date of the sale of the Registrable Securities, from the independent certified public accountants of the Company, in form
and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the underwriters; 

(viii)    Otherwise comply with all applicable rules and regulations of the Commission to the extent applicable to the
applicable registration statement and use its reasonable best efforts to make generally available to its security holders (or otherwise provide in accordance with Section 11(a) of the Securities Act) an earnings statement satisfying the
provisions of Section 11(a) of the Act, no later than forty-five (45) days after the end of a twelve (12) month period (or ninety (90) days, if such period is a fiscal year) beginning with the first month of the Company’s
first fiscal quarter commencing after the effective date of such registration statement, which statement shall cover such twelve (12) month period, subject to any proper and necessary extensions; 

  
 19 

 (ix)    Not, without the written consent of the holders of at least two
thirds of voting power of the then outstanding Registrable Securities, make any offer relating to the Securities that would constitute a “free writing prospectus,” as defined in Rule 405 promulgated under the Act; 

(x)    Provide a transfer agent and registrar for all Registrable Securities Registered pursuant to the Registration
Statement and, where applicable, a number assigned by the Committee on Uniform Securities Identification Procedures for all those Registrable Securities, in each case not later than the effective date of the Registration; 

(xi)    Cooperate with each Holder of Registrable Securities covered by the registration statement and each underwriter
or agent participating in the disposition of such Registrable Securities and their respective counsel in connection with any filings required to be made with FINRA; and 

(xii)    Take all reasonable action necessary to list the Registrable Securities on the primary exchange on which the
Company’s securities are then traded or, in connection with a Qualified IPO, the primary exchange on which the Company’s securities will be traded. 

4.2    Information from Holder. It shall be a condition precedent to the obligations of the Company to take
any action pursuant to Section 2 and Section 3 hereof with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding
itself, the Registrable Securities held by it, and the intended method of disposition of such securities as shall be required to effect the Registration of such Holder’s Registrable Securities. 

4.3    Expenses of Registration. All expenses, other than the underwriting discounts and selling
commissions applicable to the sale of Registrable Securities pursuant to this Agreement (which shall be borne by the Holders requesting Registration on a pro rata basis in proportion to their respective numbers of Registrable Securities sold in such
Registration), incurred in connection with Registrations, filings or qualifications pursuant to this Agreement, including (without limitation) all Registration, filing and qualification fees, printers’ and accounting fees, fees and
disbursements of counsel for the Company and reasonable fees and disbursement of one counsel for all selling Holders, shall be borne by the Company. The Company shall not, however, be required to pay for any expenses of any Registration proceeding
begun pursuant to Section 2.1 or Section 2.2 of this Agreement if the Registration request is subsequently withdrawn at the request of the Holders holding
two-thirds (2/3) of the voting power of the Registrable Securities requested to be Registered by all Holders in such Registration (in which case all participating Holders shall bear such expenses pro rata
based upon the number of Registrable Securities that were to be thereby Registered in the withdrawn Registration) unless the Holders of at least two thirds (2/3) of the voting power of the Registrable Securities then outstanding agree that such
registration constitutes the use by the Holders of one (1) demand registration pursuant to Section 2.1 (in which case such registration shall also constitute the use by all Holders of Registrable Securities of one
(1) such demand registration); provided, however, that if at the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business or prospects of the Company from that known to the Holders at the time of
their request and have withdrawn the request with reasonable promptness following disclosure by the Company of such material adverse change, then the Holders shall not be required to pay any of such expenses and the Company shall pay any and all
such expenses. 

  
 20 

	5.	 Registration-Related Indemnification. 

5.1    Company Indemnity. 

(i)    To the maximum extent permitted by Law and the Memorandum and Articles, the Company will indemnify and hold
harmless each Holder, such Holder’s partners, officers, directors, shareholders, members, and legal counsel, any underwriter (as defined in the Securities Act) and each Person, if any, who controls (as defined in the Securities Act) such Holder
or underwriter, against any losses, claims, damages or liabilities (joint or several) to which they may become subject under Laws which are applicable to the Company and relate to action or inaction required of the Company in connection with any
Registration, qualification, or compliance, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (each a
“Violation”): (a) any untrue statement or alleged untrue statement of a material fact contained in such Registration Statement (unless Holder is actually aware of and consent to the making of such untrue statement or alleged untrue
statement) , on the effective date thereof (including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto), (b) the omission or alleged omission to state in the Registration Statement, on
the effective date thereof (including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto), a material fact required to be stated therein or necessary to make the statements therein not
misleading, or (c) any violation or alleged violation by the Company of Applicable Securities Laws, or any rule or regulation promulgated under Applicable Securities Laws. The Company will reimburse, as incurred, each such Holder, underwriter
or controlling person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action. 

5.2    Holder Indemnity. 

(i)    To the maximum extent permitted by Law, each selling Holder that has included Registrable Securities in a
Registration will, severally and not jointly, indemnify and hold harmless the Company, its directors and officers, any other Holder selling securities in connection with such Registration and each Person, if any, who controls (within the meaning of
the Securities Act) the Company, or such other Holder, against any losses, claims, damages or liabilities (joint or several) to which any of the foregoing persons may become subject, under Applicable Securities Laws, or any rule or regulation
promulgated under Applicable Securities Laws, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such
Violation occurs solely in reliance upon and in conformity with written information furnished by such Holder for use in connection with such Registration; and each such Holder will reimburse, as incurred, any Person intended to be indemnified
pursuant to this Section 5.2, for any legal or other expenses reasonably incurred by such Person in connection with investigating or defending any such loss, claim, damage, liability or action. No Holder’s liability
under this Section 5.2 (when combined with any amounts paid by such Holder pursuant to Section 5.4) shall exceed the net proceeds received by such Holder from the offering of securities made in
connection with that Registration. 
 (ii)    The indemnity contained in this Section 5.2
shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder (which consent shall not be unreasonably withheld or delayed). 

  
 21 

 5.3    Notice of Indemnification Claim. Promptly after
receipt by an indemnified party under Section 5.1 or Section 5.2 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect
thereof is to be made against any indemnifying party under Section 5.1 or Section 5.2, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party
shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the indemnifying parties.
An indemnified party (together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the reasonably incurred fees and expenses to be paid by the
indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by
such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if prejudicial to its ability to defend such action, shall relieve such indemnifying
party, to the extent so prejudiced, of any liability to the indemnified party under this Section 5, but the omission to deliver written notice to the indemnifying party will not relieve it of any liability that it may have
to any indemnified party otherwise than under this Section 5. No indemnifying party, in the defense of any such claim or litigation, shall, except with the consent of each indemnified party, consent to entry of any judgment
or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or the plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation. 

5.4    Contribution. If any indemnification provided for in Section 5.1 or
Section 5.2 is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to herein, the indemnifying party, in lieu of
indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect the relative fault
of the indemnifying party, on the one hand, and of the indemnified party, on the other, in connection with the statements or omissions that resulted in such loss, liability, claim, damage or expense, as well as any other relevant equitable
considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material
fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission; provided,
however, that, in any such case: (A) no Holder will be required to contribute any amount (after combined with any amounts paid by such Holder pursuant to Section 5.2) in excess of the net proceeds to such Holder
from the sale of all such Registrable Securities offered and sold by such Holder pursuant to such registration statement; and (B) no person or entity guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) will be entitled to contribution from any person or entity who was not guilty of such fraudulent misrepresentation. 

5.5    Underwriting Agreement. To the extent that the provisions on indemnification and contribution
contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 

  
 22 

 5.6    Survival. The obligations of the Company and
Holders under this Section 5 shall survive the completion of any offering of Registrable Securities in a Registration Statement under this Agreement, regardless of the expiration of any statutes of limitation or extensions
of such statutes. 
  

	6.	 Additional Registration-Related Undertakings. 

6.1    Reports under the Exchange Act. With a view to making available to the Holders the benefits of Rule
144 promulgated under the Securities Act and any comparable provision of any Applicable Securities Laws that may at any time permit a Holder to sell securities of the Company to the public without Registration or pursuant to a Registration on Form F-3 or Form S-3 (or any comparable form in a jurisdiction other than the United States), the Company agrees to: 

(i)    make and keep public information available, as those terms are understood and defined in Rule 144 (or comparable
provision, if any, under Applicable Securities Laws in any jurisdiction where the Company’s securities are listed), at all times following 90 days after the effective date of the first Registration under the Securities Act filed by the Company
for an offering of its securities to the general public; 
 (ii)    file with the Commission in a timely manner all
reports and other documents required of the Company under all Applicable Securities Laws; and 
 (iii)    at any time
following ninety (90) days after the effective date of the first Registration under the Securities Act filed by the Company for an offering of its securities to the general public by the Company, promptly furnish to any Holder holding
Registrable Securities, upon request (a) a written statement by the Company that it has complied with the reporting requirements of all Applicable Securities Laws at any time after it has become subject to such reporting requirements or, at any
time after so qualified, that it qualifies as a registrant whose securities may be resold pursuant to Form F-3 or Form S-3 (or any form comparable thereto under
Applicable Securities Laws of any jurisdiction where the Company’s securities are listed), (b) a copy of the most recent annual or quarterly report of the Company and such other reports and documents as filed by the Company with the Commission,
and (c) such other information as may be reasonably requested in availing any Holder of any rule or regulation of the Commission, that permits the selling of any such securities without Registration or pursuant to Form F-3 or Form S-3 (or any form comparable thereto under Applicable Securities Laws of any jurisdiction where the Company’s Equity Securities are listed). 

6.2    Limitations on Subsequent Registration Rights. From and after the date of this Agreement, the Company
shall not, without the written consent of holders of at least two-thirds (2/3) of the voting power of the then outstanding Registrable Securities held by all Holders (calculated on an as-converted to Ordinary Share basis), enter into any agreement with any holder or prospective holder of any Equity Securities of the Company that would allow such holder or prospective holder (i) to include
such Equity Securities in any Registration filed under Section 2 or Section 3, unless under the terms of such agreement such holder or prospective holder may include such Equity Securities in any
such Registration only to the extent that the inclusion of such Equity Securities will not reduce the amount of the Registrable Securities of the Holders that are included, (ii) to demand Registration of their Equity Securities, or
(iii) to cause the Company to include such Equity Securities in any Registration filed under Section 2 or Section 3 hereof on a basis pari passu with or more favorable to such holder or
prospective holder than is provided to the Holders of Registrable Securities. 

  
 23 

 6.3    “Market
Stand-Off” Agreement. Each holder of Shares agrees, if so required by the managing underwriter(s), that it will not during the period commencing on the date of the final prospectus relating to
the Company’s IPO and ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred eighty (180) days from the date of such final prospectus) (i) lend, offer, pledge, hypothecate,
hedge, sell, make any short sale of, loan, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or
indirectly, any Equity Securities of the Company owned immediately prior to the time of the final prospectus relating to the IPO (other than those included in such offering), or (ii) enter into any swap or other arrangement that transfers to
another, in whole or in part, any of the economic consequences of ownership of such Equity Securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Equity Securities of the Company or such
other securities, in cash or otherwise; provided, that (x) the foregoing provisions of this Section 6.3 shall not apply to the sale of any securities of the Company to an underwriter pursuant to any underwriting
agreement, and shall not be applicable to any Holder unless all directors, officers and all other holders of at least one percent (1%) of the outstanding share capital of the Company (calculated on an
as-converted to Ordinary Share basis) must be bound by restrictions at least as restrictive as those applicable to any such Holder pursuant to this Section 6.3, (y) this
Section 6.3 shall not apply to a Holder to the extent that any other Person subject to substantially similar restrictions is released in whole or in part, and (z) the lockup agreements shall permit a Holder to transfer
their Registrable Securities to their respective Affiliates so long as the transferees enter into the same lockup agreement. The underwriters in connection with the Company’s IPO are intended third party beneficiaries of this
Section 6.3 and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. 

6.4    Termination of Registration Rights. The registration rights set forth in
Section 2 and Section 3 of this Agreement shall terminate on the earlier of (i) the date that is five (5) years from the date of closing of a Qualified IPO (ii) with respect to any
Holder, the date on which such Holder may sell without registration, all of such Holder’s Registrable Securities under Rule 144 of the Securities Act in any ninety (90)-day period. 

6.5    Exercise of Ordinary Share Equivalents. Notwithstanding anything to the contrary provided in this
Agreement, the Company shall have no obligation to Register Registrable Securities which, if constituting Ordinary Share Equivalents, have not been exercised, converted or exchanged, as applicable, for Ordinary Shares as of the effective date of the
applicable Registration Statement, but the Company shall cooperate and facilitate any such exercise, conversion or exchange as requested by the applicable Holder. 

6.6    Intent. The terms of Sections 2 through 6 are drafted primarily in contemplation of an
offering of securities in the United States of America. The parties recognize, however, the possibility that securities may be qualified or registered for offering to the public in a jurisdiction other than the United States of America where
registration rights have significance or that the Company might effect an offering in the United States of America in the form of American Depositary Receipts or American Depositary Shares. Accordingly: 

(i)    it is their intention that, whenever this Agreement refers to a Law, form, process or institution of the United
States of America but the parties wish to effectuate qualification or registration in a different jurisdiction where registration rights have significance, reference in this Agreement to the Laws or institutions of the United States shall be read as
referring, mutatis mutandis, to the comparable Laws or institutions of the jurisdiction in question; and 

  
 24 

 (ii)    it is agreed that the Company will not undertake any listing of
American Depositary Receipts, American Depositary Shares or any other security derivative of the Ordinary Shares unless arrangements have been made reasonably satisfactory to the Supermajority Preferred Holders to ensure that the spirit and intent
of this Agreement will be realized and that the Company is committed to take such actions as are necessary such that the Holders will enjoy rights corresponding to the rights hereunder to sell their Registrable Securities in a public offering in the
United States of America as if the Company had listed Ordinary Shares in lieu of such derivative securities. 

6.7    Assignment of Registration Rights. The registration rights of a Holder under
Sections 2 to 6 hereof may be assigned to any person acquiring Registrable Securities, provided that (i) all or at least 100,000 Registrable Securities (subject to share split, share combination, share dividend or
such other similar recapitalization event) held by such Holder are transferred; or (ii) the assignees of those Registrable Securities agree to designate one (1) representative to represent them to exercise the Registration Rights under
Sections 2 to 6; provided further, that in either case no party may be assigned any of the foregoing rights unless the Company is given written notice by the assigning party stating the name and address of the assignee
and identifying the securities of the Company as to which the rights in question are being assigned; and provided further, that any such assignee shall receive such assigned rights subject to all the terms and conditions of this Agreement, including
without limitation the provisions of this Section 6.7. 
 6.8    The term
“Ordinary Shares” (a) under registration rights set forth in Section 2, Section 3, Section 4, Section 5 and Section 6 of this
Agreement shall mean (i) Ordinary Shares or (ii) Class A Ordinary Shares or Class B Ordinary Shares, each upon the closing of a Qualified IPO (if applicable), and (b) under the definition “Registrable Securities”
shall mean Ordinary Shares or Class A Ordinary Shares upon the closing of a Qualified IPO (if applicable). 
  

	7.	 Preemptive Right. 

7.1    General. The Company hereby grants to each holder of the Preferred Shares (including holders of
Ordinary Shares that were converted from Preferred Shares) (the “Preemptive Rights Holder”) the right of first refusal to purchase such Preemptive Rights Holder’s Pro Rata Share (as defined below) (and any oversubscription, as
provided below), of all (or any part) of any New Securities (as defined below) that the Company may from time to time issue after the date of this Agreement (the “Preemptive Right”). 

7.2    Pro Rata Share. A Preemptive Rights Holder’s “Pro Rata Share” for purposes of
the Preemptive Rights is the ratio of (a) the number of the Ordinary Shares (treating any Preferred Shares on an as-converted basis) held by such Preemptive Rights Holder, to (b) the total number of
the Ordinary Shares (treating any Preferred Shares on an as-converted basis) then outstanding (calculated on a fully diluted basis) immediately prior to the issuance of New Securities giving rise to the
Preemptive Rights. 

  
 25 

 7.3    New Securities. For purposes hereof, “New
Securities” shall mean any Equity Securities of the Company issued after the date hereof, except for: 

(i)    any Ordinary Shares (and/or options or warrants therefor) (including any of such shares which are repurchased)
issued to officers, directors, employees and consultants of the Company who provide bona fide services to the Company pursuant to a share incentive plan or other arrangement approved by the Board (including the affirmative vote of each Investor
Director) and the Supermajority Preferred Holders; provided that the total sum of the Ordinary Shares issued or issuable pursuant to all share incentive plans or other arrangements is not more than 212,976,607 Ordinary Shares; 

(ii)    any Equity Securities issued under the Series E Purchase Agreement, or Ordinary Shares issued pursuant to the
conversion of Preferred Shares; 
 (iii)    any Equity Securities issued or issuable pursuant to a share split, share
dividend, combination, recapitalization or other similar transaction of the Company in which all Preemptive Rights Holders are entitled to participate on a pro rata basis; 

(iv)    any Equity Securities issued pursuant to a Qualified IPO; 

(v)    any Equity Securities issued upon the exercise of the GGV Warrant or the IDG Warrant. 

7.4    Procedures. 

(i)    First Participation Notice. In the event that the Company proposes to undertake an issuance of New
Securities (in a single transaction or a series of related transactions), it shall give to each Preemptive Rights Holder written notice of its intention to issue New Securities (the “First Participation Notice”), describing the
amount and type of New Securities, the price and the general terms upon which the Company proposes to issue such New Securities. Each Preemptive Rights Holder shall have thirty (30) Business Days from the date of receipt of any such First
Participation Notice to agree in writing to purchase up to such Preemptive Rights Holder’s Pro Rata Share of such New Securities for the price and upon the terms and conditions specified in the First Participation Notice by giving written
notice to the Company and stating therein the quantity of New Securities to be purchased (not to exceed such Preemptive Rights Holder’s Pro Rata Share). Such notice may be made by telephone if confirmed in writing within five (5) Business
Days. If any Preemptive Rights Holder fails to so respond in writing within such thirty (30) Business Day period to purchase such Preemptive Rights Holder’s full Pro Rata Share of an offering of New Securities, then such Preemptive Rights
Holder shall forfeit the right hereunder to purchase that part of its Pro Rata Share of such New Securities that it did not agree to purchase, but shall not be deemed to forfeit any right with respect to any other issuance of New Securities. 

(ii)    Second Participation Notice; Oversubscription. If there are any New Securities remaining after giving
effect to subsection (i) above (if applicable), the Company shall promptly give notice (the “Second Participation Notice”) to each Preemptive Rights Holder who exercised in full its Preemptive Rights (each an
“Oversubscription Participant”) in accordance with subsection (i) above. Each Oversubscription Participant shall have ten (10) Business Days from the date of the Second Participation Notice (the “Second
Participation Period”) to notify the Company of its desire to purchase more than its Pro Rata Share of the New Securities, stating the number of the additional New Securities it proposes to buy (the “Additional Number”).
Such notice may be made by telephone if confirmed in writing within five (5) Business Days. If, as a result thereof, such oversubscription exceeds the total number of the remaining New Securities available for purchase, each Oversubscription
Participant will be cut back by the Company with respect to its oversubscription to such number of remaining New Securities equal to the lesser of (x) the Additional Number and (y) the product obtained by multiplying (i) the number of
the remaining New Securities available for subscription by (ii) a fraction, the numerator of which is the number of Ordinary Shares (treating any Preferred Shares on an as-converted basis) held by such
Oversubscription Participant and the denominator of which is the total number of the Ordinary Shares (treating any Preferred Shares on an as-converted basis) held by all the Oversubscription Participants. 

  
 26 

 7.5    Failure to Exercise. Upon the expiration of the
Second Participation Period, or in the event no Preemptive Rights Holder exercises the Preemptive Rights within thirty (30) Business Days following the issuance of the First Participation Notice, the Company shall have ninety (90) days
thereafter to complete the sale of the New Securities described in the First Participation Notice with respect to which the Preemptive Rights hereunder were not exercised at the same or higher price and upon
non-price terms not more favorable to the purchasers thereof than specified in the First Participation Notice. In the event that the Company has not issued and sold such New Securities within such ninety
(90) days period, then the Company shall not thereafter issue or sell any New Securities without again first offering such New Securities to the Preemptive Rights Holders pursuant to this Section 7. 

 

	8.	 Information and Inspection Rights. 

8.1    Delivery of Financial Statements. The Company shall deliver to each holder of Preferred Shares
(including holders of Ordinary Shares that were converted from Preferred Shares), the following documents or reports, so long as such holder has not provided financing to any of the directly competitive companies listed under Exhibit A (which list
shall contain not more than five (5) companies and shall be updated by the Board (including the consent of all the Investor Directors) no more than once in every twelve consecutive months subject to prior written consent of Supermajority
Preferred Holders and the updated list shall be delivered to each holder of Preferred Shares (including holders of Ordinary Shares that were converted from Preferred Shares) immediately thereafter and shall become effective with respect to a Party
on the same day when such list is delivered to such Party) (collectively, the “Competitors” and each a “Competitor”), including but not limited to any subscription for equity securities or issuance of a loan (such
investment, the “Restricted Investment”): 
 (i)    within one hundred and twenty (120) days
after the end of each fiscal year of the Company, a consolidated and consolidating income statement and statement of cash flows for each Group Company for such fiscal year and a consolidated balance sheet for each Group Company as of the end of the
fiscal year, all prepared in accordance with the Accounting Standards, audited and certified by one of the “Big 4” or a reputable firm of independent certified public accountants (the “Auditors”) acceptable to the
Supermajority Preferred Holders, and a management report including a comparison of the financial results of such fiscal year with the corresponding annual budget, all prepared in accordance with the Accounting Standards applied throughout the
period; 
 (ii)    within thirty (30) days after the end of each quarter, a consolidated and consolidating
unaudited income statement and statement of cash flows for such quarter and a consolidated balance sheet for each Group Company as of the end of such quarter, and a management report including a comparison of the financial results of such quarter
with the corresponding quarterly budget, all prepared in accordance with the Accounting Standards applied throughout the period; 

  
 27 

 (iii)    within fifteen (15) days after the end of each month, a
consolidated and consolidating unaudited income statement and statement of cash flows for such month and a consolidated balance sheet for each Group Company as of the end of such month, and a management report including a comparison of the financial
results of such month with the corresponding monthly budget all prepared in accordance with the Accounting Standards applied throughout the period, and monthly statement of bank accounts of each Group Company for such month; 

(iv)    an annual consolidated budget and strategic plan for the next fiscal year at least forty-five (45) days
prior to the end of each fiscal year approved by the Board (including the affirmative vote of each Investor Director), setting forth including without limitation: the projected balance sheets, income statements and statements of cash flows for each
month during such fiscal year of each Group Company; the projected budget for operation of business; any dividend or distribution to be declared or paid; the projected incurrence, assumption or refinancing of indebtedness; projected revenue and
profit for each month during such fiscal year; all payments projected to be made not in the ordinary course of business consistent with past practice by any of the Group Companies; and all other material matters relating to the operation,
development and business of the Group Companies; 
 (v)    within fifteen (15) days after the end of each quarter,
a copy of the up-to-date capitalization table of each Group Company setting forth the holders of the Equity Securities of such Group Company together with their
respective ownership percentage on a fully diluted basis, as certified by the chief executive officer of the Company; and 

(vi)    as soon as practicable, such other financial, operational and/or business data and information matrix and/or
materials in respect of the Group Companies as the holders of Preferred Shares (including holders of Ordinary Shares that were converted from Preferred Shares) may reasonably request from time to time. 

Notwithstanding Section 8.1 and regardless of anything else contained herein or in the Charter Documents of the
Company, the Company shall deliver to the holder of Preferred Shares (including holders of Ordinary Shares that were converted from Preferred Shares) who has made Restricted Investment: 

(i)    within one hundred and twenty (120) days after the end of each fiscal year of the Company, a consolidated and
consolidating income statement and statement of cash flows for each Group Company for such fiscal year and a consolidated balance sheet for each Group Company as of the end of the fiscal year, all prepared in accordance with the Accounting
Standards, audited and certified by the Auditors acceptable to the Supermajority Preferred Holders; and 

(ii)    within thirty (30) days after the end of each quarter, a consolidated and consolidating unaudited income
statement and statement of cash flows for such quarter and a consolidated balance sheet for each Group Company as of the end of such quarter. 

8.2    Inspection Rights. Each Group Company covenants and agrees that, upon a reasonable prior notice of at
least one (1) Business Day to the Company, each holder of Preferred Shares (including holders of Ordinary Shares that were converted from Preferred Shares) shall have the right to reasonably inspect facilities, properties, records and books
(including but not limited to the books of account) of each Group Company in good faith at any time during regular working hours and the right to discuss the business, operation and conditions of a Group Company with any Group Company’s
directors, officers, employees, independent accounts, legal counsels and investment bankers, at its own cost, so long as such holder has not made any Restricted Investment. 

  
 28 

 8.3    Exceptions. Notwithstanding anything to the
contrary provided in this Agreement, the Parties agree that (i) if at the time any new entity or Person (“New Entity”) becomes a Competitor in accordance with the terms of this Agreement, and any holder of Preferred Shares (including
holders of Ordinary Shares that were converted from Preferred Shares) has had an existing interest in such New Entity, then neither such holding of interest in the New Entity nor any further investments into the New Entity by such holder of
Preferred Shares shall be deemed as a Restricted Investment under Section 8.1; and (ii) the restrictions stipulated under this Section 8 shall not restrict any direct or indirect purchase of or subscription for any Equity Securities
that are listed on a recognized stock exchange made by such holder of Preferred Shares or its Affiliates. 
  

	9.	 Election of Directors. 

9.1    Board of Directors. 

(i)    Subject to Section 9.1(ii), the Company shall have, and the Parties hereto agree to cause the Company to have,
a Board consisting of seven (7) authorized directors, with the composition of the Board determined as follows: (a) the Majority Ordinary Holders shall be entitled to appoint, replace and reappoint at any time or from time to time four
(4) directors on the Board (the “Majority Ordinary Director”), and until all four (4) Majority Ordinary Directors have been appointed, Mr. Huang shall hold additional votes so that the Majority Ordinary Directors
shall collectively hold four (4) votes; (b) IDG shall be exclusively entitled to appoint, replace and reappoint at any time or from time to time one (1) director (the “IDG Director”), (c) GGV shall be exclusively
entitled to appoint, replace and reappoint at any time or from time to time one (1) director (the “GGV Director”), and (d) Shunwei shall be exclusively entitled to appoint, replace and reappoint at any time or from time to
time one (1) director (the “Shunwei Director”, together with the IDG Director, the GGV Director, the Hillhouse Director (if applicable) and the Coatue Director (if applicable) the “Investor Directors”,
and each, an “Investor Director”) on the Board. 
 (ii)     The Parties hereto agree and acknowledge
that Hillhouse shall be exclusively entitled to appoint, replace and reappoint one (1) director of the Company (the “Hillhouse Director”) upon Hillhouse (together with its Affiliates) becoming holder(s) of, and so long as Hillhouse
(together with its Affiliates) continues to hold not less than 8% of the total share capital of the Company (calculated on a fully-diluted and as converted basis). 

(iii)    The Parties hereto agree and acknowledge that Coatue shall be exclusively entitled to appoint, replace and
reappoint one (1) director of the Company (the “Coatue Director”) upon Coatue (together with its Affiliates) becoming holder(s) of, and so long as Coatue (together with its Affiliates) continues to hold not less than 8% of the total
share capital of the Company (calculated on a fully-diluted and as converted basis). 
 (iv)    Each of the other Group
Companies shall have, and the Ordinary Holders (other than the Key Ordinary Shareholder and Aquanauts) and the Company agree to cause each of the other Group Companies to have, the same number of directors in its respective board (the
“Subsidiary Board” and collectively, the “Subsidiary Boards”) as the Company’s Board, and the Majority Ordinary Holders, IDG, GGV, Shunwei, Hillhouse (if applicable) and Coatue (if applicable) shall be entitled
to appoint the same number of directors to each Group Company as they are entitled to appoint to the Company’s Board. 

  
 29 

 (v)    Each of (a) Hillhouse, (b) Coatue, and (c) if approved
by at least eighty percent (80%) of the Directors present at a Board meeting or written consent of at least four (4) Directors, an Investor (other than Hillhouse and Coatue), shall be entitled to appoint an observer (each, an
“Observer”) to attend all meetings of the Board and the Subsidiary Boards and all committees of the Board and the Subsidiary Boards, in a nonvoting observer capacity and each of the Company and the other Group Companies (as the case
may be) shall give the Observer copies of all notices, minutes, consents, and other materials that the Company or such other Group Company provides to its directors or members of any committees of its board of directors at the same time and in the
same manner as provided to such directors or members; provided, however, that such Observer shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information so provided; and, provided
further, that the Company reserves the right to withhold any information and to exclude such Observer from any meeting or portion thereof if such Observer’s access to such information or attendance at such meeting could adversely affect the
attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets. or a conflict of interest.  

(vi)    Notwithstanding anything to the contrary provided in this Agreement, the Parties agree that for the purpose of
consummating a Qualified IPO and in accordance with the listing rules then in force, the Investor Directors shall resign from Subsidiary Boards upon reasonable request of the Company, and the Investors shall, and shall cause the Investor Directors
to take such actions and execute such instruments to cooperate with the Company to complete the SAMR filing or equivalent filings to reflect such change of the applicable Subsiary Board, provided however that, if such Qualified IPO is not
consummated within one (1) year after such resignation of Investor Directors from Subsidiary Boards, the respective Investors’ rights as provided in Section 9.1(iv) shall be restored. 

9.2    Voting Agreements 

(i)    With respect to each election of directors of the Board, each holder of voting securities of the Company shall vote
at each meeting of shareholders of the Company, or in lieu of any such meeting shall give such holder’s written consent with respect to, as the case may be, all of such holder’s voting securities of the Company as may be necessary
(x) to keep the authorized size of the Board at the number of Directors as set forth in Section 9.1 above, (y) to cause the election or re-election as members of the Board,
and during such period to continue in office, each of the individuals designated pursuant to Section 9.1, and (z) against any nominees not designated pursuant to Section 9.1. 

(ii)    Any Director designated pursuant to Section 9.1 may be removed from the Board only upon
the vote or written consent of the Person or group of Persons then entitled to designate such Director pursuant to Section 9.1, and the Parties agree not to seek, vote for or otherwise effect the removal of any such
Director without such vote or written consent. Any Person or group of Persons then entitled to designate any individual to be elected as a Director on the Board shall have the exclusive right at any time or from time to time to remove any such
Director occupying such position and to fill any vacancy caused by the death, disability, retirement, resignation or removal of any Director occupying such position or otherwise, and each other Party agrees to cooperate with such Person or group of
Persons in connection with the exercise of such right. Each holder of voting securities of the Company agrees to always vote such holder’s respective voting securities of the Company (and given written consents in lieu thereof) in support of
the foregoing. 

  
 30 

 (iii)    The Company agrees to take such action, and each other Party
hereto agrees to take such action, as is necessary to cause (x) the election or appointment to each Subsidiary Board of the directors designated by IDG, GGV ,Shunwei, Hillhouse (if applicable) and Coatue (if applicable) to serve on such
Subsidiary Board pursuant to Section 9.1 and (y) the removal of such director that IDG, GGV, Shunwei, Hillhouse (if applicable) or Coatue (if applicable) (as the case may be) elects to remove from such Subsidiary
Board. 
 9.3    Quorum. The Board and each Subsidiary Board shall hold no less than one (1) board
meeting during each fiscal quarter. A meeting of the Board shall only proceed where there are present (whether in person or by means of a conference telephone or any other equipment which allows all participants in the meeting to speak to and
hear each other simultaneously) four (4) directors of the Company then in office (in each case including each Investor Director), and the Parties shall cause the foregoing to be the quorum requirements for the Board. A meeting of each
Subsidiary Board shall only proceed where there are present (whether in person or by means of a conference telephone or any other equipment which allows all participants in the meeting to speak to and hear each other simultaneously) four
(4) directors then in office (in each case including each of the Investor Directors), and the Parties shall cause the foregoing to be the quorum requirements for each Subsidiary Board. Notwithstanding the foregoing, if notice of the board
meeting (the “Meeting Notice”) has been duly delivered to all directors of the Board or the applicable Subsidiary Board seven (7) days prior to the scheduled meeting in accordance with the notice procedures under the Charter
Documents of the applicable Group Company, and the number of directors required to be present under this Section 9.3 for such meeting to proceed is not present within one half hour from the time appointed for the meeting
because of the absence of any Director, the meeting shall be adjourned to the third following Business Day at the same time and place (or to such other time or such other place as the directors may determine) with notice delivered to all directors
one day prior to the adjourned meeting in accordance with the notice procedures under the Charter Documents of the applicable Group Company and, if at the adjourned meeting, the number of directors required to be present under this
Section 9.3 for such meeting to proceed is not present within one half hour from the time appointed for the meeting because of the absence of any Director, then the presence of such Director(s), shall not be required
at such adjourned meeting, provided that if any Investor Director is not present at such adjourned meeting, (i) the present Directors shall only discuss the matters as described in the Meeting Notice, and (ii) no
Directors’ resolutions shall be passed in such adjourned meeting in respect to anything that requires approval of the absent Investor Director as provided in this Agreement (including, without limitation, Section 10.1
and Section 10.2 below). 
 9.4    Expenses. The Company will promptly pay or
reimburse each non-employee Board member and each non-employee Subsidiary Board member for all reasonable
out-of-pocket expenses incurred in connection with attending board or committee meetings and otherwise performing their duties as directors and committee
members.    Each Observer shall be entitled to be reimbursed for all reasonable out-of-pocket expenses incurred in connection with attending board or
committee meetings. 
 9.5    Alternates. Subject to applicable Law, each Director shall be
entitled to appoint an alternate to serve at any Board meeting, and such alternate shall be permitted to attend all Board meetings and vote on behalf of the director for whom she or he is serving as an alternate. 

  
 31 

 9.6    Director Indemnification and Insurance.
To the maximum extent permitted by the Laws of the jurisdiction in which the Company is organized and the Memorandum and Articles, the Company shall (i) indemnify and hold harmless each Investor Director and shall comply with the terms of
the director indemnification agreement, and (ii) at the request of any Investor Director who is not a party to a director indemnification agreement, shall enter into a director indemnification agreement with such Investor Director. From and
after the Closing, the Company shall purchase and at all times thereafter, maintain customary directors’ and officers’ liability insurance for the Investor Directors, provided however that such directors’ and officers’ liability
insurance shall be in form and substance satisfactory to all the Investor Directors. 
  

	10.	 Protective Provisions 

10.1    Acts of the Group Companies Requiring Approval of Supermajority Preferred Holders.
Regardless of anything else contained herein or in the Charter Documents of any Group Company, no Group Company shall take, permit to occur, approve, authorize, or agree or commit to do any of the following, and no Party shall permit any Group
Company to, and the shareholders of the Company shall not permit the Company to, take, permit to occur, approve, authorize, or agree or commit to do any of the following, whether in a single transaction or a series of related transactions, whether
directly or indirectly, and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, unless approved by the Supermajority Preferred Holders in advance in writing; provided that, where any such act
requires approval of the shareholders of the Company in accordance with the Companies Law of the Cayman Islands and the approval of the Supermajority Preferred Holders has not yet been obtained, the Supermajority Preferred Holders who vote against
the relevant resolution shall have the voting rights equal to all the shareholders of the Company who voted in favor of the resolution plus one: 

(i)    any amendment or change of the rights, preferences, privileges, or powers of or concerning, or the limitations or
restrictions provided for the benefit of, any series of the Preferred Shares or any amendment of the Charter Documents of any Group Company which has adverse effect on any series of the Preferred Shares; 

(ii)    any action that authorizes, creates or issues (A) any class or series of Equity Securities having rights,
preferences, privileges, powers, limitations or restrictions superior to or on a parity with any series of the Preferred Shares, whether as to liquidation, conversion, dividend, voting, redemption, or otherwise, or any Equity Securities convertible
into, exchangeable for, or exercisable into any Equity Securities having rights, preferences, privileges, powers, limitations or restrictions superior to or on a parity with of any series of the Preferred Shares, whether as to liquidation,
conversion, dividend, voting, redemption or otherwise, or (B) any Equity Securities of any Group Company except for the Conversion Shares or those Equity Securities issued or to be issued under the Series E Purchase Agreement, in each case
excluding the issuance or sale of any Equity Securities by any Group Company in connection with the exercise of any GGV Warrant or IDG Warrant and/or the exercise of conversion right pursuant to the GGV Convertible Loan Agreement or IDG Convertible
Loan Agreement;  
 (iii)    any action that reclassifies any outstanding shares into shares having
rights, preferences, privileges, powers, limitations or restrictions senior to or on a parity with any series of the Preferred Shares, whether as to liquidation, conversion, dividend, voting, redemption or otherwise; 

  
 32 

 (iv)    any purchase, repurchase, redemption or retirements of any
Equity Security of any Group Company other than Exempted Distributions (as defined in the Memorandum and Articles); 

(v)    any amendment or modification to or waiver under any of the Charter Documents of any Group Company, other than
amendments to resolve any conflict or inconsistency with this Agreement in accordance with the terms of this Agreement; 

(vi)    any declaration, set aside or payment of a dividend or other distribution by any Group Company only to the
holders of the Ordinary Shares but not to the holders of other class of shares of the Company; 
 (vii)    the
commencement of or consent to any proceeding seeking (i) to adjudicate any Group Company as bankrupt or insolvent, (ii) liquidation, winding up, dissolution, reorganization, or arrangement of any of the Group Companies under any Law
relating to bankruptcy, insolvency or reorganization or relief of debtors, or (iii) the entry of an order for relief or the appointment of a receiver, trustee, or other similar official for any Group Company or for any substantial part of its
property; 
 (viii)    any change of the size or composition of the board of directors of any Group Company, except in
compliance with Article 67 of the Memorandum and Articles and Section 9 hereof; 
 (ix)    issuance or sale of any
Equity Securities or bonds of any Group Company, excluding the issuance or sale of any Equity Securities by any Group Company in connection with the exercise of any GGV Warrant or IDG Warrant and/or the exercise of conversion right pursuant to the
GGV Convertible Loan Agreement or IDG Convertible Loan Agreement; 
 (x)    IPO of the Company other than Qualified
IPO; 
 (xi)    any action by a Group Company to authorize, approve or enter into any agreement or obligation with
respect to any action listed above. 
 Notwithstanding anything to the contrary provided in this Agreement and/or any other Transaction
Documents, so long as any Series D+ Preferred Share remains outstanding, without the affirmative vote or the prior written consent of the Majority Series D+ Holders, the Company shall not take any actions to make any amendment or change of the
rights, preferences, privileges, or powers of or concerning, or the limitations or restrictions provided for the benefit of, Series D+ Preferred Shares, whether through amendment of the Charter Documents of any Group Company, or the reclassification
of any outstanding shares into shares having rights, preferences, privileges, powers, limitations or restrictions senior to or on a parity with any Series D+ Preferred Shares, or otherwise. 

  
 33 

 10.2    Acts of the Company Requiring Approval of Majority
Series E Holders. Notwithstanding Section 10.1 and regardless of anything else contained herein or in the Charter Documents of the Company, the Company shall not take, permit to occur, approve, authorize, or agree or
commit to do any of the following, and no Party shall permit the Company to, and the shareholders of the Company shall not permit the Company to, take, permit to occur, approve, authorize, or agree or commit to do any of the following, whether in a
single transaction or a series of related transactions, whether directly or indirectly, and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, unless the prior written consent by Majority Series E
Holders shall have been obtained: 
 (i)    any equity or equity-linked financing of the Company for a consideration
per Ordinary Share (on an as-converted basis, net of any selling concessions or commissions) less than the Series E Conversion Price (as defined in the Memorandum and Articles and as adjusted pursuant to the
terms thereof); 
 (ii)    any amendment or change of the rights, preferences, privileges, or powers of or concerning,
or the limitations or restrictions provided for the benefit of, Series E Preferred Shares, whether through amendment of the Charter Documents of any Group Company, or the reclassification of any outstanding shares into shares having rights,
preferences, privileges, powers, limitations or restrictions senior to or on a parity with any Series E Preferred Shares, or otherwise, or any amendment of the Charter Documents of any Group Company that has an adverse effect on Series E Preferred
Shares; 
 (iii)    any purchase, repurchase, redemption or retirements of any Equity Security of any Group Company
other than pursuant to Article 8.5 of the Memorandum and Articles; 
 (iv)    IPO of the Company other than a Qualified
IPO; and 
 (v)    any Trade Sale that values the Group Companies (taken as a whole) at lower than US$ 2 billion.

 10.3    Acts of WFOE Requiring Approval of Supermajority Preferred Holders. Without limitation to
Section 10.1 and regardless of anything else contained herein or in the Charter Documents of the WFOE, the WFOE shall not take, permit to occur, approve, authorize, or agree or commit to do any of the following, and no
Party shall permit the WFOE to take, permit to occur, approve, authorize, or agree or commit to do any of the following, whether in a single transaction or a series of related transactions, whether directly or indirectly, and whether or not by
amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, unless approved by the Supermajority Preferred Holders in writing in advance: 

(i)    any amendment of the articles of association or Charter Documents of the WFOE; 

(ii)    winding up, liquidation or dissolution of the WFOE; 

(iii)    any increase or reduction in the registered capital or share capital of, or transfer of profits from, the WFOE;

 (iv)    disposal of all or substantial assets of the WFOE or merger, consolidation or alliance of the WFOE with
other entities; 
 (v)    any change in the business scope of the WFOE; or 

(vi)    any action to authorize, approve or enter into any agreement or obligation with respect to any action listed
above. 

  
 34 

 10.4    Acts of the Group Companies Requiring Approval of
Board. Regardless of anything else contained herein or in the Charter Documents of any Group Company, no Group Company shall take, permit to occur, approve, authorize, or agree or commit to do any of the following, and no Party shall permit
any Group Company to, and the shareholders of the Company shall not permit the Company to, take, permit to occur, approve, authorize, or agree or commit to do any of the following, whether in a single transaction or a series of related transactions,
whether directly or indirectly, and whether or not by amendment, merger, consolidation, scheme of arrangement, amalgamation, or otherwise, unless approved by at least four (4) Directors present at a duly constituted Board meeting (including the
affirmative vote of at least two Investor Directors) or a resolution in writing signed by all the Directors in advance: 

(i)    incurrence by the Group Companies of Indebtedness or guarantees of Indebtedness in excess of US$3,000,000
individually; 
 (ii)    any loans to any Related Party; 

(iii)    any transaction or series of transactions (including but not limited to the termination, extension, continuation
after expiry, renewal, amendment, variation or waiver of any term under agreement with respect to any transaction or series of transactions) with any Related Party involving payments in excess of US$25,000 individually or in the aggregate; 

(iv)    any material change to the business plan or operation plan of any Group Company; or any material change to the
business scope, or nature of business of any Group Company, or cessation of any business line of any Group Company; or any increase or reduction in the registered capital or share capital of any Group Company; 

(v)    the adoption, amendment or termination of ESIP or any other equity incentive, purchase or participation plan for
the benefit of any employees, officers, directors, contractors, advisors or consultants of any of the Group Companies; 

(vi)    the appointment or removal of the Auditors or the auditors for any other Group Company, or the change of the term
of the fiscal year for any Group Company; 
 (vii)    any adoption of or change to, a significant tax or accounting
practice or policy or any internal financial controls and authorization policies, or the making of any significant tax or accounting election; 

(viii)    any sale, transfer, or other disposal of, or the incurrence of any Lien on, any substantial part of the assets
of any Group Company; 
 (ix)    appointment or removal of general manager of the WFOE; or 

(x)    any action to authorize, approve or enter into any agreement or obligation with respect to any action listed
above. 

  
 35 

 11 . Drag-Along Rights. 

11.1    Approved Sale. In the event that the Company receives a written bona fide offer for a Trade Sale in
which total equity valuation (calculated on an as-converted to Ordinary Share and fully-diluted basis) or total assets valuation (as the case may be) of the Company immediately prior to such offered Trade Sale
is not less than two (2) times of the post-money valuation of the Company immediately after the Closing (calculated on an as-converted to Ordinary Share and fully-diluted basis), and if such offered Trade
Sale is approved and agreed to in writing by the Dragging Parties (as so approved and agreed, the “Approved Sale”), then upon the receipt of written notice from the Dragging Parties and within thirty (30) days thereafter, the
Company and each of the other shareholders of the Company shall consent to, vote for and raise no objection against, enter into any agreement in connection with, participate in, and if applicable, shall cause all other shareholders of the Company to
promptly consent to, enter into any agreement in connection with, and participate in, such Trade Sale. 

11.2    In the event that there are any shareholders that fail to consent to, vote for, enter into any agreement in
connection with, or participate in the Approved Sale within the period as provided in Section 11.1 (each, a “Remaining Member”), the Company shall as per the Dragging Parties’ request, promptly notify
each of the Remaining Members in writing of the Approved Sale and the material terms and conditions of such Approved Sale, whereupon each Remaining Member shall, in accordance with instructions received from the Company and acceptable to the
Dragging Parties, vote all of its voting securities of the Company in favor of, otherwise consent in writing to, and/or otherwise sell or transfer all of its shares in such Approved Sale (including without limitation tendering original share
certificates for transfer, signing and delivering share transfer certificates, share sale or exchange agreements, and certificates of indemnity relating to any shares in the capital of the Company in the event that such Remaining Member has lost or
misplaced the relevant share certificate) on the same terms and conditions as were agreed by the Dragging Parties in connection with such Approved Sale; provided, however, that such terms and conditions, including with respect to price
paid or received per share, may differ as among the Ordinary Shares, the Preferred Shares and other different series of preferred shares, in order to reflect the liquidation preferences and participation rights of the Preferred Shares set forth in
the Memorandum and Articles. In furtherance of the foregoing, any Director approving the Approved Sale is expressly hereby authorized by each Remaining Member to take any and all of the following actions on such Remaining Member’s behalf
(without receipt of any further consent by such Remaining Member): (i) vote all of the voting securities of such Remaining Member in favor of any such Approved Sale; (ii) otherwise consent on such Remaining Member’s behalf to such Approved
Sale; (iii) sell all of such Remaining Member’s shares in such Approved Sale, in accordance with the terms and conditions of this Section 11.2; and (iv) act as such Remaining Member’s attorney-in-fact in relation to any such Approved Sale and have the full authority to sign and deliver, on behalf of such Remaining Member, share transfer certificates, share
sale or exchange agreements and certificates of indemnity relating to any shares in the capital of the Company in the event that such Remaining Member has lost or misplaced the relevant share certificate. 

11.3    Without limiting the generality of Sections 11.1 and 11.2 and in furtherance of the
foregoing, in the event an Approved Sale is to be brought to a vote at a general meeting of the Company, each shareholder of the Company entitled to vote at such meeting agrees: 

(i)    to be present, in person or by proxy, at all such meetings and be counted for the purposes of determining the
presence of a quorum at such meetings and the presence of the number of votes necessary for the effectiveness of any shareholder resolutions; 

(ii)    to vote (in person, by proxy or by action by written consent, as applicable) all shares of the Company as to
which it has record or beneficial ownership in favor of such Approved Sale and in opposition of (x) any and all other proposals that could reasonably be expected to delay or impair the ability of the Company to consummate such Approved Sale and
(y) any action or agreement that would result in a breach of any covenant, representation or warranty or any other obligation or agreement of the Company under the definitive agreement(s) related to such Approved Sale or that could result in
any of the conditions to the closing obligations under such agreement(s) not being fulfilled; 

  
 36 

 (iii)    to refrain from exercising any dissenters’ rights or
rights of appraisal under applicable laws at any time with respect to such Approved Sale; 
 (iv)    to execute and
deliver all related documentation and take such other action in support of the Approved Sale as shall reasonably be requested by the Dragging Parties; and 

(v)    to restructure such Approved Sale, as and if reasonably requested by the Dragging Parties, as a merger,
consolidation, restructuring or similar transaction, or a sale of all or substantially all of the assets of the Company, or otherwise. 

11.4    In any such Approved Sale, (i) each other shareholder shall bear a proportionate share (based upon the
relative proceeds received in such transaction) of the Dragging Parties’ reasonable fees and expenses incurred in the transaction, including, without limitation, legal, accounting and investment banking fees and expenses, and (ii) each
such shareholder shall severally, not jointly, join on a pro rata basis (based upon the relative proceeds received in such transaction) in any indemnification obligations that are part of the terms and conditions of such Approved Sale (other than
those that relate specifically to a particular shareholder, such as indemnification with respect to representations and warranties given by such shareholder regarding such shareholder’s title to and ownership of shares, due authorization,
enforceability, and no conflicts, which shall instead be given solely by such shareholder) but only up to the net proceeds paid to such shareholder in connection with such Approved Sale. The proceeds from any Approved Sale shall be distributed to
the shareholders in accordance with Article 8.2(B) (Distribution on Trade Sale) of the Memorandum and Articles. 

11.5    Put Option. Without prejudice to the other provisions hereof, if any shareholder of the Company (the
“Dissenting Member”) refuses to vote in favor of the Approved Sale or participate in the Approved Sale in accordance with Sections 11.1 through 11.3, then, so long as the Dragging Parties give their written consent,
each holder of a Preferred Share (including holders of Ordinary Shares that were converted from Preferred Shares) shall have the right to require the Dissenting Member to purchase in cash up to all of the Preferred Shares held by such holder at a
price per Preferred Share equal to the amount that a holder of a Preferred Share (including holders of Ordinary Shares that were converted from Preferred Shares) would have received in respect of a Preferred Share had the Company been sold for cash
in the Approved Sale and the full proceeds therefrom available for distribution to the members of the Company were distributed to the members in accordance with Article 8.2(B) (Distribution on Trade Sale) of the Memorandum and Articles. The
Dissenting Member shall also reimburse such holder of Preferred Shares for any and all reasonable fees and expense, including legal fees and expenses, incurred pursuant to the exercise or the attempted exercise of the right of such holder of
Preferred Shares under this Section 11.5. Within fifteen (15) days after a holder of Preferred Shares delivers a notice to the Dissenting Member exercising the option created hereby, such holder of Preferred Shares
shall deliver to the Dissenting Member the certificate or certificates representing Preferred Shares to be sold under this Section 11.5 by such holder of Preferred Shares properly endorsed for transfer, if certificated,
plus an executed instrument of transfer and the Dissenting Member shall pay immediately the aggregate purchase price therefor and the amount of reimbursable fees and expenses, in each case, as provided for under this
Section 11.5, in cash or by other means acceptable to such holder of Preferred Shares. 

  
 37 

 11.6    Drag-along Provisions to Control. For the
avoidance of doubt, if and to the extent that there are inconsistencies between this Section 11 and any other provisions of this Agreement or the Right of First Refusal &
Co-Sale Agreement, the terms of this Section 11 shall prevail and control. Without limiting the generality of the foregoing, none of the transfer restrictions set forth in this
Agreement, the Right of First Refusal & Co-Sale Agreement, the Restricted Shares Agreement or any other agreement imposing restrictions on transfer of Shares of the Company shall apply in connection
with an Approved Sale, notwithstanding anything contained to the contrary herein and therein. 
  

	12.	 Additional Covenants. 

12.1    ESIP. As of the Closing, the Board shall have reserved, pursuant to a bona fide employment-related
share incentive plan adopted by the Board on August 28, 2014 (as amended from time to time in accordance with Section 10.1, the “ESIP”), 212,976,607 Ordinary Shares (subject to the adjustment of share
split, share dividend, reclassification or other similar event) for issuance to management, employees, or individual consultants of the Company or any Group Company. Any grants of options, restricted shares or restricted share unit to a recipient
under the ESIP shall be subject to the approvals of the Board, including the affirmative vote of each Investor Director. Except as approved by the Board of Directors in any particular instance (including the affirmative vote of each Investor
Director), shares or share options issued under any ESIP shall be subject to the Company’s repurchase right which shall become lapsed upon such recipient’s continuous employment or consultation relationship with the Group Companies in
accordance with the following vesting schedule: twenty-five percent (25%) to vest on the first anniversary of such issuance, with the remaining seventy-five percent (75%) to vest annually thereafter in three (3) years with equal annual
installments. The Company shall cause all beneficiaries of any ESIP who receive, purchase, or receive options to purchase, Ordinary Shares under such ESIP to execute and deliver agreements in forms approved by the Board of Directors (including the
affirmative vote of each Investor Director) providing a prohibition on the transfer of the unvested options or shares purchased under ESIP, a repurchase right of shares purchased under ESIP in favor of the Company, and any other terms customary in
such agreements from time to time. Any attempt to exercise any option or other security granted or issued under the ESIP in contravention of this paragraph shall be null, void and without effect. 

As soon as practicable after the date hereof, the Company shall, and each of the Ordinary Holders (other than the Key Ordinary Shareholder and
Aquanauts) shall cause the Company to, obtain all authorizations, consents, orders and approvals of all Governmental Authorities and officials that may be or become necessary to effectuate the ESIP in the PRC in accordance with PRC Law. The Company
shall not, and the Ordinary Holders (other than the Key Ordinary Shareholder and Aquanauts) shall cause the Company not to, grant any awards pursuant to the ESIP to any grantee in the PRC if any authorization, consent, order or approval of any
Governmental Authority or official that is necessary to effectuate such ESIP in the PRC in accordance with PRC Law has not been obtained. 

  
 38 

 12.2    Control Documents. The Parties (other than the
Investors) shall ensure that each party to the relevant Control Documents fully perform its/his/her respective obligations thereunder and carry out the terms and the intent of the Control Documents. Any termination, or material modification or
waiver of, or material amendment to any Control Documents shall require the written consent of the Supermajority Preferred Holders, except for any amendment made in conection with the exercise of conversion right pursuant to the Convertible Loan
Agreement. If any of the Control Documents becomes illegal, void or unenforceable under PRC Laws after the date hereof, the Parties (other than the Investors) shall devise a feasible alternative legal structure reasonably satisfactory to the
Supermajority Preferred Holders which gives effect to the intentions of the parties in each Control Document and the economic arrangement thereunder as closely as possible. 

12.3    Control of Subsidiaries. The Company shall institute and keep in place such arrangements as are
reasonably satisfactory to the Supermajority Preferred Holders such that the Company (i) will at all times control the operations of each other Group Company, and (ii) will at all times be permitted to properly consolidate the financial
results for each other Group Company in the consolidated financial statements for the Company prepared under the Accounting Standards. 

Without limiting the generality of the foregoing, so long as an Investor or the Key Ordinary Shareholder holds any Shares in the Company, such
Investor or the Key Ordinary Shareholder shall have the right to require the Founders and other equity holders of the Domestic Company to transfer, or to cause the transfer of, the same percentage of equity interests in the Domestic Company as such
Investor or the Key Ordinary Shareholder (as the case may be) then holds in the issued and outstanding share capital of the Company (on an as-converted and fully-diluted basis) to one or more appropriate
Persons as designated by such Investor or the Key Ordinary Shareholder (as the case may be), for the lowest consideration permitted by applicable Law of the PRC (such equity transfer, a “Domestic Equity Transfer”). Further, in the
event of a Domestic Equity Transfer, each Founder shall, and shall use his best efforts to cause the other shareholders of the Domestic Company to, amend and restate the Control Documents, and each Investor or the Key Ordinary Shareholder requesting
the Domestic Equity Transfer shall procure the Person(s) designated by it to join as parties to the Control Documents so amended and restated, to the extent such amendment and restatement is necessary to enable the Company to control and consolidate
the financial results of the Domestic Company as permitted under applicable laws of the PRC. In the event an Investor or the Key Ordinary Shareholder (as the case may be) requests a Domestic Equity Transfer pursuant to this
Section 12.3, it shall notify in writing each of the other Investor(s) or the Key Ordinary Shareholder (as the case may be) within five (5) Business Days of such request. 

Notwithstanding anything to the contrary provided in this Agreement, the Parties agree that for the purpose of consummating a Qualified IPO
and in accordance with the applicable listing rules then in force, the Investors and Key Ordinary Shareholder shall, upon reasonable request of the Company, reverse or cancel (i) any Domestic Equity Transfer, (ii) the conversion of the GGV
Loan under the GGV Convertible Loan Agreement, and/or (iii) the conversion of the IDG loan under the IDG Convertible Loan Agreement (as the case may be), and the Investors and Key Ordinary Shareholder shall take such actions, execute such
instruments and do such other things as the Company may request to effect such reversal or cancellation, including but not limited to any SAMR filing required to reflect the change of shareholders of the Domestic Company resulting from such reversal
or cancellation, provided however that, (i) if such Qualified IPO is not consummated within one (1) year after such reversal or cancellation of the Domestic Equity Transfer, the respective Investors’ rights as provided in the
preceding paragraph of this Section 12.3 shall be restored, and (ii) if, for purpose of conducting such reversal or cancellation of the Domestic Equity Transfer, an Investor is required to transfer any equity interests held by it in the
Domestic Company to any other Person, the Group Companies and the Founders shall indemnify such Investor for any and all Taxes imposed on such Investor by any Governmental Authority in connection with such transfer. 

  
 39 

 12.4    Compliance with Laws. The Group Companies shall,
and each Party (other than the Investors) shall cause the Group Companies to, conduct their respective business in compliance in all material respects with all applicable Laws, and obtain, make and maintain in effect, all Consents from the relevant
Governmental Authority or other Person required in respect of the due and proper establishment and operations of each Group Company as now conducted in accordance with applicable Laws. Without limiting the generality of the foregoing, none of the
Group Companies shall, and the Parties (other than the Investors) shall cause each Group Company not to, and the Parties shall ensure that its and their respective Affiliates and its respective officers, directors, and representatives shall not,
directly or indirectly, (a) offer or give anything of value to any Public Official with the intent of obtaining any improper advantage, affecting or influencing any act or decision of any such Person, assisting any Group Company in obtaining or
retaining business for, or with, or directing business to, any Person, or constituting a bribe, kickback or illegal or improper payment to assist any Group in obtaining or retaining business, (b) take any other action, in each case, in
violation of the Foreign Corrupt Practices Act of the United States of America, as amended (as if it were a U.S. Person), or any other applicable similar anti-corruption, recordkeeping and internal controls Laws, or (c) establish or maintain
any fund or assets in which any Group Company has proprietary rights that have not been recorded in its books and records of Group Company. 

12.5    Insurance. If requested by the Supermajority Preferred Holders, the Company shall promptly purchase
and maintain, and shall cause the Group Companies to promptly purchase and maintain, in effect, insurance policies with respect to the Group Company’s properties, employees, products, operations, and/or business, each in the amounts not less
than that are customarily obtained by companies of similar size, in a similar line of business, and with operations in the PRC. 

12.6    Future Holders of Ordinary Shares. Except with the written consent of the Supermajority Preferred
Holders, the Company covenants that it will cause all future holders of the Company’s Ordinary Shares and all future holders of Ordinary Share Equivalents convertible, exchangeable or exercisable of the Company’s Ordinary Shares (other
than the Investors) to join this Agreement as a party. The Parties hereby agree that such future holders may become parties to this Agreement by executing an instrument of accession to this Agreement in a standard and customary form reasonably
satisfactory to the Supermajority Preferred Holders, without any amendment to this Agreement, pursuant to this Section 12.6. 

12.7    Intellectual Property Protection. Except with the written consent of the Supermajority Preferred
Holders, the Group Companies shall, and shall cause each of the other Group Companies to, take all reasonable steps to protect their respective material Intellectual Property rights, including without limitation (a) registering their material
respective trademarks, brand names, domain names and copyrights, and (b) requiring each employee and consultant of each Group Company to enter into a confidentiality and invention assignment agreement and a
non-competition agreement in form and substance reasonably acceptable to the Supermajority Preferred Holders requiring such persons to protect and keep confidential such Group Company’s confidential
information, intellectual property and trade secrets, prohibiting such persons from competing with such Group Company for a reasonable time after their tenure with any Group Company, and requiring such persons to assign all ownership rights in their
work product to such Group Company, in each case in form and substance reasonably acceptable to the Supermajority Preferred Holders. 

  
 40 

 12.8    Internal Control System. The Parties other than
the Investors shall cause each Group Company to maintain the books and records in accordance with sound business practices and implement and maintain an adequate system of procedures and controls with respect to finance, management, and accounting
that meets international standards of good practice and is reasonably satisfactory to the Supermajority Preferred Holders to provide reasonable assurance that (i) transactions by it are executed in accordance with management’s general or
specific authorization, (ii) transactions by it are recorded as necessary to permit preparation of financial statements in conformity with the Accounting Standards and to maintain asset accountability, (iii) access to assets of it is
permitted only in accordance with management’s general or specific authorization, (iv) the recorded accountability for assets of it is compared with the existing assets at reasonable intervals and appropriate action is taken with respect
to any material differences, (v) segregating duties for cash deposits, cash reconciliation, cash payment, proper approval is established, and (vi) any personal assets or bank accounts of the employees, directors, officers are not mingled
with the corporate assets or corporate bank account, and no Group Company uses any personal bank accounts of any employees, directors, officers thereof during the operation of the business. 

12.9    Non-compete. Unless the Supermajority Preferred
Holders otherwise consent in writing, each Founder shall (a) devote his full time and attention to the business of the Group Companies and will use his commercially reasonable efforts to develop the business and interests of the Group
Companies, (b) during the time when such Founder is a director, officer, employee, consultant or a direct or indirect holder of Equity Securities of a Group Company and for two (2) years after the later date when such person is (X) no
longer a director, officer, employee, consultant or (Y) no longer a direct or indirect holder of Equity Securities of a Group Company, shall not, and shall cause his Affiliate or Associate not to, directly or indirectly, (i) own, manage,
engage in, operate, control, work for, consult with, render services for, do business with, maintain any interest in (proprietary, financial or otherwise) or participate in the ownership, management, operation or control of, any business, whether in
corporate, proprietorship or partnership form or otherwise, that is related to the business of any Group Company or otherwise competes with any Group Company (a “Restricted Business”); provided, however, that the
restrictions contained in this clause (i) shall not restrict the acquisition by such person, directly or indirectly, of less than 5% of the outstanding share capital of any publicly traded company engaged in a Restricted Business;
(ii) solicit any Person who is or has been at any time a customer of the Group for the purpose of offering to such customer goods or services similar to or competing with those offered by any Group Company, or canvass or solicit any Person who
is or has been at any time a supplier or licensor or customer of any Group Company for the purpose of inducing any such Person to terminate its business relationship with such Group Company; or (iii) solicit or entice away or endeavor to
solicit or entice away any director, officer, consultant or employee of any Group Company, and (c) except as otherwise contemplated under the Transaction Documents, shall not disclose to others or use, whether directly or indirectly (except on
behalf of and for the benefit of the Group Companies), any information about the business conducted by any Group Company, or in relation to any Group Company, their respective clients, customers, suppliers and franchisees, and any proprietary
information of any Group Company, in whatever media. Each Founder expressly agrees that the limitations set forth in this Section 12.9 are reasonably tailored and reasonably necessary in light of the circumstances.
Furthermore, if any provision of this Section 12.9 is more restrictive than permitted by the Laws of any jurisdiction in which a Party seeks enforcement thereof, then this
Section 12.9 will be enforced to the greatest extent permitted by Law. Each of the undertakings contained in this Section 12.9 shall be enforceable by each Group Company and/or each
Investor separately and independently of the right of the other Group Companies and the other Investors (if any). 

  
 41 

 12.10    No Avoidance; Voting Trust. Each Group Company
will not, by any voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be performed hereunder by the Group Companies, and each Group Company will at all times in good faith assist and take action as
appropriate in the carrying out of all of the provisions of this Agreement. Except for the transactions contemplated by the Transaction Documents, each Ordinary Holder agrees that it shall not enter into any other agreements or arrangements of any
kind with respect to the voting of any Shares or deposit any Shares in a voting trust or other similar arrangement. 

12.11    United States Tax Matters. 

(i)    None of the Group Companies will take any action inconsistent with its treatment of the Company as a corporation
for U.S. federal income tax purposes or elect to be treated as an entity other than a corporation for U.S. federal income tax purposes. 

(ii)    The Company shall use, and shall cause each of its Subsidiaries to use, its reasonable best efforts to arrange
its management and business activities in such a way that the Company and each of its Subsidiaries are not treated as residents for tax purposes, or is otherwise subject to income tax in, a jurisdiction other than the jurisdiction in which they have
been organized. 
 (iii)    The Company shall use its best effort to avoid future status of the Company or any of its
Subsidiaries as a PFIC. Within forty-five (45) days from the end of each taxable year of the Company, the Company shall determine, in consultation with a reputable accounting firm, whether the Company or any of its Subsidiaries was a PFIC in
such taxable year (including whether any exception to PFIC status may apply). If the Company determines that the Company or any of its Subsidiaries was a PFIC in such taxable year (or if a Governmental Authority or an Investor informs the Company
that it has so determined), it shall, within sixty (60) days from the end of such taxable year, provide the following information to each holder of Preferred Shares (including holders of Ordinary Shares that were converted from Preferred
Shares) that is a United States Person (“Direct US Investor”) and each United States Person that holds either direct or indirect interest in such holder (“Indirect US Investor”) (hereinafter, collectively referred
to as a “PFIC Shareholder”): (i) all information reasonably available to the Company to permit such PFIC Shareholder to (a) accurately prepare its U.S. tax returns and comply with any other reporting requirements, if any,
arising from its investment in the Company and relating to the Company or any of its Subsidiaries’ classification as a PFIC and (b) make any election (including, without limitation, a “qualified electing fund” election under
Section 1295 of the Code), with respect to the Company (or any of its Subsidiaries); and (ii) a completed “PFIC Annual Information Statement” as described under Treasury Regulation
Section 1.1295-1(g). The Company shall be required to provide the information described above to an Indirect US Investor only if the relevant holder of Preferred Share (including holders of Ordinary
Shares that were converted from Preferred Shares) requests in writing that the Company provide such information to such Indirect US Investor and furnish the Company with written identifying information (such as name, address, and other identifying
information) about the Indirect US Investor. 

  
 42 

 (iv)    Each of the Ordinary Holders represents that such Person is not
a United States Person and such Person is not owned, wholly or in part, directly or indirectly, by any United States Person. Each of the Ordinary Holders shall provide prompt written notice to the Company of any subsequent change in its United
States Person status. The Company shall use its best efforts to avoid future status of the Company or any of its Subsidiaries as a CFC. Upon written request of a holder of Preferred Shares (including holders of Ordinary Shares that were converted
from Preferred Shares) from time to time, the Company will promptly provide in writing such information concerning its shareholders and the direct and indirect interest holders in each shareholder sufficient for such holder of Preferred Shares to
determine whether the Company is a CFC. In the event that the Company does not have in its possession all the information necessary for the holder of Preferred Shares (including holders of Ordinary Shares that were converted from Preferred Shares)
to make such determination, the Company shall promptly procure such information from its shareholders. The Company shall, (i) upon written request of a holder of Preferred Shares (including a holder of Ordinary Shares that were converted from
Preferred Shares), furnish on a timely basis all information requested by such holder to satisfy its (or any Indirect US Investor’s) U.S. federal income tax return filing requirements, if any, arising from its investment in the Company and
relating to the Company or any of its Subsidiaries’ classification as a CFC. The Company and each of its Subsidiaries shall use their commercially reasonable best efforts to avoid generating for any taxable year in which the Company or any of
its Subsidiaries is a CFC, income that would be includible in the income of such holder of Preferred Shares (or any Indirect US Investor) pursuant to Section 951 of the Code. 

(v)    The Company shall comply, and shall cause each of its Subsidiaries to comply, with all record-keeping, reporting,
and other requests necessary for the Company and each of its Subsidiaries to comply with any applicable U.S. tax law, or to allow each holder of Preferred Shares (including holders of Ordinary Shares that were converted from Preferred Shares) to
comply with any applicable U.S. tax law and/or avail itself of any provision of U.S. tax laws. The Company shall also provide each holder of Preferred Shares (including holders of Ordinary Shares that were converted from Preferred Shares) with any
information requested by such holder of Preferred Shares to allow such holder of Preferred Shares to comply with U.S. tax laws or to avail itself of any provision of U.S. tax laws. 

(vi)    The cost incurred by the Company in providing the information that it is required to provide, or is required to
cause to be provided, and the cost incurred by the Company in taking the action, or causing the action to be taken, as described in this Section 12.11 shall be borne by the Company. 

12.12    Other Tax Matters. 

(i)    The Parties (other than the Investors) agree to jointly and severally indemnify each Investor from and against any
loss, claim, liability, expense, or other damage (including diminution in the value of the Company business or the Investors’ investment in the Company) attributable to (a) any Taxes (or the
non-payment thereof) of any Group Company for all taxable periods ending on or before the Closing and the portion through the end of the Closing for any taxable period that includes (but does not end on) the
Closing, (b) any Taxes of any other Person imposed by any Governmental Authority on any Group Company as a transferee, successor, withholding agent, accomplice, or party providing conveniences in connection with an event or transaction
occurring before the Closing, and (c) any breach of any representations or warranties contained in Section 12.11. 

  
 43 

 (ii)    In the event of a subsequent sale of securities of the Company
by GGV, IDG, Matrix, Hearst, Yun Qi, Shunwei, Hillhouse or Coatue (each a “Selling Investor”) and with respect to any tax filing, tax position and other communication with the relevant PRC tax authorities for purposes of determining
any income tax, capital gains tax or any other tax calculated with reference to gains made through the purchase and sale of securities of the Company, the Company covenants that each Selling Investor shall be entitled to apply (i) the
Investment Amount (as defined in the Series E Purchase Agreement) for the Series E Preferred Shares purchased by such Selling Investor under the Series E Purchase Agreement (the “Series E Investment Amount”), (ii) the Investment
Amount (as defined in the Series D+ Purchase Agreement) for the Series D+ Preferred Shares purchased by such Selling Investor under the Series D+ Purchase Agreement (the “Series D+ Investment Amount”), (iii) the Investment Amount
(as defined in the Series D Purchase Agreement) for the Series D Preferred Shares purchased by such Selling Investor under the Series D Purchase Agreement (the “Series D Investment Amount”), (iv) the Investment Amount (as defined in
the Series C Purchase Agreement) for the Series C Preferred Shares purchased by such Selling Investor under the Series C Purchase Agreement (the “Series C Investment Amount”), (v) the Series
B-1 Investment Amount (as defined in the Series B Purchase Agreement) and/or the Series B-2 Investment Amount (as defined in the Series B Purchase Agreement) for the Series B Preferred Shares purchased by such
Selling Investor under the Series B Purchase Agreement and (vi) the investment amount for the Series A Preferred Shares and the Series A-1 Preferred Shares purchased by such Selling Investor under the
Series A Purchase Agreement (the “Series A/A-1 Investment Amount”) to its indirect basis in the equity of the WFOE, and the Company covenants that it shall not take any position that is
inconsistent with (or would otherwise adversely impact the credibility of this Section 12.12(ii) in its filings or other communications with the relevant PRC tax authorities. 

(iii)    The Group Companies and the Founders shall indemnify each Selling Investor for any and all Indemnifiable Losses
(as defined in the Series E Purchase Agreement) to the extent such Selling Investor is unable to use its indirect basis in the equity of the WFOE with respect to any tax filing, tax position respect to any tax filing, tax position and other
communication with the relevant PRC tax authorities for purposes of determining any income tax, capital gains tax or any other tax calculated with reference to gains made through the purchase and sale of the Company share due to the WFOE’s
failure to add substantially all of the Series E Investment Amount, Series D+ Investment Amount, Series D Investment Amount, the Series C Investment Amount, the Series B-1 Investment Amount, the Series B-2
Investment Amount and the Series A/A-1 Investment Amount paid by such Selling Investor into its registered capital. 

12.13    Confidentiality. 

(i)    Disclosure of Terms. The terms and conditions of the Transaction Documents, and all Exhibits and Schedules
attached to such agreements, including their existence (collectively, the “Confidential Information”), shall be considered confidential information and shall not be disclosed by any Party hereto to any third party. 

(ii)    Press Releases. No announcement regarding any of the Confidential Information in a press release,
conference, advertisement, announcement, professional or trade publication, mass marketing materials or otherwise to the general public may be made without the prior written consent of the Supermajority Preferred Holders. Any press release issued by
the Company shall not disclose any of the Confidential Information and the final form of such press release shall be approved in advance in writing by the Supermajority Preferred Holders. 

  
 44 

 (iii)    Permitted Disclosures. Notwithstanding the
foregoing, Section 12.13(i) shall not apply to (a) Confidential Information which a restricted party learns from a third party which such third party reasonably believes to have the right to make the disclosure without
breach of confidentiality, provided that the restricted party complies with any restrictions imposed by such third party; (b) Confidential Information which is rightfully in the restricted party’s possession prior to the time of disclosure
by the protected party and not acquired by the restricted party under a confidentiality obligation; (c) Confidential Information which enters the public domain without breach of confidentiality by the restricted party, (d) disclosures of
Confidential Information by a Party to its current or bona fide prospective investor, Affiliates and their respective employees, bankers, lenders, accountants, legal counsels, business partners or representatives or advisors who need to know such
information, in each case only where such persons or entities are informed of the confidential nature of the Confidential Information and are under appropriate nondisclosure obligations in writing substantially similar to those set forth in this
Section 12.13, (e) disclosures of Confidential Information to a bona fide purchaser or transferee of the Shares held by an Investor where such purchaser or transferee is informed of the confidential nature of the
Confidential Information and are under appropriate nondisclosure obligations substantially similar to those set forth in this Section 12.13, (f) disclosures of Confidential Information if such disclosure is approved in
writing by the Company, the Majority Ordinary Holders and the Supermajority Preferred Holders, (g) with respect to each Investor, for fund and inter-fund reporting purposes; and (h) disclosures of Confidential Information to the extent
required pursuant to applicable Law (including the applicable rules of any stock exchange), in which case the Party required to make such disclosure (the “Disclosing Party”) shall provide the other Parties hereto with prompt written
notice of that fact, shall consult with the other Parties hereto regarding such disclosure, and shall, to the extent reasonably possible and with the cooperation and reasonable efforts of the other Parties, seek a protective order, confidential
treatment or other appropriate remedy. In such event, the Disclosing Party shall furnish only that portion of the information which is legally required to be disclosed. 

(iv)    The provisions of this Section 12.13 shall terminate and supersede the provisions of
any separate nondisclosure agreement executed by any of the Parties hereto with respect to the transactions contemplated hereby, including without limitation, any term sheet, letter of intent, memorandum of understanding or other similar agreement
entered into by any of the Group Companies, the Ordinary Holders and the Investors in respect of the transactions contemplated hereby. 

12.14    Restrictions on Transfers. Unless it is in compliance with the Transaction Documents, each of the
Founders and the Key Ordinary Shareholder shall not (regardless of his employment status with the Group Companies), and shall use all of his efforts to cause the other equity holders of the Domestic Company not to, directly or indirectly sell,
assign, transfer, pledge, hypothecate, or otherwise encumber or dispose of in any way or otherwise grant any interest or right with respect to (“Transfer”) all or any part of any interest in any Equity Securities of the Domestic
Company now or hereafter owned or held directly or indirectly by the Founders and the Key Ordinary Shareholder or other equity holder, without the prior written consent of the Supermajority Preferred Holders. Any Transfer of Equity Securities of the
Domestic Company not made in compliance with the above shall be null and void as against the Domestic Company, shall not be recorded on the books of the Domestic Company and shall not be recognized by the Domestic Company or any other Party. 

  
 45 

 12.15    Ordinary Holders’ Further
Covenants. So long as he is an officer, director, employee or shareholder of any of the Group Companies, each Ordinary Holder (other than the Key Ordinary Shareholder and Aquanauts) hereby agrees to take, or cause to be taken, all necessary and
to do, or cause to be done, all things necessary under applicable Laws to abide by the terms of this Agreement, the Transaction Documents and the Memorandum and Articles, as may be amended from time to time, and to cause each Group Company
(including exercising his voting power) to conduct its business as if bound by the Memorandum and Articles. Each Ordinary Holder (other than the Key Ordinary Shareholder and Aquanauts) further agrees to execute and deliver, or cause to be executed
and delivered, such other documents, certificates, agreements and other writings and to take, or cause to be taken, such other actions as deemed necessary in order to consummate or implement expeditiously the provisions of the Memorandum and
Articles, each as may be amended from time to time. 
 12.16    Option to Purchase the Domestic Company.
The Parties hereby acknowledge and agree that, as part of the consideration for the Investors’ investment in the Company and other valuable consideration, the Company has the option, exercisable by the Company or any then Subsidiary thereof at
any time (provided that such purchase by the Company or such subsidiary is permitted under the then applicable Laws of the PRC), to purchase or transfer to an Affiliate of the Company the entire equity interest of the Domestic Company from the
shareholders of Domestic Company at the lowest amount permitted under the Laws of the PRC then applicable. The Parties further agree to effect such transfer of equity interest in the Domestic Company upon and only upon receipt of the written request
of the Supermajority Preferred Holders, provided that such transfer shall at the time of such request be permissible under the Laws of the PRC then applicable. 

12.17    SAFE Registration. If any holder or beneficial owner of any Equity Security of the Company (other
than the Investors) (each, a “Security Holder”) is a “Domestic Resident” as defined in the Circular on Relevant Issues concerning Foreign Exchange Administration for Domestic Residents to Engage in Overseas Investment and
Financing and in Return Investment via Special Purpose Companies issued by SAFE on July 4, 2014, as supplemented by implementing rules and regulations, or any successor rule or regulation under PRC law, including but not limited to any rule or
regulation interpreting or setting forth provisions for implementation of any of the foregoing (the “Circular 37”) and is subject to the SAFE registration or reporting requirements under Circular 37 (such as registration
and/or any amendment to such registration with SAFE), the Parties (other than the Investors) shall use their best efforts to cause such Security Holder to promptly take such actions and execute such instruments to comply with the applicable SAFE
registration or reporting requirements under Circular 37 and/or any other rules and regulations of SAFE (the “SAFE Rules and Regulations”), and in the event such Security Holder fails to comply with the applicable SAFE registration
or reporting requirements under SAFE Rules and Regulations, the Parties (other than the Investors) shall use their best efforts to promptly cause such Security Holder to cease to be a holder or beneficial owner of any Equity Security of the Company.

 12.18    Transfer of Intellectual Property. If and when it is reasonably determined by the Board or the
Supermajority Preferred Holders that there is no necessity for the Domestic Company to hold any existing or future Intellectual Property owned or held by the Domestic Company, upon the Supermajority Preferred Holders’ written request, the
Domestic Company and the WFOE shall, and the Parties (other than the Investors) shall cause the Domestic Company and the WFOE to, take all necessary actions and execute all necessary documents to procure that such Intellectual Property shall be
transferred and assigned to, owned by and/or registered in the name of the WFOE, to the extent permitted by applicable Laws. 

  
 46 

 12.19    Transfer of Key Employees. If and when it is
reasonably determined by the Board or the Supermajority Preferred Holders that there is no necessity for the Domestic Company to retain any Key Employee employed by the Domestic Company, upon the Supermajority Preferred Holders’ written
request, the Parties (other than the Investors) shall procure that such Key Employee shall terminate his/her employment relationship with the Domestic Company and shall execute an employment agreement, a confidentiality and invention assignment
agreement and a non-competition agreement with the WFOE in the form and substance satisfactory to the Supermajority Preferred Holders. 

12.20    Right to Conduct Activities. The Company and each Investor hereby agree and acknowledge that
some or all of the Investors are professional investment funds, and as such invest in numerous portfolio companies, some of which may be competitive with the Company’s business. The Company and each Investor hereby agree that, to the extent
permitted under applicable law, no Investor shall be liable to the Company or to any other Investor for any claim arising out of, or based upon, (a) the investment by an Investor in any entity competitive with the Company or (b) actions
taken by any partner, officer or other representative of any Investor to assist any such competitive company, whether or not such action was taken as a member of the board of directors of such competitive company or otherwise, and whether or not
such action has a detrimental effect on the Company; provided, however, that the foregoing shall not relieve any Investor or any party from liability associated with the misuse of the Company’s confidential information obtained
from the Company. 
 12.21    No use of Investors’ Name. Except for the disclosures permitted under
Section 12.21 hereof, without the prior written consent of the relevant Investor, none of the parties shall use, publish, reproduce, or refer to the names, photos, pictures, trademarks or logos of such Investor or its
respective Affiliate (including without limitation to “GGV” or “纪源”), or any similar name, trademark
or logo in any discussion, documents or materials, including without limitation for marketing or other purposes. This Section 12.21 shall survive the termination of this Agreement. 

12.22    Use of Name or Logo of Shunwei. Without limiting the generality of
Section 12.21 and in furtherance of the foregoing, without the prior written consent of Shunwei, and whether or not Shunwei is then a shareholder of the Company, none of the Parties (excluding Shunwei) shall use, publish or
reproduce: (i) the names or logos of Shunwei, (ii) the names, photos or pictures, or logos of any partner of Shunwei, (iii) the names, logos, trademarks of Xiaomi Corporation, or (iv) any other names, trademarks or logos similar
to the foregoing, in any of their marketing, advertising or promotion materials or otherwise for any marketing, advertising or promotional purposes. This Section 12.22 shall survive the termination of this Agreement. 

12.23    Use of Name or Logo of GGV. Without limiting the generality of
Section 12.21 and in furtherance of the foregoing, without the prior written consent of GGV, none of the parties (excluding GGV) shall use, publish, reproduce: (i) the names or logos of GGV, (ii) the names, photos
or pictures, or logos of any partner of GGV, or (iii) any other names, trademarks or logos similar to the foregoing, in any of their marketing, advertising or promotion materials or otherwise for any marketing, advertising or promotional
purposes. This Section 12.23 shall survive the termination of this Agreement. 

  
 47 

 12.24    Use of Name or Logo of Hillhouse. Without
limiting the generality of Section 12.21 and in furtherance of the foregoing, without the prior written consent of Hillhouse, and whether or not Hillhouse is then a shareholder of the Company, none of the Parties (excluding
Hillhouse) shall use, publish, reproduce, or refer to the name of Hillhouse, its affiliates and/or controlling persons, or the name “Hillhouse”, “高瓴”, “Gaoling”, “Gao Ling”, “Lei Zhang”, “张磊” or any similar name, trademark or logo in any discussion, documents or materials, including without limitation for marketing, advertising, promotional or other purposes. This
Section 12.24 shall survive the termination of this Agreement. 

12.25    Without limiting the generality of Section 12.21 and in furtherance of the foregoing, without the
prior written consent of Coatue, and whether or not Coatue is then a shareholder of the Company, none of the Parties (excluding Coatue) shall use, publish, reproduce, or refer to the name of Coatue, its Affiliates and/or Controlling persons, or the
name “Coatue” or any similar name, trademark or logo in any discussion, documents or materials, including without limitation for marketing, advertising, promotional or other purposes. This Section 12.25 shall survive the termination
of this Agreement. 
 12.26    Qualified IPO. The Group Companies shall, and each Party (other than the
Investors) shall cause the Group Companies to, use their best endeavors to complete a Qualified IPO. 

12.27    Investor Favorable Terms. If any Group Company has granted or grants rights, privileges and/or
protections (other than under the Transaction Documents) to any existing shareholder of the Company that are more favourable than those available to any of Coatue, Hillhouse, Shunwei, IDG or GGV, at any time prior to, on or after the date hereof,
Coatue, Hillhouse, Shunwei, IDG or GGV (as the case may be) shall be automatically entitled to such more favourable rights, privileges and protections. The Founders and the Group Companies shall take all necessary actions to grant such
more favourable rights, privileges and/or protections to Coatue, Hillhouse, Shunwei, IDG or GGV (as the case may be). 

12.28    Corporate Opportunities. It is acknowledged and agreed by the Company (for itself and on behalf of
its Subsidiaries and Affiliates) that, notwithstanding the appointment of the Investor Directors, subject to all applicable laws and securities regulations, and unless otherwise set forth in the Transaction Documents, each Investor and its
respective Affiliates (including investment funds, persons or accounts under its management) shall forever be entitled to, directly or indirectly: 

(i)    acquire, transfer, enter into any derivative or similar transaction, or otherwise enter into a
contract in respect of the equity securities of the Group Companies or any other person; 

(ii)    enter into any agreement, arrangement or understanding with, or otherwise acquire, hold or dispose
of equity securities in, any business which is of the same or similar type to all, or any part of, the business carried on by the Group Companies from time to time; and/or 

  
 48 

 (iii)    refer a business or investment opportunity of
any nature (the “Corporate Opportunity”) to any person whatsoever (whether or not having any affiliation to any of the Group Companies), except for, to the extent applicable, a Corporate Opportunity that is expressly directed to
such Investor Director appointed by such Investor in his/her capacity as a Director of the Company (the “Company Opportunity”), provided that a Company Opportunity is referred to the Company on a first refusal basis, the Company
acknowledges and agrees that, to the extent applicable, such Investor Director appointed by such Investor shall not be in breach of any fiduciary duty or duty of confidentiality for referring a Corporate Opportunity to any person. Any Company
Opportunity not pursued by the Company may be referred to any other person by an Investor or an Investor Director. 
  

	13.	 Miscellaneous. 

13.1    Termination. This Agreement shall terminate upon mutual consent of the Parties hereto. The provisions
of Sections 7, 8, 9, 10, and 11 shall terminate on the consummation of a Qualified IPO. If this Agreement terminates, the Parties shall be released from their obligations under this Agreement, except in respect of
any obligation stated, explicitly or otherwise, to continue to exist after the termination of this Agreement (including without limitation those under Sections 2 through 6, Section 12 and
Section 13). If any Party breaches this Agreement before the termination of this Agreement, it shall not be released from its obligations arising from such breach on termination. 

13.2    Further Assurances. Upon the terms and subject to the conditions herein, each of the Parties hereto
agrees to use its reasonable best efforts to take or cause to be taken all action, to do or cause to be done, to execute such further instruments, and to assist and cooperate with the other Parties hereto in doing, all things necessary, proper or
advisable under applicable Laws or otherwise to consummate and make effective, in the most expeditious manner practicable, the transactions contemplated by this Agreement and, to the extent reasonably requested by another Party, to enforce rights
and obligations pursuant hereto. 
 13.3    Assignments and Transfers; No Third Party Beneficiaries.
Except as otherwise provided herein, this Agreement and the rights and obligations of the Parties hereunder shall inure to the benefit of, and be binding upon, their respective successors, assigns and legal representatives, but shall not otherwise
be for the benefit of any third party. Subject to Section 6.7 hereof, the rights of any Investor hereunder are assignable to (i) their respective Affiliates; or (ii) any Person in connection with the transfer
(subject to Applicable Securities Laws and other Laws) of Equity Securities held by such Investor but only to the extent of such transfer, and any such transferee shall execute and deliver to the Company a joinder agreement becoming a party hereto
as an “Investor” subject to the terms and conditions hereof. Subject to the foregoing, this Agreement and the rights and obligations of any Party hereunder shall not otherwise be assigned without the mutual written consent of the other
Parties. 
 13.4    Governing Law. This Agreement shall be governed by and construed under the Laws of the
Hong Kong SAR, without regard to principles of conflict of laws thereunder. 
 13.5    Dispute Resolution. 

(i)    Any dispute, controversy or claim (each, a “Dispute”) arising out of or relating to this
Agreement, or the interpretation, breach, termination, validity or invalidity thereof, shall be referred to arbitration upon the demand of either party to the dispute with notice (the “Arbitration Notice”) to the other. 

(ii)    The Dispute shall be settled by arbitration in Hong Kong by the Hong Kong International Arbitration Centre (the
“HKIAC”) in accordance with the Hong Kong International Arbitration Centre Administered Arbitration Rules (the “HKIAC Rules”) in force when the Arbitration Notice is submitted in accordance with the HKIAC Rules.
There shall be three (3) arbitrators. 

  
 49 

 (iii)     The arbitration shall be conducted in English. 

(iv)    The award of the arbitral tribunal shall be final and binding upon the parties thereto, and the prevailing party
may apply to a court of competent jurisdiction for enforcement of such award. 
 (v)    The arbitral tribunal shall
decide any Dispute submitted by the parties to the arbitration strictly in accordance with the substantive Law of the State of California (without regard to principles of conflict of Laws thereunder) and shall not apply any other substantive Law.

 (vi)    Any party to the Dispute shall be entitled to seek preliminary injunctive relief, if possible, from any
court of competent jurisdiction pending the constitution of the arbitral tribunal. 
 (vii)    During the course of the
arbitral tribunal’s adjudication of the Dispute, this Agreement shall continue to be performed except with respect to the part in dispute and under adjudication. 

13.6    Notices. Any notice required or permitted pursuant to this Agreement shall be given in writing and
shall be given either personally or by sending it by next-day or second-day courier service, fax, electronic mail or similar means to the address of the relevant Party
as shown on Schedule I (or at such other address as such Party may designate by fifteen (15) days’ advance written notice to the other Parties to this Agreement given in accordance with this Section 13.6).
Where a notice is sent by next-day or second-day courier service, service of the notice shall be deemed to be effected by properly addressing, pre-paying and sending by next-day or second-day service through an internationally-recognized courier a letter containing the notice,
with a written confirmation of delivery, and to have been effected at the earlier of (i) delivery (or when delivery is refused) and (ii) expiration of two (2) Business Days after the letter containing the same is sent as aforesaid.
Where a notice is sent by fax or electronic mail, service of the notice shall be deemed to be effected by properly addressing, and sending such notice through a transmitting organization, with a written confirmation of delivery, and to have been
effected on the day the same is sent as aforesaid, if such day is a Business Day and if sent during normal business hours of the recipient, otherwise the next Business Day. Notwithstanding the foregoing, to the extent a “with a copy to”
address is designated, notice must also be given to such address in the manner above for such notice, request, consent or other communication hereunder to be effective. 

13.7    Expenses. If any action at law or in equity is necessary to enforce or interpret the terms of this
Agreement, the prevailing Party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such Party may be entitled. 

  
 50 

 13.8    Rights Cumulative; Specific Performance. Each and
all of the various rights, powers and remedies of a Party hereto will be considered to be cumulative with and in addition to any other rights, powers and remedies which such Party may have at Law or in equity in the event of the breach of any of the
terms of this Agreement. The exercise or partial exercise of any right, power or remedy will neither constitute the exclusive election thereof nor the waiver of any other right, power or remedy available to such Party. Without limiting the
foregoing, the Parties hereto acknowledge and agree irreparable harm may occur for which money damages would not be an adequate remedy in the event that any of the provisions of this Agreement were not performed in accordance with their specific
terms or were otherwise breached. It is accordingly agreed that the Parties shall be entitled to seek injunction to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement. 

13.9    Successor Indemnification. If any Group Company or any of its successors or assignees
consolidates with or merges into any other Person and is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper provision shall be made so that the successors and assignees of such
Group Company assume the obligations of such Group Company with respect to indemnification of the Investor Directors as in effect immediately before such transaction, whether such obligations are contained in the Charter Documents, or elsewhere, as
the case may be. 
 13.10    Severability. In case any provision of the Agreement shall be invalid,
illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. If, however, any provision of this Agreement shall be invalid, illegal, or unenforceable under any
such applicable Law in any jurisdiction, it shall, as to such jurisdiction, be deemed modified to conform to the minimum requirements of such Law, or, if for any reason it is not deemed so modified, it shall be invalid, illegal, or unenforceable
only to the extent of such invalidity, illegality, or limitation on enforceability without affecting the remaining provisions of this Agreement, or the validity, legality, or enforceability of such provision in any other jurisdiction. 

13.11    Amendments and Waivers. Any provision in this Agreement and Charter Documents may be amended and
the observance thereof may be waived (either generally or in a particular instance and either retroactively or prospectively), only by the written consent of (i) the Company; (ii) holders of at least 2/3 of the voting power of the then
outstanding Series A Preferred Shares and Series A-1 Preferred Shares held by all Investors (voting together as a single class and to the exclusion of other classes and series of Preferred Shares); (iii)
holders of at least 51% of the voting power of the then outstanding Series B Preferred Shares held by all Investors (voting together as a single class and to the exclusion of other classes and series of Preferred Shares); (iv) holders of at least
51% of the voting power of the then outstanding Series C Preferred Shares held by all Investors (voting together as a single class and to the exclusion of other classes and series of Preferred Shares); (v) holders of at least 51% of the voting power
of the then outstanding Series D Preferred Shares held by all Investors (voting together as a single class and to the exclusion of other classes and series of Preferred Shares); (vi) the Majority Series E Holders; and (vii) as to the Ordinary
Holders, only by the Majority Ordinary Holders; provided, however, that (1) no amendment or waiver shall be effective or enforceable in respect of a holder of the Ordinary Shares or a holder of any series of the Preferred Shares of the Company
if such amendment or waiver affects such holder, materially and adversely differently from the other holders of the Ordinary Shares or the other holders of the same series of the Preferred Shares, respectively, unless such holder consents in writing
to such amendment or waiver (for the avoidance of doubt, Series D Preferred Shares shall be a separate class of shares different from Series D+ Preferred Shares), and (2) any provision that specifically and expressly gives a right to a named
Investor shall not be amended or waived without the prior written consent of such named Investor. Notwithstanding the foregoing, any Party hereunder may waive any of its/his rights hereunder without obtaining the consent of any parties. Any
amendment or waiver effected in accordance with this Section 13.11 shall be binding upon all the Parties hereto. 

  
 51 

 13.12    No Waiver. Failure to insist upon strict
compliance with any of the terms, covenants, or conditions hereof will not be deemed a waiver of such term, covenant, or condition, nor will any waiver or relinquishment of, or failure to insist upon strict compliance with, any right, power or
remedy hereunder at any one or more times be deemed a waiver or relinquishment of such right, power or remedy at any other time or times. 

13.13    Rights of Warrant Holder. Subject to Section 10 of the GGV Warrant and Section 10 of the
IDG Warrant, each holder of any Warrant shall be treated as if it had exercised the Warrant and received all of the corresponding Series E Preferred Shares issuable under the Warrant, and shall be entitled to the same rights and privileges and
subject to the same obligations of, the class of Series E Preferred Shares as provided in the Transaction Documents, provided that if the Warrant is to be transferred to a suitable offshore successor or assigns in accordance with
Section 4.1(b)(B) of the GGV Convertible Loan Agreement and/or Section 4.1(b)(B) of the IDG Convertible Loan Agreement (as the case may be), such successor or assigns shall be entitled to the same rights and benefits as provided in this
Section 13.13. 
 13.14    Delays or Omissions. No delay or omission to exercise any right, power or
remedy accruing to any Party under this Agreement, upon any breach or default of any other Party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting Party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any
single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any Party of any breach or default under this Agreement,
or any waiver on the part of any Party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. 

13.15    No Presumption. The Parties acknowledge that any applicable Law that would require interpretation
of any claimed ambiguities in this Agreement against the Party that drafted it has no application and is expressly waived. If any claim is made by a Party relating to any conflict, omission or ambiguity in the provisions of this Agreement, no
presumption or burden of proof or persuasion will be implied because this Agreement was prepared by or at the request of any Party or its counsel. 

13.16    Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be
deemed an original, but all of which together shall constitute one and the same instrument. Facsimile and e-mailed copies of signatures shall be deemed to be originals for purposes of the effectiveness
of this Agreement. 
 13.17    Entire Agreement. This Agreement (including the Exhibit and the Schedule
hereto) constitutes the full and entire understanding and agreement among the Parties with regard to the subjects hereof, and supersedes all other agreements between or among any of the Parties with respect to the subject matter hereof. 

  
 52 

 13.18    Control. In the event of any conflict or
inconsistency between any of the terms of this Agreement and any of the terms of any of the Charter Documents for any of the Group Companies, or in the event of any dispute related to any such Charter Document, the terms of this Agreement
shall prevail in all respects as regards the shareholders, the shareholders shall give full effect to and act in accordance with the provisions of this Agreement over the provisions of the Charter Documents, and the shareholders shall
exercise all voting and other rights and powers (including to procure any required alteration to such Charter Documents to resolve such conflict or inconsistency) to make the provisions of this Agreement effective, and not to take any
actions that impair any provisions in this Agreement. 
 13.19    Performance. The Ordinary Holders
(other than the Key Ordinary Shareholder and Aquanauts) irrevocably agree to cause and guarantee the performance by each Group Company of all of their respective covenants and obligations under this Agreement. 

13.20    Aggregation of Shares. All Shares held or acquired by any Affiliates shall be aggregated together
for the purpose of determining the availability of any rights of any Investor under this Agreement. 

13.21    Adjustments for Share Splits, Etc. Wherever in this Agreement there is a reference to a specific
number of Shares of the Company, then, upon the occurrence of any subdivision, combination or share dividend of the relevant class or series of the Shares, the specific number of shares so referenced in this Agreement shall automatically be
proportionally adjusted to reflect the effect on the outstanding shares of such class or series of Shares by such subdivision, combination or share dividend. 

13.22    Grant of Proxy. Upon the failure of any Ordinary Holder (other than the Key Ordinary Shareholder
and Aquanauts) to vote the Equity Securities of the Company held thereby, to implement the provisions of and to achieve the purposes of this Agreement, such Ordinary Holder (other than the Key Ordinary Shareholder and Aquanauts), hereby grants to a
Person designated by the Company a proxy coupled with an interest in all Equity Securities of the Company held by it/him, which proxy shall be irrevocable until this Agreement terminates pursuant to its terms or this
Section 13.22 is amended to remove such grant of proxy in accordance with Section 13.11 hereof, to vote all such Equity Securities to implement the provisions of and to achieve the purposes of this
Agreement. 
 13.23    Use of English Language. This Agreement has been executed and delivered in the
English language. Any translation of this Agreement into another language shall have no interpretive effect. All documents or notices to be delivered pursuant to or in connection with this Agreement shall be in the English language or, if any such
document or notice is not in the English language, accompanied by an English translation thereof, and the English language version of any such document or notice shall control for purposes thereof. 

13.24    Independent Nature of Investors’ Obligations and Rights. The obligations of each Investor
under this Agreement are several and not joint, and no Investor is responsible in any way for the performance or conduct of any other Investor in connection with the transactions contemplated hereby. Nothing contained herein and no action taken by
any Investor pursuant hereto, shall be or shall be deemed to constitute a partnership, association, joint venture, or joint group with respect to the Investors. Each Investor agrees that no other Investor has acted as an agent for such Investor in
connection with the transactions contemplated hereby. 

  
 53 

 13.25    Termination of Prior Agreement. This Agreement
supersedes and replaces the Prior Agreement in its entirety, and the Prior Agreement shall be of no further force or effect as of the Effective Date. Each of the Group Companies, the Founders, the Key Ordinary Shareholder and the Investors that is a
party to the Prior Agreement hereby expressly consents and agrees to this amendment and restatement of the Prior Agreement and the Company, the Founders and the Key Ordinary Shareholder represents and warrants that this Agreement has been duly
approved by the requisite parties to the Prior Agreement sufficient to constitute a valid amendment to the Prior Agreement that is binding on all parties to the Prior Agreement. 

[The remainder of this page has been intentionally left blank.] 

  
 54 

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	COMPANY:	 		 	Exacloud Limited
				
		 		 	By:	 	 /s/ Xiaohuang Huang
(黄晓煌)

		 		 	Name:	 	Xiaohuang Huang (黄晓煌)
		 		 	Title:	 	Director

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
 The undersigned (1) understands that this Agreement imposes
obligations on him, (2) understands English and has read and understands the terms of this Agreement or has had this Agreement translated and explained to him, and (3) has considered this Agreement with his own tax and legal advisors and
has relied solely on such advisors for tax and legal advice and will be responsible for his own liabilities resulting from this Agreement. 
 签字人通晓英语,已阅读了本协议并且理解本协议的条款(或者已经请人提供了本协议的翻译件,

并获得了逐条的讲解),理解签字人在本协议下的义务,已与其税务和法律顾问一起审查了本协议,没有依赖任何税务和法律顾问的建议(签字人自己的税务和法律顾问除外),会履行其在本协议下的所有义务,并支付其在本协议下所需缴纳的款项。
 
 FOUNDER:     

 

	
	 /s/ Xiaohuang Huang
(黄晓煌)

	Xiaohuang Huang (黄晓煌)

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
 The undersigned (1) understands that this Agreement imposes
obligations on him, (2) understands English and has read and understands the terms of this Agreement or has had this Agreement translated and explained to him, and (3) has considered this Agreement with his own tax and legal advisors and
has relied solely on such advisors for tax and legal advice and will be responsible for his own liabilities resulting from this Agreement. 
 签字人通晓英语,已阅读了本协议并且理解本协议的条款(或者已经请人提供了本协议的翻译件,

并获得了逐条的讲解),理解签字人在本协议下的义务,已与其税务和法律顾问一起审查了本协议,没有依赖任何税务和法律顾问的建议(签字人自己的税务和法律顾问除外),会履行其在本协议下的所有义务,并支付其在本协议下所需缴纳的款项。
 
 FOUNDER:     

 

	
	 /s/ Hang Chen (陈航)

	Hang Chen (陈航)

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
 The undersigned (1) understands that this Agreement imposes
obligations on him, (2) understands English and has read and understands the terms of this Agreement or has had this Agreement translated and explained to him, and (3) has considered this Agreement with his own tax and legal advisors and
has relied solely on such advisors for tax and legal advice and will be responsible for his own liabilities resulting from this Agreement. 
 签字人通晓英语,已阅读了本协议并且理解本协议的条款(或者已经请人提供了本协议的翻译件,

并获得了逐条的讲解),理解签字人在本协议下的义务,已与其税务和法律顾问一起审查了本协议,没有依赖任何税务和法律顾问的建议(签字人自己的税务和法律顾问除外),会履行其在本协议下的所有义务,并支付其在本协议下所需缴纳的款项。
 
 FOUNDER:     

 

	
	 /s/ Hao Zhu (朱皓)

	Hao Zhu (朱皓)

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	HK COMPANY:	 		 	 Exacloud (Hong Kong) Limited

(億雲(香港
)有限公司)

				
		 		 	By:	 	 /s/ Xiaohuang Huang
(黄晓煌)

		 		 	Name:	 	Xiaohuang Huang (黄晓煌)
		 		 	Title:	 	Director

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	WFOE:	 		 	 Hangzhou Yunjiazhuang Network Technology Co., Ltd.

(杭州云家装网络科技有限公司
)

				
		 		 	By:	 	 /s/ Xiaohuang Huang
(黄晓煌)

		 		 	Name:	 	Xiaohuang Huang (黄晓煌)
		 		 	Title:	 	Legal Representative

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	WFOE’S SUBSIDIARY:	 		 	Shanghai Kujiale Network Technology Co., Ltd.
		 		 	(上海酷家乐网络科技有限公司)
				
		 		 	By:	 	 /s/ Xiaohuang Huang
(黄晓煌)

		 		 	Name:	 	Xiaohuang Huang (黄晓煌)
		 		 	Title:	 	Legal Representative

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	DOMESTIC COMPANY:	 		 	Hangzhou QunHe Information Technology Co., Ltd.
		 		 	(杭州群核信息技术有限公司)
				
		 		 	By:	 	 /s/ Xiaohuang Huang
(黄晓煌)

		 		 	Name:	 	Xiaohuang Huang (黄晓煌)
		 		 	Title:	 	Legal Representative

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

			
	 Shanghai Mengdai Internet Technology Co., Ltd.

	
上海蒙袋网络科技有限公司

		
	By:	 	 /s/ 苏奇 (Qi Su)

	Name:	 	苏奇 (Qi Su)
	Title:	 	Executive Director

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

			
	Shanghai Modai Internet Technology Co., Ltd.
	上海模袋网络科技有限公司
		
	By:	 	 /s/ 朱皓 (Hao Zhu)

	Name:	 	朱皓 (Hao Zhu)
	Title:	 	Executive Director

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
 The undersigned (1) understands that this Agreement imposes
obligations on him, (2) understands English and has read and understands the terms of this Agreement or has had this Agreement translated and explained to him, and (3) has considered this Agreement with his own tax and legal advisors and
has relied solely on such advisors for tax and legal advice and will be responsible for his own liabilities resulting from this Agreement. 
 签字人通晓英语,已阅读了本协议并且理解本协议的条款(或者已经请人提供了本协议的翻译件,

并获得了逐条的讲解),理解签字人在本协议下的义务,已与其税务和法律顾问一起审查了本协议,没有依赖任何税务和法律顾问的建议(签字人自己的税务和法律顾问除外),会履行其在本协议下的所有义务,并支付其在本协议下所需缴纳的款项。
 
  

							
	 KEY ORDINARY
 SHAREHOLDER:
	 		 	 Mountain Glacier Investments Ltd.

(冰川山脉投资有限公司)

				
		 		 	By:	 	 /s/ Huai Wang
(王淮)

		 		 	Name:	 	Huai Wang (王淮)
		 		 	Title:	 	Director

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
 The undersigned (1) understands that this Agreement imposes
obligations on him, (2) understands English and has read and understands the terms of this Agreement or has had this Agreement translated and explained to him, and (3) has considered this Agreement with his own tax and legal advisors and
has relied solely on such advisors for tax and legal advice and will be responsible for his own liabilities resulting from this Agreement. 
 签字人通晓英语,已阅读了本协议并且理解本协议的条款(或者已经请人提供了本协议的翻译件,

并获得了逐条的讲解),理解签字人在本协议下的义务,已与其税务和法律顾问一起审查了本协议,没有依赖任何税务和法律顾问的建议(签字人自己的税务和法律顾问除外),会履行其在本协议下的所有义务,并支付其在本协议下所需缴纳的款项。
 
  

							
	ORDINARY SHAREHOLDER:	 		 	Aquanauts 3820 III L.P.
				
		 		 	By:	 	 /s/ Mingming Huang

		 		 	Name:	 	Mingming Huang
		 		 	Title:	 	Authorised Signatory

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	INVESTORS:	 		 	IDG Technology Venture Investment IV, L.P.
			
		 		 	 By: IDG Technology Venture Investment IV, LLC,

Its General Partner

				
		 		 	By:	 	 /s/ Chi Sing Ho

		 		 	Name:	 	Chi Sing Ho
		 		 	Title:	 	Authorized Signatory
			
		 		 	IDG Technology Venture Investment V, L.P.
			
		 		 	 By: IDG Technology Venture Investment V, LLC,

Its General Partner

				
		 		 	By:	 	 /s/ Chi Sing Ho

		 		 	Name:	 	Chi Sing Ho
		 		 	Title:	 	Authorized Signatory

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	INVESTORS:	 		 	New Gultar Limited
				
		 		 	By:	 	 /s/ Chi Sing Ho

		 		 	Name:	 	Chi Sing Ho
		 		 	Title:	 	Authorized Signatory

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	INVESTORS:	 		 	GGV Capital V L.P.
		 		 	By: GGV Capital V L.L.C., its General Partner
				
		 		 	By:	 	 /s/ Stephen Hyndman

		 		 	Name:	 	Stephen Hyndman
		 		 	Title:	 	Attorney in Fact
			
		 		 	GGV Capital V Entrepreneurs Fund L.P.
		 		 	By: GGV Capital V L.L.C., its General Partner
				
		 		 	By:	 	 /s/ Stephen Hyndman

		 		 	Name:	 	Stephen Hyndman
		 		 	Title:	 	Attorney in Fact

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	INVESTORS:	 		 	Matrix Partners China III Hong Kong Limited
			
		 		 	 /s/ Yibo Shao

		 		 	Name:	 	Yibo Shao
		 		 	Title:	 	Director

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	INVESTORS:	 		 	Qingting Investments Pte. Ltd.
				
		 		 	By:	 	 /s/ Choun Chee Kong

		 		 	Name:	 	Choun Chee Kong
		 		 	Title:	 	Authorized Signatory

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	INVESTORS:	 		 	Yun Qi Partners I, L.P.
			
		 		 	 By: Yun Qi Partners I GP, Ltd.,
 its
general partner

				
		 		 	By:	 	 /s/ Yi Pin Ng

		 		 	Name:	 	Yi Pin Ng
		 		 	Title:	 	Director

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	INVESTORS:	 		 	HES Ventures I, Inc.
				
		 		 	By:	 	 /s/ Kenneth A. Bronfin

		 		 	Name:	 	Kenneth A. Bronfin
		 		 	Title:	 	Authorized Signatory

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	INVESTORS:	 		 	Hearst Ventures Inc.
				
		 		 	By:	 	 /s/ Kenneth A. Bronfin

		 		 	Name:	 	Kenneth A. Bronfin
		 		 	Title:	 	Authorized Signatory

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	INVESTORS:	 		 	Shunwei Growth III Limited
				
		 		 	By:	 	 /s/ Koh Tuck Lye
(许达来)

		 		 	Name:	 	Koh Tuck Lye (许达来)
		 		 	Title:	 	Director

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	INVESTORS:	 		 	Linear Venture, Ltd.
				
		 		 	By:	 	 /s/ Huai Wang (王淮)

		 		 	Name:	 	Huai Wang (王淮)
		 		 	Title:	 	Director

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	INVESTORS:	 		 	HH SUM-I Holdings Limited
				
		 		 	By:	 	 /s/ Colm O’Connell

		 		 	Name:	 	Colm O’Connell
		 		 	Title:	 	Director

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	INVESTORS:	 		 	Shanghai Yuanyan Enterprise Management Consulting Partnership (Limited Partnership)
(上海源彦企业管理咨询合伙企业)
				
		 		 	By:	 	 /s/ Bingdong Xu
(徐炳东)

		 		 	Name:	 	Bingdong Xu (徐炳东)
		 		 	Title:	 	Authorized Signatory

 IN WITNESS WHEREOF, the parties hereto have caused their respective duly authorized
representatives to execute this Agreement as of the date and year first above written. 
  

							
	INVESTORS:	 		 	Coatue PE Asia 36 LLC
		 		 	By:    Coatue Management, L.L.C., its investment manager
				
		 		 	By:	 	 /s/ Zachary Feingold

		 		 	Name:	 	Zachary Feingold
		 		 	Title:	 	Authorized SignatoryEX-10.1

 Exhibit 10.1 

EXACLOUD LIMITED 

EQUITY INCENTIVE PLAN (RESTATED IN 2017) 

ADOPTED BY THE BOARD OF DIRECTORS:
AUGUST 28, 2014 
 APPROVED BY THE SHAREHOLDERS:
AUGUST 28, 2014 
 AMENDED BY THE BOARD OF
DIRECTORS: JUNE 30, 2017 
 TERMINATION DATE: AUGUST 28,
2024 
 1. GENERAL. 

(a) Eligible Share Award Recipients. Employees, Directors and Consultants are eligible to receive Share Awards. 

(b) Available Share Awards. The Plan provides for the grant of the following types of Share Awards: (i) Options, (ii) Share
Appreciation Rights, (iii) Restricted Share Awards, (iv) Restricted Share Unit Awards, and (v) Other Share Awards. 
 (c)
Purpose. The Plan, through the granting of Share Awards, is intended to help the Company to secure and retain the services of eligible award recipients, provide incentives for such persons to exert maximum efforts for the success of the Company
and any Affiliate and provide means by which the eligible recipients may benefit from increases in value of the Ordinary Shares. 
 2.
ADMINISTRATION. 
 (a) Administration by Board. The Board will administer the Plan. The Board may delegate
administration of the Plan to a Committee or Committees, as provided in Section 2(c). 
 (b) Powers of Board. The Board will
have the power, subject to, and within the limitations of, the express provisions of the Plan: 
 (i) To determine from time to time
(A) who will be granted Share Awards; (B) when and how each Share Award will be granted; (C) what type of Share Award will be granted; (D) the provisions of each Share Award (which need not be identical), including when a person
will be permitted to exercise or otherwise receive cash or Ordinary Shares under the Share Award; (E) the number of Ordinary Shares subject to a Share Award; and (F) the Fair Value applicable to a Share Award; provided, however, such
determination shall be subject to the affirmative vote of each Investor Director (as defined in the memorandum and articles of association of the Company (as amended and restated)). 

(ii) To construe and interpret the Plan and Share Awards granted under it, and to establish, amend and revoke rules and regulations for
administration of the Plan and Share Awards. The Board, in the exercise of these powers, may correct any defect, omission or inconsistency in the Plan or in any Share Award Agreement, in a manner and to the extent it will deem necessary or expedient
to make the Plan or Share Award fully effective. 

  
 1. 

 (iii) To settle all controversies regarding the Plan and Share Awards granted under
it. 
 (iv) To accelerate, in whole or in part, the time at which a Share Award may be exercised or vest (or at which cash or
Ordinary Shares may be issued). 
 (v) To suspend or terminate the Plan at any time. Except as otherwise provided in the Plan or a
Share Award Agreement, suspension or termination of the Plan will not impair a Participant’s rights under his or her then-outstanding Share Award without his or her written consent except as provided in subsection (viii) below. 

(vi) To amend the Plan in any respect the Board deems necessary or advisable, subject to the limitations, if any, of applicable law.
However, if required by applicable law, and except as provided in Section 9(a) relating to Capitalization Adjustments, the Company will seek shareholder approval of any amendment of the Plan that (A) materially increases the number of
Ordinary Shares available for issuance under the Plan, (B) materially expands the class of individuals eligible to receive Share Awards under the Plan, (C) materially increases the benefits accruing to Participants under the Plan,
(D) materially reduces the price at which Ordinary Shares may be issued or purchased under the Plan, (E) materially extends the term of the Plan, or (F) materially expands the types of Share Awards available for issuance under the
Plan. Except as provided in the Plan (including subsection (viii) below) or a Share Award Agreement, no amendment of the Plan will impair a Participant’s rights under an outstanding Share Award unless (1) the Company requests the
consent of the affected Participant, and (2) such Participant consents in writing. 
 (vii) To submit any amendment to the Plan
for shareholder approval, including, but not limited to, amendments to the Plan intended to satisfy the requirements of Section 422 of the Code regarding Incentive Share Options. 

(viii) To approve forms of Share Award Agreements for use under the Plan and to amend the terms of any one or more Share Awards,
including, but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Share Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; provided
however, that a Participant’s rights under any Share Award will not be impaired by any such amendment unless (A) the Company requests the consent of the affected Participant, and (B) such Participant consents in writing.
Notwithstanding the foregoing, (1) a Participant’s rights will not be deemed to have been impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially impair the
Participant’s rights, and (2) subject to the limitations of applicable law, if any, the Board may amend the terms of any one or more Share Awards without the affected Participant’s consent (A) to maintain the tax qualified status
of the Share Award (B) to clarify the manner of exemption from, or to bring the Share Award into compliance with, Section 409A or Section 457A of the Code; or (C) to comply with other applicable laws. 

(ix) Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best
interests of the Company and that are not in conflict with the provisions of the Plan or Share Awards. 

  
 2. 

 (x) To adopt such procedures and sub-plans as are necessary or appropriate to permit
participation in the Plan by Employees, Directors or Consultants who are foreign nationals or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Share Award
Agreement that are required for compliance with the laws of the relevant foreign jurisdiction). Without limiting the generality of the foregoing, the Board specifically is authorized to adopt rules, procedures and subplans, regarding, without
limitation, conversion of local currency, obligations to pay payroll tax, determination of beneficiary designation requirements, withholding procedures and handling of share issuances, which may vary according to local requirements. 

(xi) To effect, with the consent of any adversely affected Participant, (A) the reduction of the exercise, purchase or strike
price of any outstanding Share Award; (B) the cancellation of any outstanding Share Award and the grant in substitution therefor of a new (1) Option, (2) Share Appreciation Right, (3) Restricted Share Award, (4) Restricted
Share Unit Award, (5) Other Share Award, (6) cash and/or (7) other valuable consideration determined by the Board, in its sole discretion, with any such substituted award (x) covering the same or a different number of Ordinary
Shares as the cancelled Share Award and (y) granted under the Plan or another equity or compensatory plan of the Company; or (C) any other action that is treated as a repricing under generally accepted accounting principles. 

(c) Delegation to Committee. The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If
administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to
delegate to a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee). Any delegation of administrative
powers will be reflected in resolutions, not inconsistent with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable). The Committee may, at any time, abolish the subcommittee and/or revest in the Committee
any powers delegated to the subcommittee. The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously delegated. 

(d) Delegation to an Officer. The Board may delegate to one (1) or more Officers the authority to do one or both of the following:
(i) designate Employees who are not Officers to be recipients of Options and SARs (and, to the extent permitted by applicable law, other Share Awards) and, to the extent permitted by applicable law, the terms of such Share Awards, and
(ii) determine the number of Ordinary Shares to be subject to such Share Awards granted to such Employees; provided, however, that the Board resolutions regarding such delegation will specify the total number of Ordinary Shares that may be
subject to the Share Awards granted by such Officer and that such Officer may not grant a Share Award to himself or herself. Any such Share Awards will be granted on substantially the form of Share Award Agreement most recently approved for use by
the Committee or the Board, unless otherwise provided in the resolutions approving the delegation authority. The Board may not delegate authority to an Officer who is acting solely in the capacity of an Officer (and not also as a Director) to
determine the Fair Value pursuant to Section 13(s) below. 

  
 3. 

 (e) Effect of Board’s Decision. All determinations, interpretations and
constructions made by the Board in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons. 
 3.
SHARES SUBJECT TO THE PLAN. 
 (a) Share Reserve. 

(i) Subject to Section 9(a) relating to Capitalization Adjustments, the aggregate number of Ordinary Shares that may be issued
pursuant to Share Awards from and after the Effective Date will not exceed 212,976,607(1) Ordinary Shares (the “Share Reserve”). For clarity, the Share Reserve in this
Section 3(a) is a limitation on the number of Ordinary Shares that may be issued pursuant to the Plan. Accordingly, this Section 3(a) does not limit the granting of Share Awards except as provided in Section 6(a). 

(b) Reversion of Shares to the Share Reserve. If a Share Award or any portion thereof (i) expires or otherwise terminates without
all of the shares covered by such Share Award having been issued or (ii) is settled in cash (i.e., the Participant receives cash from the company rather than share), such expiration, termination or settlement will not reduce (or
otherwise offset) the number of Ordinary Shares that may be available for issuance under the Plan. If any Ordinary Shares issued pursuant to a Share Award are forfeited back to or repurchased by the Company because of the failure to meet a
contingency or condition required to vest such shares in the Participant, then the shares that are forfeited or repurchased will revert to and again become available for issuance under the Plan. Any shares reacquired by the Company in satisfaction
of tax withholding obligations on a Share Award or as consideration for the exercise or purchase price of a Share Award will again become available for issuance under the Plan. 

(c) Source of Shares. The shares issuable under the Plan will be authorized but unissued or reacquired Ordinary Shares, including
shares repurchased by the Company on the open market or otherwise. 
 4. ELIGIBILITY. 

(a) Eligibility for Specific Share Awards. Share Awards may be granted to Employees, Directors and Consultants. 

(b) Consultants. A Consultant will not be eligible for the grant of a Share Award if, at the time of grant, either the offer or sale of
the Company’s securities to such Consultant is not exempt under Rule 701 because of the nature of the services that the Consultant is providing to the Company, because the Consultant is not a natural person, or because of any other provision of
Rule 701, unless the Company determines that such grant need not comply with the requirements of Rule 701 and will satisfy another exemption under the Securities Act, as applicable, as well as comply with the securities laws of all other relevant
jurisdictions. 
  

	(1)	 Approved by the board of directors and shareholders of the Company on August 12, 2019. 

  
 4. 

 5. PROVISIONS RELATING TO OPTIONS
AND SHARE APPRECIATION RIGHTS. 
 Each Option or SAR will be in such form
and will contain such terms and conditions as the Board deems appropriate. The provisions of separate Options or SARs need not be identical; provided, however, that each Share Award Agreement for Options or SARs will conform to (through
incorporation of provisions hereof by reference in the applicable Share Award Agreement or otherwise) the substance of each of the following provisions: 

(a) Term. No Option or SAR will be exercisable after the expiration of ten (10) years from the date of its grant or such shorter
period specified in the Share Award Agreement. 
 (b) Exercise Price. The exercise or strike price of each Option or SAR granted to a
US Participant will be not less than one hundred percent (100%) of the Fair Value of the Ordinary Shares subject to the Option or SAR on the date the Share Award is granted. Notwithstanding the foregoing, an Option or SAR may be granted with an
exercise or strike price lower than one hundred percent (100%) of the Fair Value of the Ordinary Shares subject to the Share Award to a US Participant if such Share Award is granted pursuant to an assumption of or substitution for another
option or share appreciation right pursuant to a Corporate Transaction and in a manner consistent with the provisions of Section 409A of the Code and other applicable law. Each SAR will be denominated in Ordinary Share equivalents. The exercise
or strike price of each Option or SAR granted to a Participant that is not a U.S. Participant shall be determined by the Board and shall comply with applicable laws. In addition, no Option or SAR may be granted with an exercise or strike price lower
than the par value of the Ordinary Shares, if any. 
 (c) Exercise and Payment of a SAR. To exercise any outstanding SAR, the
Participant must provide written notice of exercise to the Company in compliance with the provisions of the Share Award Agreement evidencing such SAR. The appreciation distribution payable on the exercise of a SAR will be not greater than an amount
equal to the excess of (A) the aggregate Fair Value (on the date of the exercise of the SAR) of a number of Ordinary Shares equal to the number of Ordinary Shares equivalents in which the Participant is vested under such SAR, and with respect
to which the Participant is exercising the SAR on such date, over (B) the aggregate strike price of the number of Ordinary Shares equivalents with respect to which the Participant is exercising the SAR on such date. The appreciation
distribution may be paid in Ordinary Shares, in cash, in any combination of the two or in any other form of consideration, as determined by the Board and contained in the Share Award Agreement evidencing such SAR. 

(d) Permitted Methods of Payment for the Purchase Price of Ordinary Shares. The purchase price of Ordinary Shares acquired pursuant to
the exercise of an Option may be paid, to the extent permitted by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of payment set forth below. Any Ordinary Shares that are not fully paid will be
subject to the forfeiture provisions in the Company’s memorandum and articles of association (as amended from time to time). The Board will have the authority to grant Options that do not permit all of the following methods of payment (or
otherwise restrict the ability to use certain methods) and to grant Options that require the consent of the Company to use a particular method of payment. The permitted methods of payment are as follows: 

(i) by cash, check, bank draft or money order payable to the Company; 

  
 5. 

 (ii) pursuant to a program (developed under Regulation T as promulgated by the U.S.
Federal Reserve Board or similar regulations in other applicable jurisdictions, if required for compliance with the laws of the relevant jurisdiction) that, prior to the issuance of the share subject to the Option results in either the receipt of
cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds; 

(iii) by delivery to the Company (either by actual delivery or attestation) of Ordinary Shares; 

(iv) if an Option is a Nonstatutory Share Option, by a “net exercise” arrangement pursuant to which the Company will reduce
the number of Ordinary Shares issuable upon exercise by the largest whole number of shares with a Fair Value that does not exceed the aggregate exercise price; provided, however, that the Company will accept a cash or other payment from the
Participant to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares to be issued. Ordinary Shares will no longer be subject to an Option and will not be exercisable
thereafter to the extent that (A) shares issuable upon exercise are used to pay the exercise price pursuant to the “net exercise,” (B) shares are delivered to the Participant as a result of such exercise, and (C) shares are
withheld to satisfy tax withholding obligations; 
 (v) according to a deferred payment or similar arrangement with the Optionholder;
provided, however, that interest will compound at least annually and will be charged at the minimum rate of interest necessary to avoid (A) the imputation of interest income to the Company and compensation income to the Optionholder
under any applicable provisions of the Code, and (B) the classification of the Option as a liability for financial accounting purposes; or 

(vi) in any other form of legal consideration that may be acceptable to the Board and specified in the applicable Share Award
Agreement. 
 (e) Transferability of Options and SARs. The Board may, in its sole discretion, impose such limitations on the
transferability of Options and SARs as the Board will determine. In the absence of such a determination by the Board to the contrary, the following restrictions on the transferability of Options and SARs will apply: 

(i) Restrictions on Transfer. An Option or SAR will not be transferable except by will or by the laws of descent and distribution (and
pursuant to subsections (ii) and (iii) below), and will be exercisable during the lifetime of the Participant only by the Participant. The Board may permit transfer of the Option or SAR in a manner that is not prohibited by applicable tax
and securities laws. Except as explicitly provided herein, neither an Option nor a SAR may be transferred for consideration. 
 (ii)
Domestic Relations Orders. Subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or
separation instrument as permitted by Treasury Regulation 1.421-1(b)(2) or regulations in other applicable jurisdictions. 

  
 6. 

 (iii) Beneficiary Designation. Subject to the approval of the Board or a duly
authorized Officer, a Participant may, by delivering written notice to the Company, in a form approved by the Company (or the designated broker), designate a third party who, upon the death of the Participant, will thereafter be entitled to exercise
the Option or SAR and receive the Ordinary Shares or other consideration resulting from such exercise. In the absence of such a designation, upon the death of the Participant, the executor or administrator of the Participant’s estate will be
entitled to exercise the Option or SAR and receive the Ordinary Shares or other consideration resulting from such exercise. However, the Company may prohibit designation of a beneficiary at any time, including due to any conclusion by the Company
that such designation would be inconsistent with the provisions of applicable laws. 
 (f) Vesting Generally. The total number of
Ordinary Shares subject to an Option or SAR vest and become exercisable in periodic installments. Specifically, twenty-five percent (25%) of the shares vest on the first anniversary of the Vesting Commencement Date, with the remaining
seventy-five percent (75%) of the shares to vest annually thereafter in three (3) years with equal annual installments, provided that the Participant continues to provide Continuous Services to the Company as of any such vesting date. In
situation that the Participant receives the Option or SAR through Special Grant Notice, the total number of Ordinary Shares subject to an Option vest and become exercisable on the first anniversary of the Vesting Commencement Date. The provisions of
this Section 5(f) are subject to any Option or SAR provisions governing the minimum number of Ordinary Shares as to which an Option or SAR may be exercised. 

(g) Termination of Continuous Service. Except as otherwise provided in the applicable Share Award Agreement or other agreement between
the Participant and the Company, if a Participant’s Continuous Service terminates (other than for Cause and other than upon the Participant’s death or Disability), the Participant may inform the Company of the intention to exercise his or
her Option or SAR (to the extent that the Participant was entitled to exercise such Share Award as of the date of termination of Continuous Service) within the period of time ending on the earlier of (i) the date three (3) months following
the termination of the Participant’s Continuous Service (or such longer or shorter period specified in the applicable Share Award Agreement, which period will not be less than thirty (30) days if necessary to comply with applicable laws
unless such termination is for Cause) and (ii) the expiration of the term of the Option or SAR as set forth in the Share Award Agreement. If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR
within the applicable time frame, the Option or SAR (as applicable) will terminate. The unvested Option or SAR will revert to and again become available for issuance under plan after termination of Continuous Service. 

(h) Extension of Termination Date. Except as otherwise provided in the applicable Share Award Agreement or other agreement between the
Participant and the Company, if the exercise of an Option or SAR following the termination of the Participant’s Continuous Service (other than for Cause and other than upon the Participant’s death or Disability) would be prohibited at any
time solely because the issuance of Ordinary Shares would violate the registration requirements under the Securities Act, then the Option or SAR will terminate on the earlier of (i) the expiration of a total period of time (that need not be
consecutive) equal to the applicable post termination exercise period after the termination of the Participant’s Continuous Service during which the exercise of the Option or SAR would not be in violation of such registration requirements, or
(ii) the expiration of the term of the Option or SAR as set forth in the applicable Share Award Agreement. In addition, unless otherwise provided in a Participant’s Share Award Agreement, if the sale of any Ordinary Shares received upon
exercise of an Option or SAR following the termination of the Participant’s Continuous Service (other than for Cause) would violate the Company’s insider trading policy, then the Option or SAR will terminate on the earlier of (i) the
expiration of a period of time (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant’s Continuous Service during which the sale of the Ordinary Shares received upon
exercise of the Option or SAR would not be in violation of the Company’s insider trading policy, or (ii) the expiration of the term of the Option or SAR as set forth in the applicable Share Award Agreement. 

  
 7. 

 (i) Disability of Participant. Except as otherwise provided in the applicable Share
Award Agreement or other agreement between the Participant and the Company, if a Participant’s Continuous Service terminates as a result of the Participant’s Disability, the Participant may inform the Company of the intention to exercise
his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i) the date twelve
(12) months following such termination of Continuous Service (or such longer or shorter period specified in the Share Award Agreement, which period will not be less than six (6) months if necessary to comply with applicable laws), and
(ii) the expiration of the term of the Option or SAR as set forth in the Share Award Agreement. If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR within the applicable time frame, the Option
or SAR (as applicable) will terminate. The unvested Option or SAR will revert to and again become available for issuance under plan after termination of Continuous Service. 

(j) Death of Participant. Except as otherwise provided in the applicable Share Award Agreement or other agreement between the
Participant and the Company, if (i) a Participant’s Continuous Service terminates as a result of the Participant’s death, or (ii) the Participant dies within the period (if any) specified in the Share Award Agreement for
exercisability after the termination of the Participant’s Continuous Service (for a reason other than death), then the Option or SAR may be exercised (to the extent the Participant was entitled to exercise such Option or SAR as of the date of
death) by the Participant’s estate, by a person who acquired the right to exercise the Option or SAR by bequest or inheritance or by a person designated to exercise the Option or SAR upon the Participant’s death, but only within the period
ending on the earlier of (i) the date eighteen (18) months following the date of death (or such longer or shorter period specified in the Share Award Agreement, which period will not be less than six (6) months if necessary to comply
with applicable laws), and (ii) the expiration of the term of such Option or SAR as set forth in the Share Award Agreement. If, after the Participant’s death, the Option or SAR is not exercised within the applicable time frame, the Option
or SAR (as applicable) will terminate. The unvested Option or SAR will revert to and again become available for issuance under plan after the Participant’s death. 

(k) Termination for Cause. Except as explicitly provided otherwise in a Participant’s Share Award Agreement or other individual
written agreement between the Company or any Affiliate and the Participant, if a Participant’s Continuous Service is terminated for Cause, the Option (both vested and unvested) or SAR will terminate immediately upon such Participant’s
termination of Continuous Service, and the Participant will be prohibited from exercising his or her Option or SAR from and after the time of such termination of Continuous Service. 

  
 8. 

 (l) Early Exercise of Options. An Option may, but need not, include a provision
whereby the Optionholder may elect at any time before the Optionholder’s Continuous Service terminates to exercise the Option as to any part or all of the Ordinary Shares subject to the Option prior to the full vesting of the Option. 

(m) Right of Repurchase. The Company may elect to repurchase all or any part of the unvested options, vested options, and/or vested
Ordinary Shares acquired by the Participant pursuant to the Plan. 
 (i) Repurchase of Unvested Options. The Company is authorized to
repurchase all or a portion of the options acquired by the Participant through the special grant notice, pursuant to which the Participant whose Continuous Service has been terminated (other than for cause) within one (1) year of the option
grant would be subject to the Company’s repurchase right with respect to the said options. The repurchase price is the same as the grant price which is determined by the Board. 

(ii) Repurchase of Vested Options. The Company is authorized to elect to repurchase, within the three months after the
Participant’s termination of his or her Continuous Service (other than for cause), all or a portion of the Participant’s granted options that have vested pursuant to the Plan during a period of up to two years prior to the
Participant’s termination. The repurchase price is determined by the Board. 
 (iii) Repurchase of Shares. The Option or SAR may
include a provision whereby the Company may elect to repurchase all or any part of the vested Ordinary Shares acquired by the Participant pursuant to the exercise of the Option or SAR. The Option or SAR may include a provision whereby the Company
may elect to exercise a right of first refusal following receipt of notice from the Participant of the intent to transfer all or any part of the Ordinary Shares received upon the exercise of the Option or SAR. The terms of any repurchase right or
right of first refusal will be specified in the Share Award Agreement. The repurchase price for vested Ordinary Shares will be the Fair Value of the Ordinary Shares on the date of repurchase. 

6. PROVISIONS OF SHARE AWARDS OTHER THAN OPTIONS
AND SARS. 
 (a) Restricted Share Awards. Each Restricted Share Award Agreement will be in such
form and will contain such terms and conditions as the Board deems appropriate. To the extent consistent with the Company’s memorandum and articles of association (as amended from time to time) and other constitutional and governance documents,
at the Board’s election, Ordinary Shares underlying a Restricted Share Award may be held in book entry form subject to the Company’s instructions until any restrictions relating to the Restricted Share Award lapse; and may be evidenced by
a certificate, which certificate will be held in such form and manner as determined by the Board. The terms and conditions of Restricted Share Award Agreements may change from time to time, and the terms and conditions of separate Restricted Share
Award Agreements need not be identical. Each Restricted Share Award Agreement will conform to (through incorporation of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions: 

  
 9. 

 (i) Consideration. A Restricted Share Award may be awarded in consideration for
(A) cash, check, bank draft or money order payable to the Company, (B) past services to the Company or an Affiliate, or (C) any other form of legal consideration (including future services) that may be acceptable to the Board, in its
sole discretion, and permissible under applicable law. 
 (ii) Vesting. Subject to the “Right of Repurchase” in
Section 5(m), Ordinary Shares awarded under the Restricted Share Award Agreement may be subject to forfeiture to the Company in accordance with a vesting schedule to be determined by the Board. 

(iii) Termination of Participant’s Continuous Service. If a Participant’s Continuous Service terminates, the Company may
receive through a forfeiture condition or a repurchase right, any or all of the Ordinary Shares held by the Participant as of the date of termination of Continuous Service under the terms of the Restricted Share Award Agreement. 

(iv) Transferability. Rights to acquire Ordinary Shares under the Restricted Share Award Agreement will be transferable by the
Participant only upon such terms and conditions as are set forth in the Restricted Share Award Agreement, as the Board will determine in its sole discretion, so long as Ordinary Shares awarded under the Restricted Share Award Agreement remains
subject to the terms of the Restricted Share Award Agreement. 
 (v) Dividends. A Restricted Share Award Agreement may provide that
any dividends paid on Restricted Shares will be subject to the same vesting and forfeiture restrictions as apply to the shares subject to the Restricted Share Award to which they relate. 

(b) Restricted Share Unit Awards. Each Restricted Share Unit Award Agreement will be in such form and will contain such terms and
conditions as the Board deems appropriate. The terms and conditions of Restricted Share Unit Award Agreements may change from time to time, and the terms and conditions of separate Restricted Share Unit Award Agreements need not be identical. Each
Restricted Share Unit Award Agreement will conform to (through incorporation of the provisions hereof by reference in the Agreement or otherwise) the substance of each of the following provisions: 

(i) Consideration. At the time of grant of a Restricted Share Unit Award, the Board will determine the consideration, if any, to be
paid by the Participant upon delivery of each Ordinary Share subject to the Restricted Share Unit Award. The consideration to be paid (if any) by the Participant for each Ordinary Share subject to a Restricted Share Unit Award may be paid in any
form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law. 
 (ii)
Vesting. At the time of the grant of a Restricted Share Unit Award, the Board may impose such restrictions on or conditions to the vesting of the Restricted Share Unit Award as it, in its sole discretion, deems appropriate. 

  
 10. 

 (iii) Payment. A Restricted Share Unit Award may be settled by the delivery of
Ordinary Shares, their cash equivalent, any combination thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Share Unit Award Agreement. 

(iv) Additional Restrictions. At the time of the grant of a Restricted Share Unit Award, the Board, as it deems appropriate, may impose
such restrictions or conditions that delay the delivery of the Ordinary Shares (or their cash equivalent) subject to a Restricted Share Unit Award to a time after the vesting of such Restricted Share Unit Award. 

(v) Dividend Equivalents. Dividend equivalents may be credited in respect of Ordinary Shares covered by a Restricted Share Unit Award,
as determined by the Board and contained in the Restricted Share Unit Award Agreement. At the sole discretion of the Board, such dividend equivalents may be converted into additional Ordinary Shares covered by the Restricted Share Unit Award in such
manner as determined by the Board. Any additional shares covered by the Restricted Share Unit Award credited by reason of such dividend equivalents will be subject to all of the same terms and conditions of the underlying Restricted Share Unit Award
Agreement to which they relate. 
 (vi) Termination of Participant’s Continuous Service. Except as otherwise provided in the
applicable Restricted Share Unit Award Agreement, such portion of the Restricted Share Unit Award that has not vested will be forfeited upon the Participant’s termination of Continuous Service. 

(c) Other Share Awards. Other forms of Share Awards valued in whole or in part by reference to, or otherwise based on, Ordinary Shares,
including the appreciation in value thereof (e.g., options or share rights with an exercise price or strike price less than one hundred percent (100%) of the Fair Value of the Ordinary Shares at the time of grant) may be granted either alone or
in addition to Share Awards provided for under Section 5 and the preceding provisions of this Section 6. Subject to the provisions of the Plan, the Board will have sole and complete authority to determine the persons to whom and the time
or times at which such Other Share Awards will be granted, the number of Ordinary Shares (or the cash equivalent thereof) to be granted pursuant to such Other Share Awards and all other terms and conditions of such Other Share Awards. 

7. COVENANTS OF THE COMPANY. 

(a) Availability of Shares. The Company will keep available at all times the number of Ordinary Shares reasonably required to satisfy then-outstanding Share Awards. 
 (b) Securities Law Compliance. The Company will use commercially
reasonable efforts to seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as may be required to grant Share Awards and to issue and sell Ordinary Shares upon exercise of the Share Awards;
provided, however, that this undertaking will not require the Company to register the Plan, any Share Award or any Ordinary Shares issued or issuable pursuant to any such Share Award under the Securities Act or other applicable securities
regulatory scheme. If, after reasonable efforts and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary for the lawful issuance and sale of
Ordinary Shares under the Plan, the Company will be relieved from any liability for failure to issue and sell Ordinary Shares upon exercise of such Share Awards unless and until such authority is obtained. A Participant will not be eligible for the
grant of a Share Award or the subsequent issuance of cash or Ordinary Shares pursuant to the Share Award if such grant or issuance would be in violation of any applicable securities law or any other applicable law or regulation. 

  
 11. 

 (c) No Obligation to Notify or Minimize Taxes. The Company will have no duty or
obligation to any Participant to advise such holder as to the time or manner of exercising such Share Award. Furthermore, the Company will have no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of a
Share Award or a possible period in which the Share Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of a Share Award to the holder of such Share Award. 

8. MISCELLANEOUS. 
 (a)
Use of Proceeds from Sales of Ordinary Share. Proceeds from the sale of Ordinary Shares pursuant to Share Awards will constitute general funds of the Company. 

(b) Corporate Action Constituting Grant of Share Awards. Corporate action constituting a grant by the Company of a Share Award to any
Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Share Award is communicated to, or actually received or
accepted by, the Participant. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (e.g., exercise price, vesting schedule or number of shares)
that are inconsistent with those in the Share Award Agreement as a result of a clerical error in the papering of the Share Award Agreement, the corporate records will control and the Participant will have no legally binding right to the incorrect
term in the Share Award Agreement. 
 (c) Shareholder Rights. No Participant will be deemed to be the holder of, or to have any of
the rights of a holder with respect to, any Ordinary Shares subject to a Share Award unless and until (i) such Participant has satisfied all requirements for exercise of, or the issuance of Ordinary Shares under, the Share Award pursuant to its
terms, and (ii) the issuance of the Ordinary Shares subject to the Share Award has been entered into the books and records of the Company and the register of members of the Company has been accordingly updated. 

(d) No Employment or Other Service Rights. Nothing in the Plan, any Share Award Agreement or any other instrument executed thereunder
or in connection with any Share Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Share Award was granted or will affect the right of
the Company or an Affiliate to terminate (i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant to the terms of such Consultant’s agreement with the Company or an
Affiliate, or (iii) the service of a Director pursuant to the Company’s memorandum and articles of association (as amended from time to time) and other constitutional and governance documents of the Company or an Affiliate, and any
provisions of the applicable laws of the jurisdiction in which the Company or the Affiliate is incorporated, as the case may be. 

  
 12. 

 (e) Investment Assurances. The Company may require a Participant, as a condition of
exercising or acquiring Ordinary Shares under any Share Award, (i) to give written assurances satisfactory to the Company as to the Participant’s knowledge and experience in financial and business matters and/or to employ a purchaser
representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial and business matters and that he or she is capable of evaluating, alone or together with the purchaser representative, the merits and risks of
exercising the Share Award; and (ii) to give written assurances satisfactory to the Company stating that the Participant is acquiring Ordinary Shares subject to the Share Award for the Participant’s own account and not with any present
intention of selling or otherwise distributing the Ordinary Shares. The foregoing requirements, and any assurances given pursuant to such requirements, will be inoperative if (A) the issuance of the shares upon the exercise or acquisition of
Ordinary Shares under the Share Award has been registered under a then currently effective registration statement under the Securities Act, or (B) as to any particular requirement, a determination is made by counsel for the Company that such
requirement need not be met in the circumstances under the then applicable securities laws or other applicable laws. The Company may, upon advice of counsel to the Company, place legends on share certificates issued under the Plan as such counsel
deems necessary or appropriate in order to comply with applicable securities laws or other applicable laws, including, but not limited to, legends restricting the transfer of the Ordinary Shares. 

(f) Withholding Obligations. Unless prohibited by the terms of a Share Award Agreement, the Company may, in its sole discretion,
satisfy any tax withholding obligation relating to a Share Award by any of the following means or by a combination of such means: (i) causing the Participant to tender a cash payment; (ii) withholding Ordinary Shares from the Ordinary
Shares issued or otherwise issuable to the Participant in connection with the Share Award; provided, however, that no Ordinary Shares are withheld with a value exceeding the minimum amount of tax required to be withheld by law (or such lesser
amount as may be necessary to avoid classification of the Share Award as a liability for financial accounting purposes); (iii) withholding cash from a Share Award settled in cash; (iv) withholding payment from any amounts otherwise payable
to the Participant; or (v) which may be set forth in the Share Award Agreement. 
 (g) Electronic Delivery. Any reference herein
to a “written” agreement or document will include any agreement or document delivered electronically or posted on the Company’s intranet (or other shared electronic medium controlled by the Company to which the Participant has
access). 
 (h) Deferrals. To the extent permitted by applicable law, the Board, in its sole discretion, may determine that the
delivery of Ordinary Shares or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Share Award may be deferred and may establish programs and procedures for deferral elections to be made by Participants. The
Board is authorized to make deferrals of Share Awards and determine when, and in what annual percentages, Participants may receive payments, including lump sum payments, following the Participant’s termination of Continuous Service, and
implement such other terms and conditions consistent with the provisions of the Plan and in accordance with applicable law. 

  
 13. 

 9. ADJUSTMENTS UPON CHANGES IN
ORDINARY SHARE; OTHER CORPORATE EVENTS. 
 (a)
Capitalization Adjustments. In the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust: (i) the class(es) and maximum number of securities subject to the Plan pursuant to
Section 3(a), (ii) the class(es) and maximum number of securities that may be issued pursuant to the exercise of Incentive Share Options pursuant to Section 11(a)(i), and (iii) the class(es) and number of securities and
price per share of shares subject to outstanding Share Awards. The Board will make such adjustments, and its determination will be final, binding and conclusive. 

(b) Dissolution or Liquidation. Except as otherwise provided in the Share Award Agreement, in the event of a dissolution or liquidation
of the Company, all outstanding Share Awards (other than Share Awards consisting of vested and outstanding Ordinary Shares not subject to a forfeiture condition or the Company’s right of repurchase) will terminate immediately prior to the
completion of such dissolution or liquidation, and the Ordinary Shares subject to the Company’s repurchase rights or subject to a forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of
such Share Award is providing Continuous Service, provided, however, that the Board may, in its sole discretion, cause some or all Share Awards to become fully vested, exercisable and/or no longer subject to repurchase or forfeiture (to the
extent such Share Awards have not previously expired or terminated) before the dissolution or liquidation is completed but contingent on its completion. 

(c) Corporate Transactions. The following provisions will apply to Share Awards in the event of a Transaction unless otherwise provided
in the Share Award Agreement or any other written agreement between the Company or any Affiliate and the Participant or unless otherwise expressly provided by the Board at the time of grant of a Share Award. In the event of a Transaction, then,
notwithstanding any other provision of the Plan, the Board may take one or more of the following actions with respect to Share Awards, contingent upon the closing or completion of the Transaction: 

(i) arrange for the surviving corporation or acquiring corporation (or the surviving or acquiring corporation’s parent company) to
assume or continue the Share Award or to substitute a similar share award for the Share Award (including, but not limited to, an award to acquire the same consideration paid to the shareholders of the Company pursuant to the Transaction); 

(ii) arrange for the assignment of any reacquisition or repurchase rights held by the Company in respect of Ordinary Shares issued
pursuant to the Share Award to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation’s parent company); 

(iii) accelerate the vesting, in whole or in part, of the Share Award (and, if applicable, the time at which the Share Award may be
exercised) to a date prior to the effective time of such Transaction as the Board determines (or, if the Board does not determine such a date, to the date that is five (5) days prior to the effective date of the Transaction), with such Share
Award terminating if not exercised (if applicable) at or prior to the effective time of the Transaction; provided, however, that the Board may require Participants to complete and deliver to the Company a notice of exercise before the effective date
of a Transaction, which exercise is contingent upon the effectiveness of such Transaction; 

  
 14. 

 (iv) arrange for the lapse, in whole or in part, of any reacquisition or repurchase
rights held by the Company with respect to the Share Award; 
 (v) cancel or arrange for the cancellation of the Share Award, to the
extent not vested or not exercised prior to the effective time of the Transaction, in exchange for such cash consideration, if any, as the Board, in its sole discretion, may consider appropriate; and 

(vi) make a payment, in such form as may be determined by the Board equal to the excess, if any, of (A) the value of the property
the Participant would have received upon the exercise of the Share Award immediately prior to the effective time of the Transaction, over (B) any exercise price payable by such holder in connection with such exercise. For clarity, this payment
may be zero ($0) if the value of the property is equal to or less than the exercise price. Payments under this provision may be delayed to the same extent that payment of consideration to the holders of the Company’s Ordinary Shares in
connection with the Transaction is delayed as a result of escrows, earn outs, holdbacks or any other contingencies. 
 The Board need not take the same
action or actions with respect to all Share Awards or portions thereof or with respect to all Participants. The Board may take different actions with respect to the vested and unvested portions of a Share Award. 

(d) Change in Control. A Share Award may be subject to additional acceleration of vesting and exercisability upon or after a Change in
Control as may be provided in the Share Award Agreement for such Share Award or as may be provided in any other written agreement between the Company or any Affiliate and the Participant, but in the absence of such provision, no such acceleration
will occur. 
 10. PLAN TERM; EARLIER TERMINATION OR SUSPENSION
OF THE PLAN. 
 (a) Plan Term. The Board may suspend or terminate the Plan at any
time. Unless terminated sooner by the Board, the Plan will automatically terminate on the day before the tenth (10th) anniversary of the earlier of (i) the date the Plan is adopted by the Board, or (ii) the date the Plan is approved
by the shareholders of the Company. No Share Awards may be granted under the Plan while the Plan is suspended or after it is terminated. 

(b) No Impairment of Rights. Suspension or termination of the Plan will not impair rights and obligations under any Share Award granted
while the Plan is in effect except with the written consent of the affected Participant or as otherwise permitted in the Plan. 

  
 15. 

 11. ADDITIONAL PROVISIONS APPLICABLE TO US
PARTICIPANTS. 
 (a) Incentive Share Options. 

(i) Subject to Section 9(a) relating to Capitalization Adjustments, the aggregate maximum number of Ordinary Shares that may be
issued pursuant to the exercise of Incentive Share Options will be the Share Reserve. 
 (ii) Incentive Share Options may be granted
only to employees of the Company or a “parent corporation” or “subsidiary corporation” thereof (as such terms are defined in Sections 424(e) and (f) of the Code). 

(iii) A Ten Percent Shareholder shall not be granted an Incentive Share Option unless the exercise price of such Option is at least one
hundred ten percent (110%) of the Fair Value on the date of grant and the Option is not exercisable after the expiration of five (5) years from the date of grant or such shorter period specified in the Share Award Agreement.
“Ten Percent Shareholder” means a person who Owns (or is deemed to Own pursuant to Section 424(d) of the Code) shares possessing more than ten percent (10%) of the total combined voting power of all classes of
shares of the Company or any Affiliate. 
 (iv) To the extent that the aggregate Fair Value (determined at the time of grant) of
Ordinary Shares with respect to which Incentive Share Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and any Affiliates) exceeds one hundred thousand dollars ($100,000) (or
such other limit established in the Code) or otherwise does not comply with the rules governing Incentive Share Options, the Options or portions thereof that exceed such limit (according to the order in which they were granted) or otherwise do not
comply with such rules will be treated as Nonstatutory Share Options, notwithstanding any contrary provision of the applicable Option Agreement(s). 

(b) Compliance with Section 409A of the Code. To the extent that the Board determines that any Share Award granted hereunder is
subject to Section 409A of the Code, the Share Award Agreement evidencing such Share Award shall incorporate the terms and conditions necessary to avoid the consequences specified in Section 409A(a)(1) of the Code. To the extent
applicable, the Plan and Share Award Agreements shall be interpreted in accordance with Section 409A of the Code. 
 12. CHOICE
OF LAW; ARBITRATION. 
 (a) Governing Law. The laws of the State of California, the
United States of America will govern all questions concerning the construction, validity and interpretation of this Plan, without regard to that state’s conflict of laws rules. 

(b) Dispute Resolution. All and any of the disputes arising from and in connection with this Agreement shall be referred to Hong Kong
International Arbitration Center (“HKIAC”) for binding arbitration in Hong Kong by a sole arbitrator in accordance with the rules then in effect of the HKIAC. The parties shall jointly select the sole arbitrator. If the parties fail to
reach an agreement on the arbitrator, such an arbitrator shall be appointed by the Secretary-General of HKIAC. The decision of the arbitrator shall be final, conclusive and binding on the parties to the arbitration. Judgment may be entered on the
arbitrator’s decision in any competent court having jurisdiction. The parties to the arbitration shall each pay an equal share of the costs and expenses of such arbitration, and each party shall separately pay for its respective counsel fees
and expenses, provided, however, that the prevailing party in any such arbitration shall be entitled to recover from the non prevailing party its reasonable costs and attorney fees. 

  
 16. 

 13. DEFINITIONS. As used in the Plan, the following definitions will apply to the
capitalized terms indicated below: 
 (a) “Affiliate” means, at the time of determination, any Subsidiary and
any “parent corporation” or “subsidiary corporation” of the Company, as such terms are defined in Sections 424(e) and (f) of the Code. The Board will have the authority to determine the time or times at which “parent
corporation” or “subsidiary corporation” status is determined within the foregoing definition. 
 (b)
“Board” means the Board of Directors of the Company. 
 (c) “Capitalization
Adjustment” means any change that is made in, or other events that occur with respect to, the Ordinary Shares subject to the Plan or subject to any Share Award after the Effective Date without the receipt of consideration by the Company
through merger, consolidation, reorganization, recapitalization, reincorporation, share dividend, dividend in property other than cash, large nonrecurring cash dividend, share split, reverse share split, liquidating dividend, combination of shares,
exchange of shares, change in corporate structure, or any similar equity restructuring transaction. Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment. 

(d) “Cause” will have the meaning ascribed to such term in any written agreement between the Participant and
the Company defining such term and, in the absence of such agreement, such term means, with respect to a Participant, the occurrence of any of the following events: (i) such Participant’s commission of any felony or any crime involving
fraud, dishonesty or moral turpitude under the laws of the applicable jurisdiction; (ii) such Participant’s attempted commission of, or participation in, a fraud or act of dishonesty against the Company; (iii) such Participant’s
intentional, material violation of any contract or agreement between the Participant and the Company or of any statutory duty owed to the Company; (iv) such Participant’s unauthorized use or disclosure of the Company’s confidential
information or trade secrets; or (v) such Participant’s gross misconduct. The determination that a termination of the Participant’s Continuous Service is either for Cause or without Cause will be made by the Company, in its sole
discretion. Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Share Awards held by such Participant will have no effect upon any determination of the
rights or obligations of the Company or such Participant for any other purpose. 
 (e) “Change in Control”
means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events: 
 (i)
there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the shareholders of the Company
immediately prior thereto do not Own, directly or indirectly, either (A) outstanding voting securities representing more than fifty percent (50%) of the combined outstanding voting power of the surviving Entity in such merger,
consolidation or similar transaction or (B) more than fifty percent (50%) of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially
the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction; 

  
 17. 

 (ii) the shareholders of the Company approve or the Board approves a plan of complete
dissolution or liquidation of the Company, or a complete dissolution or liquidation of the Company will otherwise occur, except for a liquidation into a parent corporation; or 

(iii) there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets
of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, more than fifty percent (50%) of the combined
voting power of the voting securities of which are Owned by shareholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or
other disposition. 
 Notwithstanding the foregoing definition or any other provision of this Plan, (A) the term Change in Control will not include a
sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company or the initial public offering of the Company, and (B) the definition of Change in Control (or any analogous term) in an
individual written agreement between the Company or any Affiliate and the Participant will supersede the foregoing definition with respect to Share Awards subject to such agreement; provided, however, that if no definition of Change in
Control or any analogous term is set forth in such an individual written agreement, the foregoing definition will apply. 
 (f)
“Code” means the US Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder. 

(g) “Committee” means a committee of one (1) or more Directors to whom authority has been delegated by the
Board in accordance with Section 2(c). 
 (h) “Company” means Exacloud Limited, a Cayman Islands company
with limited liability. 
 (i) “Consultant” means any person, including an advisor, who is (i) engaged
by the Company or an Affiliate to render consulting or advisory services and is compensated for such services, or (ii) serving as a member of the board of directors of an Affiliate and is compensated for such services. However, service solely
as a Director, or payment of a fee for such service, will not cause a Director to be considered a “Consultant” for purposes of the Plan. 

  
 18. 

 (j) “Continuous Service” means that the Participant’s
service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Director or
Consultant or a change in the Entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant’s service with the Company or an Affiliate, will not terminate a Participant’s
Continuous Service; provided, however, that if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board in its sole discretion, such Participant’s Continuous Service will be
considered to have terminated on the date such Entity ceases to qualify as an Affiliate. For example, a change in status from an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of
Continuous Service. To the extent permitted by law, the Board or the chief executive officer of the Company, in that party’s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i) any
leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii) transfers between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a
leave of absence will be treated as Continuous Service for purposes of vesting in a Share Award only to such extent as may be provided in the Company’s leave of absence policy, in the written terms of any leave of absence agreement or policy
applicable to the Participant, or as otherwise required by law. 
 (k) “Corporate Transaction” means the
consummation, in a single transaction or in a series of related transactions, of any one or more of the following events: 
 (i) a
sale or other disposition of all or substantially all, as determined by the Board in its sole discretion, of the consolidated assets of the Company and its Subsidiaries; 

(ii) a sale or other disposition of at least ninety percent (90%) of the outstanding securities of the Company; 

(iii) a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or 

(iv) a merger, consolidation or similar transaction following which the Company is the surviving corporation but the Ordinary Shares
outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.

 (l) “Director” means a member of the Board. 

(m) “Disability” means, with respect to a Participant, the inability of such Participant to engage in any
substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than twelve
(12) months, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances. 

(n) “Effective Date” means the effective date of this Plan, which is the earlier of (i) the date that this
Plan is first approved by the Company’s shareholders, and (ii) the date this Plan is adopted by the Board. 

  
 19. 

 (o) “Employee” means any person employed by the Company or an
Affiliate. However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an “Employee” for purposes of the Plan. 

(p) “Entity” means a corporation, partnership, limited liability company or other entity. 

(q) “Exchange Act” means the US Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder. 
 (r) “Fair Value” means, as of any date, the value of the Ordinary Shares
determined by the Board. 
 (s) “Incentive Share Option” means an Option that is intended to be, and that
qualifies as, an “incentive stock option” within the meaning of Section 422 of the Code. 
 (t)
“Nonstatutory Share Option” means any Option that does not qualify as an “incentive stock option” within the meaning of Section 422 of the Code. 

(u) “Officer” means any person designated by the Company as an officer. 

(v) “Option” means an option to purchase Ordinary Shares granted pursuant to the Plan. 

(w) “Option Agreement” means a written agreement between the Company and an Optionholder evidencing the terms
and conditions of an Option grant. Each Option Agreement will be subject to the terms and conditions of the Plan. 
 (x)
“Optionholder” means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option. 

(y) “Ordinary Share” means a Ordinary Share of the Company. 

(z) “Other Share Award” means an award based in whole or in part by reference to the Ordinary Shares which is
granted pursuant to the terms and conditions of Section 6(c). 
 (aa) “Other Share Award Agreement”
means a written agreement between the Company and a holder of an Other Share Award evidencing the terms and conditions of an Other Share Award grant. Each Other Share Award Agreement will be subject to the terms and conditions of the Plan. 

(bb) “Own,” “Owned,” “Owner,”
“Ownership” means a person or Entity will be deemed to “Own,” to have “Owned,” to be the “Owner” of, or to have acquired “Ownership” of securities if such person or Entity,
directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities. 

(cc) “Participant” means a person to whom a Share Award is granted pursuant to the Plan or, if applicable, such
other person who holds an outstanding Share Award. 

  
 20. 

 (dd) “Plan” means this Exacloud Limited, 2017 Restated Equity
Incentive Plan. 
 (ee) “Restricted Share Award” means an award of Ordinary Shares which is granted pursuant
to the terms and conditions of Section 6(a). 
 (ff) “Restricted Share Award Agreement” means a written
agreement between the Company and a holder of a Restricted Share Award evidencing the terms and conditions of a Restricted Share Award grant. Each Restricted Share Award Agreement will be subject to the terms and conditions of the Plan. 

(gg) “Restricted Share Unit Award” means a right to receive Ordinary Shares which is granted pursuant to the
terms and conditions of Section 6(b). 
 (hh) “Restricted Share Unit Award Agreement” means a written
agreement between the Company and a holder of a Restricted Share Unit Award evidencing the terms and conditions of a Restricted Share Unit Award grant. Each Restricted Share Unit Award Agreement will be subject to the terms and conditions of the
Plan. 
 (ii) “Rule 405” means Rule 405 promulgated under the Securities Act. 

(jj) “Rule 701” means Rule 701 promulgated under the Securities Act. 

(kk) “Securities Act” means the US Securities Act of 1933, as amended. 

(ll) “Share Appreciation Right” or “SAR” means a right to receive the appreciation on
Ordinary Shares that is granted pursuant to the terms and conditions of Section 5. 
 (mm) “Share Appreciation Right
Agreement” means a written agreement between the Company and a holder of a Share Appreciation Right evidencing the terms and conditions of a Share Appreciation Right grant. Each Share Appreciation Right Agreement will be subject to the
terms and conditions of the Plan. 
 (nn) “Share Award” means any right to receive Ordinary Shares granted
under the Plan, including an Option, a Restricted Share Award, a Restricted Share Unit Award, a Share Appreciation Right or any Other Share Award. 

(oo) “Share Award Agreement” means a written agreement between the Company and a Participant evidencing the
terms and conditions of a Share Award grant. Each Share Award Agreement will be subject to the terms and conditions of the Plan. 
 (pp)
“Subsidiary” means, with respect to the Company, (i) any corporation of which more than fifty percent (50%) of the outstanding capital share having ordinary voting power to elect a majority of the board of
directors of such corporation (irrespective of whether, at the time, share of any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly,
Owned by the Company, and (ii) any partnership, limited liability company or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than
fifty percent (50%) . 

  
 21. 

 (qq) Transaction” means a Corporate Transaction or a Change in
Control. 
 (rr) “US” means the United States. 

(ss) “US Participant” means a Participant that is either a US resident or a US taxpayer. 

  
 22.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]